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Abstract 
Currently, there is an increasing interest of cosmetic industry on natural 
extracts. The inclusion of antioxidants in topical formulations can contribute to minimize 
oxidative stress in the skin, which has been associated with aging. Agro-industrial by-
products have the potential to be used with different purposes, providing economical 
advantage to otherwise disposable residues. In particular, the field of skin care 
products and cosmetics may benefit from these remaining materials. Also, questions of 
sustainability are leading to the study of new cosmetic ingredients obtained from food 
by-products. Coffee Silverskin (CS) is the most abundant solid by-product generated 
during coffee roasting. Medicago is a leguminous crop used as animal feeding, 
normally discarded as waste. Thus, this work aims to explore the use of food by-
products extracts as cosmetic active ingredients. 
Hydroalcoholic extracts of seven species of Medicago (M. minima, M. tornata, 
M. truncatula, M. rigidula, M. scutelata, M. segitalis and M. sativa) and aqueous, 
hydroalcoholic and alcoholic extracts of CS were characterized for total phenolic and 
flavonoid contents (TPC and TFC, respectively), antioxidant activity (by 1,1-diphenyl-2-
picrylhydrazyl (DPPH) and ferric reducing antioxidant power (FRAP), antimicrobial 
activity and cytotoxicity in two skin cell lines (fibroblasts and keratinocytes). For both 
antioxidant activity methods CS extracts displayed the highest antioxidant activity. The 
TPC of the different extracts were in the same range, varying from 18 to 36 mg GAE/g 
db sample, being the highest TPC obtained for M. minima. The highest TFC were 
obtained with M. rigidula. All extracts demonstrated a low cytotoxicity. Preliminary 
assays for antimicrobial potential showed that extracts display antibacterial activity, 
particularly CS extracts. Regarding the isoflavones content in Medicago extracts, two 
glycosides (daidzin and genistin) and six aglycones (daidzein, glycitein, genistein, 
formononetin, prunetin and biochanin A) were determined by HPLC/DAD. In all 
samples genistin, daidzein and genistein were the most abundant isoflavone 
compounds.  
An in vitro skin and ocular irritation assay using reconstructed human epidermis, 
EpiSkinTM, and human corneal epithelial model, SkinEthicTM HCE, and an in vivo assay 
were performed for CS extracts. The in vitro results showed that extracts were not 
classified as irritant and the histological analyses proved that extracts did not affect the 
both models structure. The content of caffeine (CAF), 5-hydroxymethyl furfural (HMF) 
and chlorogenic acid (CGA) was quantified after the epidermal assay. The in vivo test 
carried out with the most promising extract (hydroalcoholic) in 20 volunteers proved 
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that extracts can be regarded as safe for topical application. Therefore, different 
formulations with M. sativa and/or CS extract were developed and characterized. 
Formulations showed stable physical properties and antioxidant activity during 180 
days of storage at 25 °C/ 65% relative humidity (RH ) and 40 °C/ 75% RH. In vitro 
toxicity was screened in two skin cell lines (fibroblasts and keratinocytes) and any 
toxicity was reported. A sensorial test was carried out for all formulations and the 
consumer acceptance was very high, with more than 90% of volunteers classifying 
them as very pleasant. An in vivo test carried out showed that, with respect to irritant 
effects, formulations can be regarded as safe for topical application and the skin 
hydratation improved after 30 days of its use.  
A facial formulation with CS and the same cream enriched with hyaluronic acid 
were evaluated in vivo and compared. Formulations were applied twice a day by 
volunteers (n=20 for each formulation) during 28 days. The influence on skin hydration 
and viscoelastic properties were investigated with validated devices (Corneometer® 
and Cutometer®). Wrinkles depth, roughness, volume of cavities and Visioface® images 
were analysed at time 0 and after 28 days. Volunteers were asked about efficacy 
perception. Significant changes in skin hydration and viscoelastic parameters were 
detected for both formulations, without differences between them. However, no 
differences were observed regarding wrinkles depth, roughness and volume of cavities 
for both formulations. CS represents an effective ingredient for cosmetic creams which 
are intended to increase skin hydration and firmness. These natural extracts, which 
toxicology, safety and effectiveness were evaluated in vitro and in vivo according to the 
international guidelines, proved to be promising active ingredients for cosmetics.  It can 
be also concluded that this study highlights the need to explore new food wastes as 
active ingredients to be used on skin care. 
Finally, nanostructured lipid carriers (NLCs) loaded with caffeine obtained from 
CS were developed and evaluated as a new approach. The produced NLCs were 
within the nanosized range (≈200 nm) with relatively low polydispersity index (<0.25) 
and zeta potential values around - 30 mV. NLCs demonstrated storage stability at 25 
°C/ 65% RH and 40 °C/ 75% RH up to 180 days. The as sociation efficiency of caffeine 
was about 30% at time of production and after the storage period. The in vitro skin 
permeation study demonstrated that caffeine loaded into NLCs was similarly 
permeable through skin compared to non encapsulated caffeine. 
 
Key-words: Coffee silverskin; Medicago; Cosmetic; 3-D in vitro models; Skin 
biophysical techniques; In vivo studies 
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Resumo 
Há, atualmente, um interesse crescente da indústria cosmética na utilização de 
extratos naturais. A inclusão de antioxidantes em formulações tópicas contribui para 
minimizar o stresse oxidativo na pele, associado ao envelhecimento cutâneo. Os 
resíduos agroindustriais têm sido estudados como fonte de compostos bioativos para 
diferentes finalidades. Os produtos cosméticos e de higiene corporal (PCHC) podem 
beneficiar destas matérias-primas. Acresce ainda o fato de questões de 
sustentabilidade conduzirem ao estudo de novos ingredientes ativos obtidos a partir de 
produtos sem valor acrescentado. A pele de prata (CS) é um subproduto do café 
gerado durante a torrefação. Por outro lado, o género Medicago é recorrentemente 
utilizado na alimentação animal, sendo o excesso normalmente descartado. Este 
trabalho tem como objetivo avaliar o potencial uso de subprodutos alimentares na 
obtenção de novos ingredientes ativos para PCHC. 
Com efeito, avaliou-se o teor total de polifenóis e flavonóides (TPC e TFC, 
respetivamente), a atividade antioxidante (DPPH e FRAP), a atividade antimicrobiana 
e a citotoxicidade (em fibroblastos e queratinócitos) de extratos hidro-alcoólicos de 
sete espécies de Medicago (M.minima, M. tornata, M. truncatula, M. rigidula, M. 
scutelata, M. segitalis e M. sativa) e de extratos aquosos, hidro-alcoólicos e alcoólicos 
de CS. Constatou-se que os extratos de CS apresentaram uma maior atividade 
antioxidante. O TPC dos diferentes extratos encontra-se na mesma ordem de 
grandeza (18-36 mg amostra GAE/ db g), sendo o mais elevado obtido com o M. 
mínima. O M. rigidula apresentou os valores mais elevados de TFC. Todos os extratos 
mostraram uma reduzida citotoxicidade. Ficou igualmente comprovada a capacidade 
antibacteriana dos extratos, em particular dos extratos de CS. Em relação ao teor de 
isoflavonas, estas foram determinadas por HPLC/DAD nos extratos de Medicago, 
sendo a genistina, daidzeína e genisteína as mais abundantes.  
Avaliou-se igualmente a irritação cutânea e ocular, respetivamente, com um 
modelo de epiderme humana reconstruída, EpiSkinTM, e um modelo de epitélio da 
córnea humana, SkinEthicTM HCE. Efetuou-se também um ensaio in vivo de irritação 
cutânea em 20 voluntários. Os teores de cafeína (CAF), 5-hidroximetil furfural (HMF) e 
ácido clorogénico (CGA) foram quantificados após o ensaio epidérmico. Os resultados 
in vitro permitiram classificar os extratos como não irritantes. A avaliação in vivo 
realizada com o extrato mais promissor (hidroalcoólico) assegurou que este pode ser 
considerado seguro para aplicação tópica. Procedeu-se, assim, ao desenvolvimento e 
caracterização de diferentes formulações de PCHC com M. sativa e/ou extrato de CS. 
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Nenhuma das formulações apresentou toxicidade em fibroblastos ou queratinócitos. 
As formulações demonstraram ser estáveis quer nas propriedades físicas, quer na 
atividade antioxidante, durante 180 dias, quando armazenadas a 25 °C/ 65% de 
humidade relativa (HR) e 40 °C/ 75% HR. A avaliação  sensorial foi realizada para 
todas as formulações e de um modo geral, a aceitação do consumidor foi muito 
elevada, tendo sido classificadas por mais de 90% dos voluntários como muito 
agradáveis. O ensaio in vivo realizado assegurou que as formulações podem ser 
considerados como seguras para aplicação tópica, aumentando a hidratação da pele 
após 30 dias de utilização.  
De seguida, efetuou-se a avaliação e comparação in vivo de um creme de rosto 
com CS e a mesma formulação enriquecida com ácido hialurónico. As formulações 
foram aplicadas de manhã e à noite durante 28 dias por 20 voluntários (para cada 
formulação). A influência sobre a hidratação e as propriedades viscoelásticas da pele 
foram avaliadas recorrendo ao Corneometer® e ao Cutometer®. A profundidade das 
rugas, o volume das cavidades e a rugosidade da pele foram analisadas no tempo 0 e 
após 28 dias. No final realizou-se um questionário de perceção de eficácia. Os 
resultados mostraram diferenças significativas na hidratação da pele e nos parâmetros 
viscoelásticos para ambas as formulações, mas sem diferenças entre elas. No 
entanto, não foram observadas diferenças em relação à profundidade das rugas, 
rugosidade e volume das cavidades para ambas as formulações. A CS surge, deste 
modo, como um novo ingrediente eficaz para aumentar a hidratação e a firmeza da 
pele. A toxicidade, segurança e eficácia destes extratos foram demonstradas de 
acordo com as diretrizes internacionais.  
Por fim, foram igualmente desenvolvidos e caracterizados transportadores 
lipídicos nanoestruturados (NLC) de cafeína obtida a partir de CS. Os NLC produzidos 
estavam dentro da gama nanométrica (≈200 nm), apresentando um baixo índice de 
polidispersão (<0,25) e valores de potencial zeta em torno de -30 mV. Demonstraram 
igualmente estabilidade quando armazenados a 25 °C/  65% HR e 40 °C/ 75% HR 
durante 180 dias. A eficiência de associação da cafeína foi de cerca de 30% 
imediatamente após a produção, tendo-se mantido após o período de 
armazenamento. No entanto, o estudo in vitro de permeação em pele de porco 
demonstrou que a cafeina encapsulada teve uma permeação semelhante à cafeína no 
extrato de CS. 
 
Palavras-chave: Pele de prata; Medicago; Cosmético; Modelos in vitro 3-D; Técnicas 
de biofísica para avaliação da pele; Estudos in vivo 
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“Recomeça… 
Se puderes, 
Sem angústia e sem pressa. 
E os passos que deres, 
Nesse caminho duro 
Do futuro, 
Dá-os em liberdade. 
Enquanto não alcances 
Não descanses. 
De nenhum fruto queiras só metade. 
E, nunca saciado, 
Vai colhendo 
Ilusões sucessivas no pomar 
E vendo 
Acordado, 
O logro da aventura. 
És homem, não te esqueças! 
Só é tua a loucura 
Onde, com lucidez, te reconheças” 
 
Miguel Torga
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1. Sustainability in Cosmetic Industry 
The global population has reached 7 billion and is projected to reach 9 billion by 
2050 [1]. There is a general agreement that the planet’s resources cannot support with 
such arise in human population, especially at this consumption rates [1]. Simultaneously, 
consumers become more informed, demanding more benefits from the products they buy 
[1]. The rising education levels and the World Wide Web make consumers more aware, 
leading them to questioning product origins, production methods, ecological implications, 
as well as safety issues. This rise in ethical consumerism is having a major impact on the 
cosmetics industry. A core component of industry responsibility is it commitment to 
sustainable development.  
Human history has always been closely linked to the control, extraction and use of 
natural resources [2]. However, over the past decades, demand for natural resources has 
accelerated to the extent that it is now widely considered a serious threat to the well-
functioning of economies and societies due to associated environmental problems such 
as climate change, biodiversity loss, desertification, and ecosystem degradation [2]. At a 
time when eco-consumerism is increasingly focusing end-user attention on all aspects of 
products like raw material sourcing, manufacturing and disposal, the beauty product 
sector has been accused of numerous environmentally unfriendly practices [3]. According 
to Cosmetics Europe - The Personal Care Association, each day 450 million Europeans 
use a variety of cosmetic products such as soap, shampoo, hair conditioner, toothpaste, 
deodorant, shaving cream, skin care, perfume, make-up, etc [4]. These products do not 
only help with personal hygiene, and thus contribute to the improvement of public health; 
for most people, using cosmetics improves their self-esteem and self-confidence, 
therefore, their general well-being [4]. The European cosmetic industry provides 
employment for some 1.7 million people and is the world's largest exporter of cosmetic 
products, thereby significantly contributing to economic growth in Europe [4].  
In fact, within the rapidly growing market for personal care products, a number of 
studies show that the highest environmental impact of cosmetic products is at the 
consumer level. The consumers concerns range from unsustainable sourcing of raw 
materials, pollution both in the manufacturing phase and the disposal of packaging and 
products, to animal testing [3]. In response to that, companies have attempted to address 
these issues holistically by focusing on sustainable raw material sourcing and greener 
formulations, as well as through packaging reductions and lower overall resource 
consumption [3]. However, these laudable practices face both consumer scepticism that 
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often views these activities as “green washing” and the reality of the market, where in a 
global economy, there is little desire for premium pricing to cover the increased costs of 
these products compared to traditional ones [3]. 
Sustainability has many interpretations. A widely accepted definition is that of the 
Brundtland Commission of the United Nations which refers to sustainability in the concept 
of sustainable development: ‘meeting the needs of the present without compromising the 
ability of future generations to meet their own needs’ [5]. The three pillars or dimensions of 
sustainability are environmental, social and economic dimension, as depicted in Figure 
1.1. 
 
Figure 1.1 - The three pillars of sustainability. 
 
It is against this backdrop that the idea of this research came about. Is it possible 
to develop new cosmetic ingredients based on food by-products? With growing scarcity of 
resources and rising ethical consumerism, how can the food industry, associated with the 
cosmetic industry, become more sustainable? What are the best ways to improve this 
food by-products use? Are they safe? This PhD thesis aims to address such questions. 
 
2. Coffee Industry 
  Coffee, one of the most popular beverages, is consumed by millions of people 
every day, being highly appreciated in Portugal. The coffee fruit (also called berry or 
cherry - Figure 1.2) consists of a smooth, tough outer skin or pericarp, usually green in 
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unripe fruits but turns red-violet or deep red when ripe (even yellow or orange in particular 
genotypes) [6]. 
 
Figure 1.2 - Coffee cherry (Available from http://hiloliving.blogspot.pt/2009_07_01_archive.html - accessed on 
01.02.16). 
 
The economic importance of coffee is mainly due to the coffee brew or beverage, 
an infusion prepared from the roasted and ground beans. Most coffee beverage 
consumed around the world is produced by the species Coffea arabica (Arabica) and 
Coffea canephora (Robusta) [6]. According to the International Coffee Organization (ICO) 
in their last report, the total coffee production in 2013/14 was estimated at 146.8 million 60 
kg bags, very slightly down on the 147.5 million bags produced in 2012/13 [7]. Also, the 
United States Department of Agriculture has released its latest estimates for annual global 
coffee production, predicting a 1.5 million total drop to 147.8 million bags in 2014/15, 
despite rising demand [8]. World coffee exports amounted to 9.10 million bags in August 
2015, compared with 9.35 million bags in August 2014 [8]. The total demand has been 
growing at around 2.1% per annum for the last four years. This growth has mostly been 
driven by increased demand in exporting countries and new consuming countries, which 
have registered average annual growth rates of 3.1% and 2.7%, respectively, since 2010 
[7]. Portugal is a consumer country with a high number of roasting companies distributed 
all over the territory.   
The coffee tree is part of the subkingdom of plants known scientifically as the 
Angiosperm, which means that the plant reproduces by seeds that are enclosed in a box-
like compartment, known as ovary, that are the base of the flower. It belongs to the 
botanical family Rubiaceae and to the genus Coffea. 
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Although widely consumed, during production this beverage originates a lot of food 
by-products that are still poorly characterized, especially in what concerns to its bioactive 
compounds and sustainable re-uses.  
2.1 Coffee processing techniques 
Coffee is internationally traded as green coffee which is produced by either wet or 
dry processing. Both processes are summarized in Figure 1.3. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 - Coffee curing processes. 
 
- Wet method 
Coffee processed by wet method is also called washed or parchment coffee [9]. 
The process is called wet because water is the primary means to both moving the coffee 
through the process and to making the extraction of the seed possible.  Basically, the 
coffee outer fruit skin is removed, floated in water (to 
remove defective beans), fermented (to break down the fruit mucilage layer), washed (to 
remove the fruit) and dried. At this point, green coffee seed is inside an 
outer parchment shell, rested for a period of time and dried into the green bean. Wet 
processing often produces a brighter, cleaner flavour profile, with lighter body than dry 
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process coffees or the hybrid pulp natural process. This process is also referred as 
washed coffees or fully washed. The coffee seed is not fermented in this process, just the 
other fruit layer between the skin and the parchment shell, in order to avoid the loss of 
bean color and moisture absorption by the beans. The fermentation occurs to break down 
the mucilage layer on the parchment into simple non-sticky substances, being digested. 
This is a natural action of peptic enzymes in the coffee. The skin and most pulp of the 
sunken fruits are mechanically removed by pressing the fruit in water through a screen (by 
using a pulper) [6]. Pulp remnants and the mucilage layer have to be removed in a 
following step. This can be conducted through “controlled” fermentation (for 12 - 48 h) and 
wash in concrete tanks, or through mechanical scrubbing (aqua pulping) [6]. The possible 
mechanical removal of the pulp reduces the amount of water used and, in consequence, 
the waste polluted water, and allows recovering the mucilage fraction [6, 9]. After washing, 
is usual to soak the parchment in clean water for 12 h in order to improve the visual 
appearance of the beans and the quality by removing diterpenes and polyphenolic 
substances which impart hardness to brew [9]. Coffee beans are dried until the moisture 
reaches around 10% [9]. Normally beans are dried in the sun or by machine but in most 
cases it is dried in the sun to 12-13% moisture and brought down to 10% by machine. 
Ecologically sensitive farms reprocess the wastewater along with the shell and mucilage 
as compost to be used in soil fertilization programs. After the drying process (in the sun 
and/or through machines), the parchment skin is thoroughly dry and crumbly, and easily 
removed in the hulling process. 
- Dry method 
The dry-process (also known as unwashed or natural method) is the oldest method 
of processing coffee, producing a heavy in body, sweet, smooth, and complex coffee.  This 
process is often used in countries where rainfall is scarce and long periods of sunshine 
are available to dry the coffee properly such as Indonesia, Ethiopia, Brazil or Yemen. In 
this method, the freshly harvested fruits are spread evenly to a thickness of about 8 cm on 
clean drying yard [9]. They are stirred and ridged once every hour and normally get fully 
dried in 12-15 days under bright weather conditions [9]. Drying rate of parchment is 
dependent on the initial moisture of the parchment, ambient air temperature, humidity, 
thickness of the spread and periodicity of stirring [9]. 
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2.2 Coffee industry by-products 
The industrial processing of coffee cherries occurs to separate coffee powder by 
removing shell and mucilaginous part from the cherries. This process generates large 
amount of coffee by-products. The cherry structure is shown in Figure 1.4.  
 
Figure 1.4 - Cross-section of a coffee cherry (Adapted from https://pt.pinterest.com/pin/545709679817527226/ 
- accessed on 01.02.16). 
 
The processing of coffee generates expressive amounts of agricultural waste. 
Depending upon the method of coffee cherries processing, roasting and brewing solid 
residues like pulp, husk, silverskin, parchment or mucilage are obtained. Table 1.1 
summarizes the residues obtained from the different coffee processes. 
Table 1.1 – Coffee by-products generated during coffee processing. 
 
Process Type of by-product Amount (for every 1 ton of green bean processed) 
Pulping Pulp Nearly 1 ton of pulp is generated 
Washing Mucilage & parchment 40 m3 of water with mucilage and parchment are 
generated 
Milling Mucilage & parchment 105 kg of dry parchment and 44 kg of dry mucilage 
Polishing Silverskin The amount varies due to the thickness of upper layers 
 
 
Coffee husks 
The main by-product of the dry processing is composed by the skin, pulp, mucilage 
and parchment, all together in a single fraction (coffee husks), that are probably the major 
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residues from the handling and processing of coffee [6]. According to Saenger et al., for a 
ton of coffee beans produced, approximately 1 ton of husks are generated during dry 
processing, whereas for wet and semi-wet processing this residue amounts to more than 
2 ton [10]. Murthy et al. consider that coffee husk encloses the coffee beans and 
represents about 12% of the berry on dry-weight basis [9]. The main composition of coffee 
husks are carbohydrates, being viewed as a potential raw material for bio-ethanol 
production [11]. Proteins, fibers and minerals are also present in huge amounts [12]. 
Other proposed alternative uses include employing this solid residue as a supplement for 
animal feed, direct use as fuel, fermentation for the production of a diversity of products 
(enzymes, citric acid and flavoring substances), use as a substrate for growth of 
mushrooms and as adsorbents [11]. 
 
Coffee pulp 
Coffee pulp have a similar composition to that of the husks: protein (7.5-15.0%), fat 
(2.0-7.0%) and carbohydrates (21-32%), representing about 29% on dry-weight of the 
whole berry [9, 13]. The organic components present in coffee pulp (dry weight) includes 
tannins (1.80-8.56%), total pectic substances (6.5%), reducing sugars (12.4%), non-
reducing sugars (2.0%), caffeine (1.3%), chlorogenic acid (2.6%) and total caffeic acid 
(1.6%) [9]. 
 
Coffee mucilage 
The coffee mucilage fraction remains adhered to the coffee bean in the wet 
processing after depulping without enzymatic degradation [6]. According to Belitz et al. 
water is the main component of coffee mucilage (84.2%), followed by protein (8.9%) and 
sugar (4.1%) [14]. 
 
Coffee parchment 
Coffee parchment is the fibrous endocarp that covers both hemispheres of the 
coffee seed and separates them from each other [6]. In the dry processing, the parchment 
is separated from the green coffee beans together with the peel and pulp, in a single step, 
while in the  wet process, the parchment is removed after drying and hulling, in separate 
steps [14]. The composition is similar to coffee mucilage [6]. 
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Coffee silverskin 
Coffee silverskin (CS) is obtained after coffee beans roasting, being completely 
removed and releasing the ground roasted coffee beans for coffee beverage production. 
Different authors had intensively studied this coffee by-product. Regarding its 
macronutritional composition, is well documented its high content in dietary fiber (50-60%, 
including 85% and 15% of soluble and insoluble fiber, respectively), protein (16.2-19%) 
and minerals (4-5%) [15-17]. However, the exact mineral composition of CS have not 
been clarified [18]. Different authors had also demonstrated the high antioxidant capacity, 
probably due to the concentration of phenolic compounds of CS [15, 19-22]. 
 
3. Medicago 
Legumes are important agricultural and commercial crops consumed in large 
amounts by both humans and animals. Nowadays, an integrated and sustainable 
exploitation of plant resources is a must as only few amounts are used for actual human 
consumption. Waste and by-products from vegetable origin are currently rising, driven by 
both a net increase in plant products consumption and the changing consumer trend 
toward ready-to-use products [23].  
The Leguminosae taxonomic class includes a variety of plants with significant 
economic value, including soybean, alfalfa, clover, pea, peanut and various beans, often 
proposed as potential natural sources of specific bioactive components, with emphasis in 
phenolic compounds [24]. The genus Medicago is part of the botanical family 
of Leguminosae and includes about 56 different species mainly distributed in 
Mediterranean climatic conditions areas [25]. Alfalfa (Medicago sativa) is the main 
Medicago species widely grown throughout the world, predominantly as a source of high 
quality forage for livestock, renewable energy production, phytoremediation, and as a 
source of phytochemicals [26-27]. It is also used as a human food ingredient, consumed 
as sprouts in salads, in sandwiches or soups [28], as leaf protein concentrates [29], or as 
food supplements [30]. Despite this use, alfalfa have pharmacological activities, being 
used in some human health dysfunctions, such as anaemia, diabetes, endometriosis, 
stomach ulcers, osteoporosis, menopausal symptoms, breast and prostate cancers and 
low bone density [31-32]. Also, it is considered that the main applications of Medicago 
species are grazing food for cattle and other livestock. Like other plants of the same 
family, it was reported that high levels of isoflavones are desirable on lamb feeding, that 
gain weight more quickly, as well as in milk production, but, in some cases, reproductive 
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disorders have also been reported in sheep and cattle fed on forages with high isoflavone 
content [33-34]. Thus, depending on the final objective for cattle, Medicago could not be 
desired for farmers, originating a high amount of by-products. 
Medicago species are important sources of phytochemicals, including carotenoids, 
saponins or phytoestrogens, which are known to act as antimicrobial agents, 
phytoanticipins, phytoalexins, structural barriers, modulators of pathogenicity, plant 
defence genes activators or fungitoxic agents [24, 27, 35-36]. Over this panoply of 
compounds, phytoestrogens are the most interesting for cosmetic products. 
Phytoestrogen is a general term used to define a wide variety of compounds that are non-
steroidal and are either of plant origin or derived from the in vivo metabolism of several 
plants used as food [37]. Isoflavones are phenolic compounds with antioxidant activity and 
structural similarity to estradiol molecule [38-39], being primarily found in plants of the 
Fabaceae family, including soy, lentils, bean plant, chickpeas, alfalfa and red clover [40]. 
A number of epidemiological studies associate the consumption of isoflavone-rich foods 
with low incidence of the major hormone-dependent cancers [41], cardiovascular diseases 
[42], osteoporosis [39], and climateric complaints [43]. Because of their structural similarity 
to ß-estradiol, health benefits of isoflavones have been evaluated in age-related and 
hormone-dependent diseases [44]. These compounds are largely described in redclover, 
a Leguminosae plant [45-48]. Biochanin A (5,7-dihydroxy-4’-methoxyisoflavone)and 
formononetin (7-hydroxy-4’-methoxyisoflavone) are methylated precursors of genistein 
and daidzein, respectively, and existing high amounts in red clover [45, 49].  
Therefore, estrogens can slow down the aging process of the skin in 
postmenopausal women. For this reason, isoflavones are also very interesting 
compounds for cosmetic formulations. When incorporated in creams, natural estrogens 
could result in morphological modifications to the aged skin, characterized mainly by an 
increased number of fibroblasts and glycosaminoglycans (GAGs), and, consequently, 
collagen and hyaluronic acid. 
 
4. Re-Use of Food by-Products 
Very few studies report possible uses for these agro-industrial wastes [50-51]. 
Cosmetic application could be a new way to reuse them. As it is well known, human skin 
is a complex organ that regulates body heat and water loss, whilst preventing the entry of 
toxic substances and microorganisms. Natural ingredients, phytonutrients, microbial 
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metabolites, dairy derived actives, minerals and animal protein components have long 
been believed to benefit healthy skin aging [52]. Indeed, from a sustainable point of view, 
this new application could provide, in the near future, a way of recycling for food 
companies, developing cost-efficient processing methods, decreasing the negative 
impacts of wastes on the environment and providing other economical advantages for 
companies. But, how could these new ingredients act on skin?  
 
4.1 Skin morphology: Structure and composition 
Skin has historically been used for the topical delivery of compounds. The human 
skin is the largest organ of human body, forming the outermost biological barrier between 
the human body and the external environment. Among the multiple complex functions of 
mammalian skin, one of its major roles is to prevent invasion of the organism by acting as 
a defensive barrier to threats from the external environment [53]. In the 1960s the 
tremendous influence of the thickness of the stratum corneum (SC) became obvious [54]. 
It consists of different layers exhibiting individual composition and physiology [55]. The 
barrier function of the skin consists of a cornified layer of protein-rich dead cells 
(corneocytes) embedded in a lipid matrix, namely the SC [56]. The corneocytes are held 
together by corneodesmosomes, which help to form a tough outer layer by maintaining 
cellular shape and regular packing [53]. The lipid-enriched component consists 
predominantly of ceramides (about 50% by weight), as well as cholesterol and free fatty 
acids [57]. This layer is formed at the end of a balanced differentiation process, beginning 
at the basal layer of the epidermis, where progenitor cells divide and newly emerged 
keratinocytes are pushed towards the apical side of the epidermis [56]. Keratinocytes 
undergo a process of keratinisation, in which the cell differentiates and moves upward 
from the basal layer (stratum basale), through the stratum spinosum and stratum 
granulosum, to the outermost layer, the stratum corneum, where they anucleated and 
flattened and are eventually sloughed off [53]. Interspersed amongst the keratinocytes, in 
the viable epidermis are cells with roles such as melanin production (melanocytes), 
sensory perception (Merkel cells) and immunological function (Langerhans and other 
cells) [53]. The water content at normal skin surface is low (10-15%) [54]. Deeper skin 
layers are constituted by the viable epidermis (50-100 µm) with the basal membrane 
(consisting of at least one member of the protein family of laminin, type IV collagen and 
nidogen, and the proteoglycan perlecan) as well as by the dermis (1-2 mm), where 
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appendices like sweat glands and hair follicle are located [54-55]. The dermis is divided 
into an upper papillary layer containing loosely arranged collagen fibers and a reticular 
layer with dense collagen fibers arranged in parallel to the surface of the skin. As well as 
collagen, the dermal matrix comprises a high amount of elastin, to provide the elastic 
properties of the skin [56]. This matrix is produced by fibroblasts, which are the main cell 
type of the dermis. Dermis is pervaded by blood and lymph vessels. Nerves, sweat and 
sebaceous glands as well as hair follicles and shafts are embedded in the dermis. 
Beneath the dermis lies the subcutis, also known as the hypodermis. The subcutis 
functions as both an insulator, conserving the body's heat, and as a shock-absorber. Next 
to fibroblasts, adipocytes are the most prominent cells type in this compartment [56]. 
Figure 1.5 summarizes the skin structure. 
 
Figure 1.5 - Schematic picture of the native skin that is sub-classified into three main compartments: 
epidermis, dermis and subcutis (hypodermis) (Adapted with permission from Macmillan Publishers Ltd:  
Nature Reviews Immunology ([58]), 3792130776332 (2016)). 
 
In addition to the structured cellular components of skin, there are appendages 
including the pilosebaceous units (hair follicles and associated sebaceous glands), 
apocrine and eccrine sweat glands [53]. 
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The surface of the skin has long been recognised to be acidic, with a pH of 4.2-5.6, 
being described as the acid mantle [59]. This acid mantle has a number of diverse 
functions such as antimicrobial defence, maintenance of the permeability barrier by effects 
on extracellular lipid organisation and processing, preservation of optimal corneocyte 
integrity and cohesion, regulated by pH-sensitive proteolytic enzymes, and restriction of 
inflammation by inhibiting the release of pro-inflammatory cytokines [60]. 
The transport of substances across the SC mainly occurs by passive diffusion and 
based on the dual-compartment bricks and mortar structure of the SC, interrupted by 
appendages. Three possible routes are considered: the transcellular, the intercellular and 
the appendageal routes [53]. Polar solutes normally takes the transcellular route and more 
lipophilic solutes go via the intercellular lipids [53]. The delivery of drugs or particles via 
the appendageal route is regarded as a realistic alternative to delivery across the SC, 
covering only 0.1% of the human skin surface area.  
Disorders of the skin can occur by several means, such as by an imbalance in 
molecular events that govern communication between the cells, infections, neoplastic 
transformation, immunological and non-immunological responses to foreign agents and 
autoimmune events, venous insufficiency and pressure or shear on the skin, as it is the 
case for certain ulcers, as well as by physical and chemical external insults [56]. 
Epidermal regeneration is initiated by epidermal stem cells, which are present in 
different compartments of the skin, i.e. in interfollicular compartments as well as in 
epidermal appendages, such as sweat glands and hair follicles with their associated 
sebaceous glands [56]. 
In the last few decades, owing to a rapid and unprecedented expansion of the 
elderly population, skin aging has emerged as a field of the utmost importance. Skin aging 
is thought to be a complex biological process that is traditionally classified as intrinsic and 
extrinsic aging, affected by a variety of internal (like genetic predisposition, hormonal 
disorders, vitamin deficiencies) and external factors (such as ultraviolet (UV) radiation, 
environmental pollution, improper care) [61-64].  This complex and multifactorial process 
whose baseline rate is genetically determined, may be accelerated by environmental, 
mechanical, or socioeconomic factors [62]. Traditionally, the clinical signs of skin aging 
are thinning skin with exaggerated expression lines, wrinkles, age spots and actinic 
keratoses [61]. Until now, the number of published works about the histological structure 
of wrinkles is not very large. There are salient features exhibited by aged skin, regardless 
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of the cause(s) of skin aging. The changes undergone by skin as it ages occur throughout 
the epidermis, dermis and subcutaneous tissue and can manifest in discrete and broad 
alterations in skin topography [65]. 
- Epidermis 
Epidermis manifests some important changes related to aging. Some studies 
related that aged skin is characterized by a thinner epidermis, however, is general the 
concept that SC does not change with age [65]. In aged skin the intersection of the 
epidermis and dermis, known as dermal-epidermal junction, is altered, being flatter and 
diminishing the connecting area surface [65]. This lower surface contact could contribute 
to the increase fragility of skin observed in aged people and may also lead to the 
reduction of nutrient transfer between dermal and epidermal layers [65]. A decrease in the 
cell turnover is also observed in the epidermal layer. According to Kilgman et al. the SC 
transit time is of 20 days in young adults and 30 or more days in older adults [66]. This 
slow turnover leads to a protracted SC replacement rate, epidermal atrophy, slower 
wound healing and often less effective desquamation [65]. 
The molecular basis for epidermal aging is only beginning to be studied 
systematically. On a cellular level, apoptosis and decreased proliferative capacity, two key 
features of aging, affect epidermal structure and function, while on a molecular level, 
telomere shortening and reactive oxygen species (ROS), respectively, account for the 
characteristic structural and functional changes of chronologically aged skin [67]. 
Telomeres, which shorten with chronological aging, are repetitive deoxyribonucleic acid 
(DNA) sequences, in all mammals TTAGGG and its complement, that cap the ends of 
chromosomes [68]. Telomeres do not encode genes, but rather protect the proximal 
genes and regulatory sequences in several ways [69]. Since terminal base pairs are lost 
with each round of mitosis, progressive chromosome shortening occurs with each somatic 
cell division. Destabilization of the loop structure by progressive depletion with 
chronological aging, exposes the telomeric repeat sequence. Then, an as-yet-unidentified 
sensing mechanism interacts with the overhang to initiate a signal cascade that can lead 
to cell cycle arrest, premature senescence or apoptosis [68].  
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- Dermis  
Approximately 20% of dermal thickness disappears as people become elderly [65]. 
Even more striking changes occur in the dermis: massive elastosis (deposition of 
abnormal elastic fibres), collagen degeneration, and twisted, dilated microvasculature [70]. 
As the three primary structural components of the dermis, collagen, elastin and GAGs 
have been the subjects of the majority of anti-aging research pertaining to the skin [65]. 
The cosmetic approach to wrinkles includes cleansing, photoprotection and active 
ingredients [71]. 
Collagen is the primary structural component of the dermis and the most abundant 
protein found in humans, comprising about 25-35% of total body protein content, being 
responsible for strength and support of human skin [72]. This protein comprises 
approximately 70% to 80% of the dry weight of the dermis [73]. Human skin contains over 
14 types of collagen, of which 80% is type I - the collagen that is responsible for skin 
strength - and 15% is type III - the collagen that is responsible for the elastic properties of 
skin [72]. Each collagen molecule consists of three polypeptide chains (particularly rich in 
four amino acids: lysine, proline, hydroxylysine and hydroxyproline), each containing 
about 1000 amino acids in their primary sequence [73]. Alterations in collagen play an 
integral role in the aging process. This, in turn, partly explains the popularity of collagen-
containing products intended for anti-aging purposes [65]. The ratio of collagen types 
found in human skin also changes with age [65]. During aging process, a marked loss of 
fibrillin-positive structures as well as a reduced content of collagen VII is observed, 
weakening the bond between dermis and epidermis [74-75]. In young skin, collagen I 
comprises 80% and collagen III comprises about 15% of total skin collagen; in older skin, 
the ratio of type III to type I collagen has been shown to increase, due significantly to an 
appreciable loss of collagen I [76-77]. In older skin, collagen looks irregular and 
disorganized [76]. The overall collagen content per unit area of the skin surface is known 
to decline approximately 1%/year [78]. Although collagen I is the most abundant and 
significant collagen type found in the skin, the effects of aging are seen in other types of 
collagen in human dermis. For example, an integral constituent of the dermal-epidermal 
junction is collagen IV that imparts a structural framework for other molecules and plays a 
key role in maintaining mechanical stability [65]. Significantly lower levels of collagen IV 
have been identified at the base of wrinkles. 
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Dermal fibroblasts make precursor molecules called procollagen, which is 
converted into collagen. Fibroblast collapse, due to the accumulation of degraded 
collagen fibres that prohibit construction of a healthy collagen matrix, causes the ratio of 
collagen synthesis to collagen degradation to become deranged in a self-perpetuating 
cycle [79]. There are two important regulators of collagen production: transforming growth 
factor (TGF)-β, a cytokine that promotes collagen production, and activator protein (AP-1), 
a transcription factor that inhibits collagen production and up regulates collagen 
breakdown by up-regulating enzymes called matrix metalloproteinases (MMPs) [80]. In 
aged skin there is elevation of AP-1 as compared to young skin [81]. MMP activity is 
increased in aged human skin, being associated with dramatic increased levels of 
degraded collagen [67]. Also, synthesis of type I and III procollagen is reduced in aged 
human skin [82]. This combination results in an overall decrease in collagen levels in the 
dermis.  
MMP are a family of ubiquitous endopeptidases playing a role in many different 
physiological and pathological processes in the skin, including cutaneous aging [83-84]. 
These zinc-containing proteinases family are responsible for degradation of extracellular 
matrix (ECM) proteins, which form skin dermal connective tissue. MMPs are classified as 
collagenases, gelatinases, stromelysins, and membrane-type MMPs according to their 
substrate specificities and whether they are secreted soluble proteins or bound to cell 
surface membrane. Four MMPs in particular are thought to be important in matrix 
degradation in the skin [85]. The combined actions of collagenase (MMP1), 92 kDa 
gelatinase (MMP2), 72 kDa gelatinase (MMP9) and stromelysin 1 (MMP3) can fully 
degrade collagen and components of the elastic network of skin [85-86]. Together with 
collagen, elastin and elastic fibers, MMP are essential for strengthening of muscles, 
tendons and joints [87]. Degradation of these vital tissues and/or oxidative damage of 
DNA lead to loosening of the skin and eventually formation of wrinkles [87]. Coupled with 
these changes, elastic gene expression is markedly reduced after the age of 40-50 [85]. 
Functional elastin also declines in the dermis with age, as elastin becomes 
calcified in aged skin and elastin fibers degrade [88]. The turnover also declines. GAGs, 
the primary dermal skin matrix constituents assisting in binding water and an important 
contributor to the skin structure, declines with age [76]. The same occurs with the amount 
of hyaluronic acid produced by fibroblasts and the amount of interfibrillary ground 
substance, also a component of a healthy dermal matrix [89]. 
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- Hypodermis 
The overall volume of subcutaneous fat typically diminishes with age, as well as fat 
distribution. The physiological significance may be to increase thermoregulatory function 
by further insulating internal organs [90]. 
Table 1.2 summarizes the changes in aged skin. 
 
Table 1.2 – Changes observed in aged skin. 
 
 
Observed effect of skin 
 Lower lipid content 
Epidermis - Dermal–epidermal junction flattens  
- ↓ Number of enzymatically active melanocytes  
- ↓ Number of Langerhans cells 
- ↓ Capacity for re-epithelization 
- ↑ Number of pores  
Dermis - Thickness reduced (atrophy) 
- ↓ Vascularity and cellularity  
- ↓ Collagen synthesis  
- Pacinian and Meissner’s corpuscles degenerate  
- Structure of sweat glands becomes distorted, 
- ↓number of functional sweat glands  
- Elastic fibers degrade 
- ↓ Number of blood vessels 
- ↓ Number of nerve endings  
Hypodermis - Distribution of subcutaneous fat changes 
- Overall volume decreases 
Appendages - Hair loses normal pigments  
- Hair thins 
- ↓ Number of sweat glands  
- Nail plates become abnormal 
- ↓ Sebum production  
 
Chapter │1  
State-of-Art 
____________________________________________________________________________ 
20 
 
Thus, wrinkle cosmetic treatments are exerted by a variety of active functional 
ingredients. The modern anti-aging cosmetics go well beyond the simple moisturizing 
function of traditional anti-wrinkle creams, by exerting a more complex function in 
protecting the skin from external injuries, nourishing it, and removing its superficial layers 
[71]. The efficacy of active ingredients is related to their diffusion through the barrier and 
their concentration in the formulation [91]. Small soluble molecules with lipophilic and 
hydrophilic properties have greater ability to cross the SC than particles, polymers, or 
highly lipophilic substances [91]. There are numerous synthetic skincare formulations 
containing active ingredients such as alpha hydroxyl acids (AHAs), hyaluronic acid, 
cohesive polydensified matrix (CPM), etc., that have adverse reactions; for instance, 
allergic contact dermatitis, irritant contact dermatitis, phototoxic and photo-allergic 
reactions [87]. Plant-derived polyphenolic substances such as alloin, catechin, 
epicatechin, curcumin, myricetin, quercetin, etc., are beneficial as anti-aging ingredients 
[87]. Many herbal polyphenolic substances have found to be effective in reducing the rate 
and intensity of wrinkle formation. But, how these ingredients work? How can they reach 
the final function desired in aging? 
 
4.2 Antioxidant activity 
The skin naturally relies on antioxidants (AOs) to protect it from oxidant stress 
generated by sunlight and pollution [92]. Both the cutaneous permeability and the 
antioxidant barriers largely reside in the outer layers of the epidermis [68]. ROS, whether 
generated as by-product of cellular metabolism or of environmental origin, can modify 
amino acid structure sufficiently to result in loss of function [68]. To counteract oxidative 
injury, human skin is equipped with a network of enzymatic and non-enzymatic antioxidant 
systems. An imbalance between ROS and antioxidant protection mechanisms leads to 
oxidation of macromolecules, including DNA, lipids and proteins [68]. The oxidative 
modifications could result in loss of structural and/or functional integrity of components of 
epidermal barrier.  
Antioxidants are a very heterogeneous class of functional substances: they include 
vitamins, minerals, and essential amino acids, all endowed with a specific property, 
among others, of fighting free radicals [71]. The antioxidant activity is an excellent 
example of a functional benefit that plant extracts can deliver. Cosmetic treatments of the 
latest generation, developed against wrinkles, rely on antioxidant properties of some 
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ingredients, especially those derived from plants [71]. Plants are known to contain a 
variety of natural antioxidants that protect and preserve themselves [93]. Many of these 
compounds and extracts from plants are emerging as candidates for moderating the 
effects of the aging process on skin by limiting biochemical consequences of oxidation 
[93]. Skin is a shield protecting us from harmful exposure to UV radiation and air 
pollutants and naturally uses antioxidants to protect itself from photodamage [86, 94]. At 
low concentrations, ROS exert essential intracellular functions, as second messengers, 
gene regulators, and mediators for cell activation (kinases and transcription factors), and 
could also play a key role in body’s defense against infectious organisms [95]. Due to the 
high metabolic activity, human skin present a high risk of undergoing oxidative stress that 
can be brought on by internal and external conditions [96]. Oxidative stress is defined by 
an imbalance between ROS and antioxidants, with ROS being in excess [95]. Of the three 
types of UV rays, mid-range UVB (290 nm to 320 nm) and long-wave UVA (320 nm to 400 
nm) rays are widely known to be the chief causes of premature photoaging, immune 
dysfunction and certain skin cancers. UVB rays are absorbed by epidermal chromophores 
such as melanin and urocanic acid and lead to direct molecular damage while also 
generating ROS [95]. UVA rays penetrate more deeply in the dermis, increase the 
production of ROS, and contribute to long-term actinic damage [95]. Symptoms of 
cutaneous damage, including wrinkling and pigmentation, develop earlier in sun-exposed 
skin than in unexposed skin, a phenomenon referred to as photoaging [97]. Both UVA and 
UVB induce the activation of a wide range of transcription factors in skin cells, which in 
turn may increase the production of MMPs, degrading collagen and elastin [95]. This 
exposure results in direct damage to the nucleus of the cell itself and in formation of ROS 
and other free radicals that subsequently react with important molecules in connective 
tissue and cell membranes [94].These photochemical reactions can result in DNA 
damages, including oxidation of nucleic acids, with oxidative reactions also modifying 
proteins and lipids, leading to changes in its function and destabilizing the membranes of 
keratinocytes [86]. The human body is well equipped to deal with oxidative stress, using 
enzymatic and non-enzymatic antioxidants to decrease these changes. Many antioxidants 
come into a control mechanism to keep in vivo generated ROS balanced, being involved 
endogenous (e.g. superoxide dismutase, superoxide reductase, catalase, and glutathione 
peroxidase) and exogenous antioxidants (vitamins, trace elements, and 
phytoantioxidants) [86, 95]. 
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An increasing importance is given to the formation of ROS inside the epidermal 
cell, not only by solar rays but also by the oxireduction reactions that take place inside the 
cell [96]. This modifies the phospholipids in the membrane, by peroxidation of their 
polyunsaturated fatty acids, with cell destruction and eventual cell death [96]. The skin's 
susceptibility to peroxidation is strictly connected to the presence or absence of an 
adequate antioxidant system represented by: the enzymes superoxide-dismutase and 
glutathione peroxidase; α-tocopherol, β-carotene, and squalene; and the phenol 
compounds [96]. Free radical peroxidation is a theory that explains aging. Oxygen free 
radicals cause progressive damage to biologic membranes and subcellular organelles, 
impairing their functionality, and modifying DNA replication [96]. According to Viola et al. 
biologic membrane sensitivity to peroxidative phenomena increases with aging [96]. A 
progressive loss of functionality, with increased activity of phospholipase A2 enzyme, 
which hydrolyzes phospholipids and release arachidonic acid, is described [96]. By the 
action of cicloxigenase, this leads to an increased synthesis of thromboxane with 
consequent vasoconstriction, increased platelet aggregation, and hypertension, and the 
subsequent reduction of nutrients and oxygen in the tissues [96]. After lipoperoxidation, 
the skin forms lipofuscin (an indicator of skin aging) and cancer risk is increased [96].   
In the cosmetic field, anti-aging products are one of the main goals. Nowadays, all 
consumers are focused on their health without forgetting the appearance, creating a great 
demand for anti-aging cosmetic products. In the field of cosmetic treatments, antioxidants 
are innovative ingredients for topical applications. Because low-molecular-weight 
antioxidants protect skin against oxidative stress, undergoing depletion in the process, it 
should be desirable to apply the antioxidants directly to skin as an available source for 
protection [86]. Diet and oral supplementation can supply skin with antioxidants. However, 
the metabolic process limits the amount that can be delivered into skin. Skin is 
increasingly used for topical administration of substances. Thus, the application of 
exogenous antioxidants might be proficuous on reducing the effects of free radicals. 
Topical use of antioxidants can provide additional protection to neutralize ROS from both 
endogenous and exogenous sources [98]. Since many relatively simple bioassays are 
readily available to assess antioxidant activity, a large number of plant compounds and 
extracts have been shown to act as antioxidants in vitro, and many have also 
demonstrated the capacity to reduce oxidative stress in skin in vivo, as well as in skin cells 
in vitro [93].  However, very few studies reported the use of by-products as antioxidant 
sources for cosmetic field [22-23, 99-103]. According to these researches, the majority of 
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these antioxidants are polyphenols and isoflavones. According to the composition 
previously reported for coffee silverskin, in an environmental and economic point of view, 
they could be considered a promising cosmetic ingredient source. Nevertheless, to 
guarantee the safety of these new ingredients stability and toxicity assays should be 
performed in order to avoid the presence of irritant constituents [102]. The cytotoxicity of 
these compounds can be evaluated using MTS and LDH assays in different monolayer’s 
skin cell lines. Also, a number of in vitro three-dimensional models tests have been 
developed to assess the potential skin or eye irritants by cosmetic industry, such as the 
reconstructed human epidermis test (EpiSkinTM) or the Human Corneal Epithelial Model 
(SkinEthicTM HCE), respectively.  
 
 
4.3 Isoflavones 
Changes in skin aging and function occur at variable rates and are also influenced 
by hormonal factors unique to each individual. Over time, the skin experiences a 
progressive increase in extensibility and a reduction in elasticity, thereby becoming more 
frail and susceptible to trauma. This in turn leads to an increased risk of skin injury (e.g., 
lacerations, tears, ulcerations, bruising), and an impairment of wound healing [72]. Since 
the average woman in a developed nation spends about one third of her life after the 
onset of menopause, the benefits and risks of estrogen replacement therapy (ERT) - also 
known as hormone replacement therapy (HRT), and menopausal hormone therapy (MHT) 
- have become major areas of focus for research [72]. ERT increases skin collagen 
content and preserves thickness, thereby reducing wrinkling. Skin moisture content 
improves with ERT, as it increases the skin’s hyaluronic acid, acid mucopolysaccharides, 
and sebum levels, and possibly maintains stratum corneum barrier function [72]. Collagen 
becomes progressively sparse, disordered, and atrophied as skin ages - one of the chief 
reasons for the skin transformations resulting from aging. Copious studies establish 
menopause leads to estrogen deficiency, and research over the past 60 years 
demonstrates skin thickness, estrogen content, and skin collagen are closely correlated 
[72]. Topical estrogen administration could preserve the dermal collagen with significant 
improvement in skin appearance [104]. Estrogens have significant effects on skin 
physiology and modulate epidermal keratinocytes, dermal fibroblasts and melanocytes, in 
addition to skin appendages including the hair follicle and the sebaceous gland [104]. 
Many of the effects of estrogen on human skin are based on the changes that are seen in 
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post-menopausal women, with a number of studies documenting the differences seen 
following the menopause, although there is also a variation in skin thickness during the 
menstrual cycle, with skin thickness lowest at the start of the menstrual cycle, when 
estrogen and progesterone levels are low, which then increases with the rising levels of 
estrogen [104].  In skin tissue estrogen increase vascularization and show effects at 
various levels of dermal tissue [105]. Estrogen compounds were shown to be effective in 
the treatment of skin aging symptoms of perimenopausal women, increasing epidermal 
hydration, skin elasticity, skin thickness, and also reducing skin wrinkles and improving 
the content and quality of collagen and the level of vascularization [105-107]. 
 
4.4 Moisture 
The presence of water is crucial to the maintenance of skin elasticity and integrity. 
The loss of moisture, which leads to dry skin, is closely linked to age-related skin condition 
[72]. The topical and systemic estrogen therapies probably preserve skin moisture 
probably due to an increase of acid mucopolysaccharides and hyaluronic acid in the 
dermis (high water holding capacity), higher sebum levels and water-holding capacity of 
the SC, and changes in the corneocytes surface area [72]. 
 
But how could a new cosmetic ingredient be evaluated and classified as safe? 
Which studies should be performed? In vitro? In vivo? 
 
5. How to Evaluate a New Cosmetic Ingredient/Product? 
 
The safety evaluation of a new cosmetic ingredient is a complex matter. In order to 
make sure that a cosmetic ingredient or product is safe for its intended use, a 
multidisciplinary team is completely requested. Cosmetics and personal care products 
companies uses a multi-tiered scientific approach to extensively evaluate the safety of 
cosmetic products and ingredients. First of all the definition of cosmetic ingredient should 
be highlighted. According to Scientific Committee on Consumer Safety (SCCS) a cosmetic 
ingredient is “any chemical substance or mixture of synthetic or natural origin, used in the 
formulation of cosmetic products. A cosmetic ingredient may be: 1- a chemically well-
defined single substance with a molecular and structural formula, 2- a complex mixture, 
requiring a clear definition and often corresponding to a mixture of substances of unknown 
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or variable composition and biological nature, 3- a mixture of 1 and 2, used in the 
formulation of a finished cosmetic product” [108]. Also, the definition of a cosmetic product 
is of extremely importance: “Any substance or mixture intended to be placed in contact 
with the external parts of the human body (epidermis, hair system, nails, lips and external 
genital organs) or with the teeth and the mucous membranes of the oral cavity with a view 
exclusively or mainly to cleaning them, perfuming them, changing their appearance, 
protecting them, keeping them in good condition or correcting body odours” [109]. In a 
simple way of view, the key components of this strict and methodical safety process 
include not only the evaluation and testing of human health impacts, but also the 
examination of cumulative exposure to the human body and the test and evaluation 
performed by scientists trained in product safety [110].  
Following a thorough review of each ingredient in a cosmetic formulation, 
additional safety data on ingredients and finished product are reviewed. These may 
include cell culture (in vitro) and clinical (human) tests conducted on the final product and 
on products similar in composition to the product being evaluated. The potential for 
ingredient interactions within the product leading to unexpected adverse effects is also 
considered. Confirmatory testing of cosmetic product compatibility and acceptability on 
human volunteers (clinical testing) is often undertaken with informed consent and with the 
appropriate safeguards to detect any undesirable effects that could occur. Factors to be 
considered in determining exposure levels for personal care products and ingredients 
include: product type, amount used per application, frequency of application, site of body 
contact, duration of product contact, concentration of individual ingredients in the final 
product, use by sensitive subpopulations (such as infants, elderly, and pregnant women), 
method of application, external factors (such as sunlight exposure and variation in use 
related to weather), local or temporal habits, trends and cultural considerations, and 
possible conditions of foreseeable misuse [108, 110]. To ensure the reliability of testing, 
cosmetic product safety studies are designed and monitored, and the results are 
interpreted and evaluated by scientists who are specially trained and experienced in 
toxicology and safety evaluation. These scientists have a fundamental understanding of 
cosmetic, personal care and fragrance products and of tests being used.  
The assessment of the toxicological potential is the first step in the hazard 
evaluation of a ingredient and consists in a series of distinct toxicity studies, specific for 
distinct toxicological end points. Besides, phototoxicity studies have to be performed for 
some specific cases [111]. Furthermore, animal testing in the European Union is already 
prohibited since 2004 for cosmetic products and since 2009 for cosmetic ingredients 
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('testing ban') [112]. As from March 2009, it is also prohibited to market in the European 
Union cosmetic products containing ingredients which have been tested on animals 
('marketing ban'). For the most complex human health effects (repeated-dose toxicity, 
including skin sensitisation and carcinogenicity, reproductive toxicity and toxicokinetics) 
the deadline for the marketing ban was extended to 11 March 2013 [112]. For these 
endpoints no alternative in vitro methods are available. This approved delay has now 
expired.  Table 1.3 summarizes the evolution on assays allowed for cosmetic ingredients. 
 
Table 1.3 – Allowed assays for cosmetic ingredients. 
 
EU Cosmetic Ingredient tested 
before March 2009 
EU Cosmetic Ingredient tested 
after March 2009 
EU Cosmetic Ingredient 
tested after March 2013 
Physico-chemical Identification Physico-chemical Identification Physico-chemical Identification 
Acute Toxicity   
Skin Corrosivity and Irritation Skin Corrosivity and Irritation Skin Corrosivity and Irritation 
Eye Irritation Eye Irritation Eye Irritation 
Skin Sensitisation Skin Sensitisationa  
In vitro Dermal Absorption In vitro Dermal Absorption In vitro Dermal Absorption 
Repeated Dose Toxicity Repeated Dose Toxicitya  
Mutagenicity/ Genotoxicity in vitro 
and in vivo 
Mutagenicity/ Genotoxicity in vitro  Mutagenicity/ Genotoxicity in 
vitro  
Reproductive Toxicity Reproductive Toxicitya  
Carcinogenicity Carcinogenicitya  
Chronic Toxicity Chronic Toxicitya  
Toxicokinetic Studies Toxicokinetic Studiesa  
In vitro Photo-induced Toxicity In vitro Photo-induced Toxicity In vitro Photo-induced Toxicity 
Human Data Human Data Human Data 
a
 - animals tests developed outside the European Union 
 
 
The point is: How to evaluate these new ingredients? There are any in vitro models 
that could be used for dermal permeability? And which in vivo assays should be 
performed? 
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5.1 Cell-based in vitro models for dermal permeability studies 
 
Skin absorption processes are useful to evaluate/understand safety aspects of 
chemicals, xenobiotics and cosmetic formulations. The main aim of skin absorption is the 
opportunity to deliver drug substances to the skin and further to the systemic circulation 
[113].  Therefore, the knowledge of dermal absorption phenomena is relevant for safety 
issues as well as for therapeutic aspects. Changes in regulatory requirements and social 
views on animal testing have incremented the development of reliable alternative tests for 
predicting skin absorption potential of new compounds and to evaluate dermal 
permeability. Although some procedures on conducting skin permeation studies are 
reported, no formal standardization is available [114-116]. The assessment of dermal 
permeation is one of the primary procedures to evaluate a substance and classify it as 
hazard, particularly, in cosmetics or pharmaceutical industries [117]. Skin is a multilayered 
biomembrane with particular absorption characteristics, answering differently to different 
substance classes.  
Skin is a dynamic, living tissue and as such its absorption characteristics are 
susceptible to constant changes. Upon contact with the skin, the molecules penetrate into 
the dead SC and can subsequently reach the viable epidermis, the dermis and the 
vascular network [114].  Dermal absorption is influenced by many factors such as 
physicochemical properties of the substance, the vehicle, possible occlusion, the 
substance concentration, the exposure pattern or even the skin particularities in the 
different body parts [114]. 
A vast number of studies in the past have compared the in vitro with in vivo 
methods for measuring dermal absorption. They concluded, if properly conducted, that in 
vitro measurements can be used to predict in vivo absorption [118]. Organization of 
Economic Cooperation and Development (OECD) Guidance document 28 for the conduct 
of skin absorption studies allows the use of reconstructed human skin, if its application 
leads to absorption results similar to the ones obtained with excised human skin [118]. 
Also, in line with the 7th amendment deadlines, European Union bans the in vivo 
skin permeation assessment on ingredients for cosmetic purposes. Alternative methods 
are needed and require validation by European Center for the Validation of Alternative 
Methods (ECVAM). In response to that, OECD adopted a guideline for assessment of skin 
corrosion based on reconstructed human epidermis (RHE) [119]. In 2004, a technical 
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guidance of OECD also states skin equivalents that can be used for skin permeation 
assays [118].  
For ethical reasons, fundamental skin absorption data cannot normally be obtained 
by conducting in vivo studies [113]. According to European Union and Regulation on 
Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) guidelines, 
animal testing for skin studies should only be performed if all other approaches have failed 
to provide a conclusive result. Therefore, other techniques must be used to obtain the 
desired information such as in vitro penetration and permeation studies. Concerns about 
the test’s predictivity and reproducibility, plus animal welfare and political pressure in 
Europe, have prompted a search for alternative test methods [120]. Since the early 90’s, 
several models of the skin have been developed, characterized, validated and accepted 
as valid replacement method for animal experimentation.  
Thus, all in vitro models based on skin equivalents available in the market for 
permeation studies are described below. 
 
5.1.1 Human skin and dermal permeability  
Human skin performs a wide range of protective, perceptive, and regulatory 
functions, being the role as protective barrier, the most critical for survival [121]. Skin, the 
largest organ of the human body, is organized into an elaborated layered structure 
consisting mainly of the outermost epidermis and the underlying dermis. A subcutaneous 
adipose-storing hypodermis layer and various appendages such as hair follicles, sweat 
glands, sebaceous glands, nerves, lymphatics and blood vessels are also present in the 
skin. These multiple components of the skin ensure survival by providing critical functions 
in protection, thermoregulation, excretion, absorption, metabolic functions, sensation, 
evaporation management and aesthetics [122]. 
The barrier function of skin is performed by the epidermis, which is comprised 
mainly by keratinocytes [121]. The epidermis is a keratinized stratified squamous 
epithelium without a vascular system. The highly hydrophobia comes from differentiated 
non-nucleated cells, the corneocytes. This non-viable layer is the rate limiting step for skin 
absorption of most molecules [123]. Keratinocytes accounts for about 80% of epidermal 
cells [122], but epidermis is also composed of the pigment-producing melanocytes, Merkel 
cells, which are thought to play also a sensory role [124-125], and specialized dendritic 
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Langerhans cells (which have an essential role in the skin immune defense system) [126-
127]. One of the most important criteria for evaluation of the performance of any in vitro 
skin culture system is the formation of a competent permeability barrier [128]. The human 
skin permeability resides in the uppermost layer of the epidermis, the stratum corneum, 
that consists of protein-enriched corneocytes embedded in a lipid-enriched, intercellular 
matrix [128]. The extracellular lipids are organized in multiple bilayers originating from 
small organelles, the so-called lamellar bodies, that are synthesized in the spinous and 
granular cells [128]. The stratum corneum provides the greatest barrier function against 
hydrophilic compounds, whereas the viable epidermis is most resistant to highly lipophilic 
compounds [114]. The lack of correlation in transdermal permeation of molecules between 
species or from different application sites in the same animal model is due mainly to 
variations in stratum corneum thickness, in the composition of intercellular stratum 
corneum lipids and in the number of skin shafts [123]. 
 
5.1.2 Drug permeability in vitro models 
The limited availability and poor reproducibility of ex vivo human skin samples 
have led various investigators to develop three-dimensional models to allow the metabolic 
behaviour of human skin [129]. To determine dermal absorption by in vitro experiments, 
the freshly prepared human skin is nearest to the human in vivo situation. However, 
supply of fresh human skin by surgical departments is minimal and irregular, with 
considerable difficulties associated with legal and ethical issues, linked to the use of 
human tissues for commercial purposes. Also, the access to human material is limited and 
their freezer storage may influence its properties. Furthermore, high variability is possible 
due to donor or preparation techniques, which led to increased efforts to develop high 
reproducible and cost effective skin models equivalents. The development of genetically 
controlled and well-characterized skin models can have important implications, not only 
for scientists and physicians, but also for manufacturers, consumers, governing regulatory 
boards and animal welfare organizations [122]. Therefore, since 1970's a considerable 
interest has focused on three-dimensional reconstructed human skin models. Nowadays, 
for dermal penetration studies epidermal models (containing keratinocytes) and "full 
thickness" models (containing keratinocytes and fibroblasts) are commercially available.  
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5.1.2.1 Two-dimensional (2-D) models 
Monolayer cultures of human cells as human derived cell lines have been used for 
many years. Data of the past 30 years demonstrated the significant limitations of 
traditional two-dimensional (2-D) cell monolayers in predicting the behaviour of cells in 
living organisms [130]. 2D monolayer models not only fail to reproduce the complex and 
dynamic environments of in vivo tissues, but can also trigger false results by forcing cells 
to adapt to an artificial, flat and rigid surface [122]. The chemically and spatially defined 
three-dimensional (3-D) network of tissue-specific architecture, mechanical and 
biochemical signals, and cell–cell communication are lost. All these mechanisms that 
governs differentiation, proliferation and function of cells in vivo are, in fact, lost under the 
simplified 2-D conditions [130]. Interactions between individual cells, its immediate 
neighbors and the extracellular matrix are responsible for the control of cell behavior, 
which means that cells in 2-D mono layers cannot capture the relevant complexity of the 
in vivo microenvironment [130]. Keratinocytes in monoculture produce only a thin 
epidermal layer and without mesenchymal support undergo apoptosis after about 2 weeks 
in culture [131]. They are also influenced by dermal fibroblasts that induce the production 
of basement membrane proteins or melanogenic factors by secretion of soluble factors 
that diffuse to the overlying epidermis, being another limitation of 2-D models [131-132].  
Dermal fibroblasts promote not only keratinocyte proliferation, but also the development of 
identifiable keratinocytes layers [122]. Consequently, properly stratified epithelia fails to 
form in simple 2-D feeder-layer co-cultures, upon combination of post mitotic dermal 
fibroblasts (feeder cells) and epidermal keratinocytes [122], submerged cultures restrict 
the testing to materials that can be dissolved in aqueous media. Thus, oil-soluble 
ingredients and finished products such as creams, lotions, or powders cannot be 
adequately tested in submerged culture systems. Furthermore, submerged culture 
systems of skin cells do not possess differentiated functions and barrier properties of 
stratified skin tissues and thus do not accurately reflect the in vivo physiology of the skin. 
However, as they are easy and convenient to set up, they still represent the most popular 
models for in vitro studies, as the 3-D models are very expensive [130]. 
Therefore, strategies that allow the reconstitution of artificial human skin 
equivalents in a 3-D setting provide versatility as well as answers to physiological 
questions that cannot be answered in the context of monolayer tissue culture [122]. 
Introducing skin models also used for skin absorption, beside skin corrosion and skin 
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irritation, would allow comparing results for specific chemicals across endpoints more 
easily. 
5.1.2.2 Three-dimensional (3-D) models 
Skin equivalents have been used to measure percutaneous absorption [123], 
being able to reproduce specific tissue-like structures and to mimic functions and 
responses of real tissues in a way that is more physiologically relevant than what can be 
achieved through traditional 2-D cell monolayers. Thus, 3-D cell culture represents a 
potential bridge to cover the gap between animal models and human studies. In vivo, cells 
develop and grow within the 3-D architecture of tissues and organs [130]. Since the 1970s 
the design of a 3-D microenvironment to assess dermal permeability has been proposed. 
Today a variety of 3D in vitro reconstructed human skin models for dermal permeation are 
commercially available on a routine basis, with a very similar structure to native skin 
(Figure 1.6).  
 
Figure 1.6 - Morphology of human skin and different in vitro dermal permeation models (A) normal human skin 
epidermis, (B) EpiSkinTM model, (C) EpiDermTM model, (D) StrataTestTM, (E) SkinEthicTM RHE model, (F) 
Epiderm FTTM and (G) epiCSTM by Hematoxylin and Eosin (HE). 
 
Table 1.4 summarizes the 3-D models available in the market for dermal 
permeation studies. 
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Table 1.4 - Summary of commercially available human skin equivalents. 1 
In vitro model Company Product description Membrane Biological origin of cells 
SkinEthicTM Rhe 
(Reconstructed 
Human Epidermis) 
SkinEthic 
Human keratinocytes cultured on an inert polycarbonate filter at the 
air-liquid interface in chemically defined medium 
Polycarbonate 
Single neonatal donor - 
foreskin or abdomen 
EpiSkinTM SkinEthic 
Human keratinocytes cultured on a collagen base which permit 
terminal differentiation and reconstruction of the epidermis with a 
functional stratum corneum 
Collagen I sheet Several donors - abdomen 
EpidermTM MatTek 
Neonatal human-derived epidermal keratinocytes (NHEK) cultured to 
form a multi-layered, highly differentiated model of the human 
epidermis  
Collagen coated 
Single donor (neonatal or 
adult) - foreskin or 
abdomen 
Epiderm FTTM MatTek 
Neonatal human-derived dermal fibroblasts (NHFB) and NHEK co-
cultured to form a multi-layered, highly differentiated model of the 
human dermis and epidermis 
Collagen matrix 
Single donor (neonatal or 
adult) - foreskin or 
abdomen 
epiCSTM 
CellSystems 
Biotechnologie 
GmbH 
Reconstructed epidermal model made from primary human 
keratinocytes; it comprises a fully differentiated epidermis with viable 
and cornified cell layers 
Polycarbonate 
Single neonatal donor - 
foreskin or abdomen 
StrataTestTM StrataTech 
Full thickness skin model where a near-diploid human keratinocytes 
cell line, NIKS, was utilized. 
Collagen I sheet - 
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These skin models constitute a platform for cosmetic, photoaging and cancer 
models, as well as an excellent system for pharmacological analyses [122]. Moreover, 
they represent time and cost-effective alternatives to the use of laboratory animals that 
are currently being used for such studies [122]. 
According to different authors, cells growing in 3-D have different cell surface 
receptor expression, proliferative capacity, extracellular matrix synthesis, cell density, and 
metabolic functions [130, 133-134]. The performance of an in vitro skin culture system 
could be evaluated by the formation of a competent permeability barrier, which resides in 
the upper layer of the epidermis, the stratum corneum, that consists of protein-enriched 
corneocytes embedded in a lipid-enriched, intercellular matrix [128].  To be accepted as a 
valid human skin model, several criteria must be met. According to Schaefer et al., the 
artificial skin must compromise a functional stratum corneum, as well as the viability of the 
epidermis [113]. The chemicals to be tested are applied up to 4 h as a liquid or a wet 
powder onto the skin model. Afterwards, careful washing has to be performed before 
sequential analyses.  
However, these models still have some deficiencies such as the absence of skin 
appendages including pilosebaceous units, hair follicles and sweat glands [135]. 
Moreover, these tissues provide much lower barrier properties than the whole skin due to 
their structure and lipid composition. For this reason, the kinetic parameters of skin 
permeation obtained overestimate flux across human skin [135]. 
Different types of reconstructed human skin models can be produced, depending 
on the substrate used:  reconstructed epidermis and reconstructed "full thickness models". 
Both types are described in detail below. 
 
5.1.3 Reconstructed dermal equivalents 
5.1.3.1 EpiSkinTM 
The EpiSkinTM model (L’Oréal, Lyon, France) is one of the most used in skin 
permeation/absorption studies [135]. Research work with skin models is carried out at the 
research center of L’Oréal, leading to the development of artificial skin models.  The 
EpiSkinTM model was first developed by E. Tinois and was bought by L’Oréal in April 1997 
[135]. According to the manufacture, it consists of a dermal substrate generated on type I 
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bovine collagen matrix, representing the dermis, with a film of type IV human collagen, 
upon which is laid, after 13 days in culture, stratified differentiated epidermis derived from 
second passage human keratinocytes. If a more suitable model for studying drug 
penetration is required, keratinocytes are cultured for 20 days prior transferring to the 
collagen substrate [136].  
The EpiSkinTM model contains the epidermal layers of native skin. In general, the 
overall ultrastructural appearance of the epidermis is highly similar to native tissue, with 
seven cell layers (38-48 µm) in penetration skin models [128]. It is also possible to 
observe the presence of a thick stratum corneum of about 60-100 layers (73-102 µm) 
[128]. All major epidermal strata, including stratum basale, stratum spinosum, stratum 
granulosum and stratum corneum, are present. However, according to Ponec et al. it is 
not always possible to distinguish the different strata of the viable cell layers (basale, 
spinosum and granulosum) in EpiSkinTM penetration models [128].  
The stratum corneum present a significantly increased number of cell layers 
compared to most native stratum corneum samples, being thicker [135]. The cells of the 
viable portion of the EpiSkinTM model are organized somewhat differently than in native 
epidermis. Also, sudden changes in cell shape in the suprabasal compartment occurred 
and basal cells tend to be cubical in shape, while the upper cell layers are relatively flat. 
Granular cells with keratohyalin are present but with irregular shape. Regarding the lipid 
composition, all major epidermal classes are present. The phosphatidylcholine, 
phosphatidylserine, phosphatidylinositol, phosphatidylethanolamine and cholesterol 
contents are closed to native tissue [128]. Some differences are found regarding 
lanosterol, di-/triglycerides and free fatty acids as well as phospholipids amounts which 
are considerably lower. Also, the ceramide amounts in the EpiSkinTM models differed from 
native epidermis. The basal cell layer had a more irregular appearance, with lipid droplets 
short keratin filaments in the cytoplasm of basal cells [128]. Regarding stratum spinosum, 
cells could be irregular in shape [128]. In stratum granulosum numerous lamellar bodies 
were ubiquitously present at amounts similar to native tissue [128]. 
Currently, EpiSkinTM kit has 12 well plates and the assay mimics the normal route 
of exposure. The model is adapted to safety or efficacy assays from products for several 
applications. Regarding safety assays, at the moment the model is validated by OECD for 
skin corrosion (OECD 431) [119] and irritation (OECD 439) [137].  The protocol was 
based on a short treatment time (15 min) with the compound, placed on the top of the 
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model, followed by an extended 42 hour post treatment incubation period. The prediction 
model is mainly based on the validate cell viability measurement (MTT) as endpoint. 
Complementary assays could be done such as LDH, cytokine release, histology analyses 
or even gene arrays. It should also be noted the low intra-batch variation, but a greater 
inter-batch variation.  
Different authors had used EpiSkinTM in vitro model to evaluate permeation of 
different compounds. Rozman et al. evaluated the absorption of vitamins C and E from 
topical microemulsions using reconstructed human epidermis as skin model [138]. In this 
particular study, RHE were placed on static Franz diffusional cells and the formulations 
placed on the donor compartment [138].  Dreher et al. investigated caffeine’s and α-
tocopherol’s cutaneous bioavailability from cosmetic vehicles such as a water-in-oil 
emulsion, an oil-in-water emulsion, a liposome dispersion and a hydrogel applied at finite 
dose using the reconstructed human skin models EpiDermTM and EpiSkinTM [139].  
 
5.1.3.2 EpidermTM 
The EpidermTM model (MatTek Corporation, MA, USA) was introduced in 
commercial market in 1993. The dermal penetration of drugs can be easily predicted by 
this model. It is composed by human epidermal keratinocytes as fully-differentiated 
epidermal tissue (fully-differentiated natural epidermis displaying a basement membrane, 
proliferating keratinocytes and a stratum corneum) after air-liquid interface cultivation on 
inert polycarbonate membranes. The model tissue consists on metabolica and mitotically 
active cells organized into a basal, spinous and granular layers, along with a multi-layered 
stratum corneum [136].  
Regarding their composition, EpiDermTM cultures have an epidermal thickness of 
about six to eight layers (28-43 µm) and a stratum corneum with  16-25 layers (12-28 µm) 
[128]. Stratum basale have columnar to round in shape basal cells and lamellar 
bodies and lipid droplets were found in stratum spinosum [128]. In both native skin and 
EpidermTM model, stratum granulosum is characterized by two cytoplasmic organelles: 
stellate shaped keratohyalin granules and lamellar bodies. 
Regarding stratum corneum, EpiDermTM cultures are characterized by 
intracellularly located lipid droplets in corneocytes [128]. The total lipid content was 
the highest in EpiDermTM models and similar to native skin (0.997±0.06 mg/cm2, 
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representing 35%) [128]. Lipid analyses revealed that the major barrier lipids are 
synthesized in vitro but in different proportions of native skin. It has a low content of fatty 
acids and an incomplete profile of glucosphingolipids and ceramides. The relative amount 
of individual phospholipid classes is similar to EpiSkinTM. 
An evaluation of dermal penetration with EpiDermTM used two hair dye ingredients, 
p-aminophenol and p-phenylenediamine [140]. Both compounds were applied topically or 
from the bottom of the tissue via the culture media. More recently, Lombardi Rogia et al. 
compared six commercial prednicarbate preparations for topical use using EpidermalTM 
model [141]. 
5.1.3.3 SkinEthicTM 
The SkinEthic Reconstructed Human Epidermis (RHE)™ model was developed by 
M. Rosdy in 1990 and became commercially available in 1993 by SkinEthic Laboratories, 
acquired by L’Oreal in 2006.  The model is generated on inert polycarbonate filters where 
normal human keratinocytes are cultured. The epidermis consisted of five to nine cell 
layers (23-59 µm) and 14-24 layers (15-32 µm) in the stratum corneum [128]. The 
presence of layer hemidesmosomes could be demonstrated [128]. Stratum basale present 
columnar to round in shape basal cells and  lipid droplets in the cytoplasm [128]. The RHE 
expresses the major differentiation markers (filaggrin and involucrin in granular cell layers, 
transglutaminase I and keratin 10 in supra basal cell layers and loricrin in upper granular 
cell layers), as well as expressing the basement membrane markers (type IV collagen; 
integrin alpha 6, integrin beta 4, antigen BP, laminin I and laminin V). Free fatty acids and 
ceramides are detected in the lipid profile. The ultra-structural features show secretion 
and normal arrangement of bi-layered lipid content into the intercellular spaces of the 
cornified cell layers (formation of normal permeability barrier). 
An advantage of RHE is the possibility of incorporating various additional cell 
types, such as melanocytes, in combination with keratinocytes or the creation of 
pathological models. 
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5.1.4 Reconstructed "full thickness models" 
 
5.1.4.1 StrataTestTM  
The StrataTestTM human skin model has been developed to simulate the 
architecture and biological responses of human skin [142]. The model was developed and 
commercialized by Stratatech Corporation (Madison, WI, USA), founded in 2000, under 
the same standards as the company’s flagship StrataGraftTM human skin substitute, which 
recently was evaluated in a human clinical safety trial.  
This model is constituted by pathogen-free NIKSTM keratinocyte progenitors - a 
human keratinocytes cell line that produces living tissue nearly identical to the native 
human skin. It is a fully-stratified tissue containing epidermal and dermal components that 
possesses barrier function. According to the manufacturer, NIKSTM reproduce normal 
human skin tissue architecture and barrier function when cultured appropriately [142]. 
These novel cells possess the ability to undergo normal epidermal differentiation, 
generating a fully-stratified epithelium similar to that of native human epidermis [143]. The 
full-thickness model is produced in individual cell culture inserts with a surface area of 
0.6 cm2, where normal human dermal fibroblasts are embedded in type I collagen and 
NIKSTM cells seeded onto dermal equivalents and later lifted to the air interface to promote 
terminal differentiation. Histological and indirect immunofluorescent analysis confirmed the 
formation of epidermal tissue with the appropriate expression of proteins, essential for the 
integrity, structure, and function of human skin. The analysis of the full-thickness 
StrataTestTM human skin model confirmed the formation of tissue typical of the 
interfollicular epidermis, as well as the expression and appropriate localization of proteins 
essential to cell–cell adhesion, basement membrane formation, and epidermal function 
[142]. The model is supplied in 24 well plates format not yet validated by OECD or 
ECVAM. Nevertheless, according to the manufacturers, the main advantage of this model 
is the use of NIKSTM cells that yields a skin model with a high degree of consistency, 
advantageous over other in vitro models such as EpiDerm™, EpiSkinTM or EST1000. The 
later ones must periodically change the source of donor cells or are manufactured using 
cells pooled from multiple donors [142]. 
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5.1.4.2 Epiderm FTTM 
Recently, MatTek has developed EpiDerm FTTM, a full thickness skin model. It 
contains normal, epidermal keratinocytes and dermal fibroblasts human-derived, cultured 
to form a highly differentiated model of the human dermis and epidermis. Both cell lines 
are cultured on specially prepared cell culture inserts using serum free medium. 
Ultrastructurally, the EpiDerm FTTM closely parallels human skin, being mitotic and 
metabolically active, providing a useful in vitro way to assess dermal irritancy and toxicity. 
The model present organized basal, spinous, granular, and cornified epidermal 
layers and a dermal compartment composed by a collagen matrix containing viable 
normal human dermal fibroblasts. A set of markers proves the epidermis-specific 
differentiation.  Immunohistochemical analysis shows the presence of basement 
membrane structure and signaling proteins including collagen IV, Laminin, collagen VII 
and integrin α6. 
 
5.1.4.3 epiCSTM 
epiCSTM (CellSystems, Germany), available since 2004, consists of normal human 
epidermal keratinocytes from a single neonatal donor. A submerse culture of the 
keratinocytes is followed by a culture at air-liquid interphase. This “airlift culture” under 
defined media conditions stimulates the differentiation of the cells and the generation of 
the physiological epidermal layers. The model presents basement membrane, proliferating 
keratinocytes and a stratum corneum with an intact barrier function on a polycarbonate 
membrane. The epidermis model is supplied in convenient 24-well formats. Until recently 
the epiCSTM test method was formerly known under the name EST-1000 and was recently 
renamed.  
epiCSTM (CellSystems, Germany) is validated for the classification of compounds 
concerning skin corrosion according to the OECD test guideline 431 for testing of 
chemicals and ECVAM has accepted this method to be used for distinguishing between 
corrosive and non-corrosive chemicals [144]. 
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5.2 Models limitations 
The in vitro 3-D models are close to reproducing human skin due to their general 
histological architecture and physiological properties. Although their similarity to human 
native skin, some important limitations could be reported: models are considerably more 
permeable than human skin and the barrier function is weak. However, the culture models 
appear to be more consistent in permeability and responsiveness with less variability. 
Thus, the major goal of manufacturers is to fit skin models with a barrier similar to human 
skin in vivo. Nevertheless, it should be noted the constant development of commercially 
available skin models, representing a considerable improvement over the years. As 
alternative methods, they are useful for the development of new products by the 
pharmaceutical and cosmetics industries. Further researches and studies with in vitro 
models still represent an important challenge. Also, development of 3-D tissue models 
and the validation of applications based on those tissues will need to occur in the future.  
 
 
5.3 Skin biophysical techniques 
About twenty years ago cosmetic products promotion took more importance and 
advertising claims became more aggressive and closer to the limit of what could be 
scientifically shown and consumer perceived [145]. In order to monitor the claims made 
about cosmetic products and protect the consumer against misleading advertisement, 
European Commission have issued rules under the form of laws, or directives, to ensure 
that proper substantiation of claims exists [145]. In the European Union, cosmetic claims 
substantiation is regulated since 1997, stating that cosmetics and toiletries manufacturers 
making claims for their products have to demonstrate the proof of their claims [109].  
Skin biophysical techniques are used to support claims. Claims on cosmetic 
products are extremely varied and often depend on the product, the market, and the 
current trends. However, several claims have been used on different product types for 
many years. Different claims could be evaluated such as safety-related claims (e.g., 
mildness, sensitive skin-designed products, non comedogenicity claims), some efficacy 
claims (e.g., skin-hydration effect, smoothing and anti-wrinkle effect) or sensory claims. 
The application of biophysical techniques in the study of cosmetics efficacy is of huge 
importance. Biophysical instruments are objective and quantitative tools for 
characterization of different skin conditions and have widely been used in the evaluation 
of the effect of formulations of topical use, mainly due to the fact of facilitating the 
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evaluation of products in its real use conditions, that is to say, directly in the human skin. 
The confirmation of the effects of cosmetic products and its action mechanism, by means 
of experimental protocols properly elaborated using the skin biophysics is of fundamental 
importance. In the later 20 years, skin engineering techniques have been considerably 
improved especially since the implementation of the European Directive 2003/15/EC2 
prohibiting animal experiments for testing cosmetic ingredients and products [146]. In vivo 
skin mechanical testing was primarily developed for the dermocosmetic industry [146]. 
There are numerous biophysical methodologies available that allow the non-invasive 
evaluation of different skin properties. Through these techniques it is possible to assess 
the effectiveness of cosmetic products as well as to ascertain the normal functioning of 
the skin. The skin biophysical techniques comprises a set of methods that, through not 
invasive instruments, evaluates the physicochemical properties of the skin, such as 
sebum, hydration, pH, mechanical properties, transepidermal water loss, pigment or 
temperature [147-148]. In this brief section, the biophysical methods commonly used in 
the assessment of the effects of the skin care formulations will be discussed. 
 
5.3.1 Hydratation 
Cosmetic and dermato-pharmaceutical products often claim skin-moisturizing 
benefits. The measurement of hydration in the surface layer of the skin, stratum corneum, 
gives important information on the biophysical properties and function of the skin barrier 
[149]. With an adequate amount of water in the SC the skin maintains it intact barrier 
function, feels soft and flexible, looking smooth and healthy. Different methods could be 
used for determining the hydration state of SC. The degree of hydration is most frequently 
determined by measuring electrical properties of skin [150]. Infrared and photoacoustic 
spectroscopy have also been used [150]. Measurement of skin permeability to alternating 
electric current (impedance) reflects electromagnetic interaction with skin dipoles 
(proteins) and electrolytes.  
Since 80th decade, many types of instruments have been developed and used 
widely for diagnosis and the development of moisturizing agents and other topical drugs 
[151]. The equipments commonly used are based on the measurement of electrical 
capacitance, impedance and conductance. Inside these, the most used equipments are 
based on electrical capacitance measurements. By definition, electrical impedance 
corresponds to the opposition that skin offers when is subjected to an alternating current. 
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In turn, capacitance is an electrical quantity determined by the amount of electrical energy 
that can be accumulated in the skin and the amount of alternating current there through at 
a certain frequency.  Finally, the conductance measurement principle, also known as the 
electrodermal response (and in older terminology as "galvanic skin response"), is known 
to measure the water binding capacity of the stratum corneum. In this phenomenon skin 
momentarily becomes a better conductor of electricity when either external or internal 
stimuli occur that are physiologically arousing. Different equipments are available in the 
market for hydration evaluation. The most commonly used is Corneometer® (Courage & 
Khasaka, Köln, Germany) that is based on a capacitive measurement principle - Figure 
1.7.  
 
Figure 1.7 – Corneometer® probe (Available from http://www.courage-khazaka.de/index.php/en/faq-en/faq-
scientific-devices/61-corneometer; accessed on 25.01.16). 
 
The probe is made of two finger-type metal plates close to each other, with a 
measurement depth of approximately 40 µm [152]. The capacitance measurement is 
based on the difference between the dielectric constant of water and other substances 
(the constant value dielectric is, in most cases, less than 7) [152]. The measurement is 
performed by placing the head of the probe on the skin surface. During the measurement, 
an electric field penetrates the skin and allows the determination of the difference between 
dielectric constants [152]. The modification of the registered capacitance by Corneometer® 
in contact with the SC is a function of the water content. The hydration of the SC values is 
expressed in arbitrary units (AU).  
 
5.3.2 Transepidermal water loss (TEWL) 
Measurement of transepidermal water loss (TEWL), expressed in grams per 
squaremeter and per hour, is used for studying the water barrier function of the human 
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skin. Based on the estimation of the water vapor gradient in an open chamber, it is being 
used to support claims of cosmetics including product mildness, reduction of skin irritation 
reactions, skin hydration, skin repair, protective effect against UV damage and others 
[153]. TEWL measurement can also screen ingredients that have a beneficial effect on the 
barrier function and offer the possibility to monitor in vivo, in human skin, the effect of 
topical treatment in an objective and non-invasive way [153]. This method uses an electric 
hygrometer to measure the amount of water being lost slowly from the body through the 
stratum corneum. The measurement principle is based on Fick's diffusion law, defining the 
mass of water transported per unit area of skin over a period of time. A high number of 
variables affecting TEWL measurements have been identified. Because the measurement 
is affected by perspiration, it is performed at an ambient temperature of 22°C or less and 
under conditions that cause no sweating [151]. According to Martini et al. the average flow 
of water that evaporates at the skin surface is 5 g/m2/hour, corresponding to a water loss 
of 300 and 400 ml/24 hours [154]. However, despite being a permanent evaporation, 
water is renewed by a process of diffusion from the deeper layers of skin and is also offset 
by a nutritional support, calling up this process by TEWL [154]. The Standardization 
Group of the European Society of Contact Dermatitis had published guidelines on 
exposure testing with sodium lauryl sulfate (SLS) [155].  
Different equipments are available in the market: ServoMed® (SeroMed AB, 
Stockholm, Sweden), Tewameter® (Courage & Khazaka, Köln, Germany), AquaFlux® 
(Biox Systems Ltd, London, United Kingdom) or VapoMeter® (Delfin Technology, Kuopio, 
Finland). The most used equipment for the TEWL evaluation is Tewameter®. According to 
Courage & Khazaka the Tewameter® probe measures the density gradient of the water 
evaporation from the skin indirectly by the two pairs of sensors (temperature and relative 
humidity) inside the hollow cylinder (Figure 1.8) [156].  
 
Figure 1.8 - Tewameter® probe (Available from http://www.courage-
khazaka.de/index.php/en/products/scientific/139-tewameter; accessed on 25.01.16). 
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5.3.3 pH 
The pH (hydrogen ionic concentration) determination of cutaneous surface is seen 
as an important functional indicator of the skin, since it arises from the production of lactic 
acid which confers the so-called "cutaneous acid mantle” [157]. Healthy skin presents a 
slightly acid pH (4.6-5.8), which contributes to the bactericidal and fungicidal protection of 
its surface [157]. Furthermore, the cutaneous secretions present an appreciable buffering 
capacity, which are extremely important when skin pH is altered as a consequence of use 
of inappropriate topical products. Hence, the determination and control of cutaneous pH, 
from the cosmetic and/or dermatological point of view, are of extreme importance. 
Skin-pH-meter® (Courage & Khazaka, Köln, Germany) uses the direct 
potentiometry method through a special electrode for measurement of this variable and 
allows sensitivity in the order of 0.1 of the pH unit. According to the manufacture, both 
glass H+ ion sensitive electrode and additional reference electrode are placed in one 
housing that is connected to a probe handle containing the measurement electronics 
[158]. Figure 1.9 shows a Skin-pH-meter® probe. 
 
 
Figure 1.9 - Skin-pH-meter® probe (Available from http://www.courage-
khazaka.de/index.php/en/products/scientific/132-skinphmeter; accessed on 25.01.16). 
 
5.3.4 Skin color 
The measurement of the redness, whiteness, and pigmentation of the skin has 
been showing extremely remarkable progress. Most color measurements of the skin 
surface are based on reflectance colorimetry instruments, such as Chromameter (Minolta, 
Tokyo, Japan), erythema index, Erythema meter (Diastron, Hampshire, United Kingdom), 
Mexameter® (Courage & Khazaka, Köln, Germany) or Dermaspectrometer (Cortex 
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Technology, Hadsund, Denmark). One of the most notable developments is Minolta 
Chromameter®. These instruments are based on the same optical principle, namely, 
measurements of light absorption and reflection of respectively the melanin and 
hemoglobin components of the skin. The specific absorption of melanin and hemoglobin in 
the visible (green and red) and in the near infrared is determined and these instruments 
quantify redness by a relative erythema index. The erythema index is proportional to the 
hemoglobin content of the upper layers of the dermis. The Minolta Chromameter®, 
considered by many investigators as a sort of reference instrument, quantifies skin 
surface color using the three-dimensional CIE color representation with the L*a*b* system.  
 
5.3.5 Mechanical properties of skin 
Skin and its subcutaneous layer represent a complex composite of tissues, whose 
mechanical characteristics depend upon the mutual interdependence of their constituent 
parts. The stratum corneum, the association between the living epidermis and papillary 
dermis, the reticular dermis and the hypodermis have each their own intimate structures 
whose tensile functions are ideally balanced to respond adequately to the casual 
mechanical demands [159]. The viscoelastic functions of aging skin can be tested by 
altering the orientation and magnitude of imposed stresses and strains over time [160]. 
The assessment of tensile functions of skin can be performed by distinct approaches 
mainly characterized by the orientation and magnitude of the imposed stress and strain 
over time. Testing methods are basically grouped into six major classes: tensile, torsional, 
acoustic shear wave, indentation, impact and elevation [160-161]. This topic was 
extensively addressed by the Efficacy Measurements on Cosmetics and Other Topical 
Products (EEMCO) group [159-160].  
Non invasive suction devices were employed for the study of the elastic properties 
of the skin.  Different equipments are available in the market considering the major 
classes mentioned: Frictiometer® (Courage & Khazaka, Köln, Germany) that uses 
torsional tests; Reviscometer® (Courage & Khazaka, Köln, Germany) with acoustic shear 
wave; or Cutometer® (Courage & Khazaka, Köln, Germany) and Dermaflex® (Cortex 
Technology, Hadsund, Denmark) with indentation.  
In the present work, Cutomer® was the device selected. Cutometer® is a 
commercially available device that comprehensively measures the mechanical and 
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physical properties of the skin, such as extensibility and viscoelasticity [151]. This 
instrument applies suction to the skin and measures its displacement and time to recovery 
[151]. Briefly, the measuring principle is based on the suction method [162]. A negative 
pressure (a maximum of 500 mbar) is created in the device, the skin is drawn into the 
aperture of the probe, and after a defined time released again. Inside the probe, the 
penetration depth is determined by a non-contact optical measuring system. This optical 
measuring system consists of a light source and a light receptor, as well as two prisms 
facing each other, which project the light from transmitter to receptor. The light intensity 
varies due to the penetration depth of the skin. Figure 1.10 represents a Cutometer®. 
 
Figure 1.10 – Cutometer® probe (Available from http://www.courage-khazaka.de/index.php/en/faq-en/faq-
scientific-devices/69-cutometer; accessed on 25.01.16). 
 
The resistance of the skin to the negative pressure (firmness) and its ability to 
return into its original position (elasticity) are displayed as curves (penetration depth in 
mm/time) in real time during the measurement - Figure 1.11.  
 
Figure 1.11 – Graphical scheme of a skin deformation curve obtained with the Cutometer®. 
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With these curves different parameters could be obtained, such as: 
Uf (Ue+Uv) - maximum amplitude and represents the passive behavior of the skin to force 
(firmness). 
Ur - The ability of the skin to return to its original state (minimum amplitude after 
relaxation). 
Ua - Complete relaxation after the pressure is cut off. 
Ua/Uf - Gross elasticity: resistance versus ability of returning. 
Ur/Ue - Net elasticity: elastic portion of the suction part versus the elastic portion of the 
relaxation part. 
Uv/Ue - Portion of the viscoelasticity of the curve. 
Ur/Uf - Portion of the elasticity compared to the complete curve. 
This measurement principle allows getting information about the elastic and 
mechanical properties of skin surface and enables to objectively quantify skin aging [162].  
 
5.3.6 Skin surface topography 
Wrinkles can be easily visualized and many clinical studies have involved the use 
of ranking scales that rely on subjective assessments by expert graders. To make 
possible to achieve this goal, fast and exactly working 3D in vivo measurement methods 
are necessary, which permit a direct access to the three-dimensionality of the human skin 
surface. 
Evaluation of wrinkles using skin replicas has also been used along with the visual 
evaluation [163]. The most common approach for measuring the geometric properties of 
human skin is to transfer the details of the skin’s topography to a material suitable for the 
selected method of measurement [164]. Various measuring instruments and systems 
have been developed to gauge these replicas of human skin [164]. The most widely used 
method for detailed observation of skin surface topography seems to be the replica 
(microrelief) method [151]. The surface topography of the skin is transferred to a soft 
nitrocellulose or silicone rubber material, transferred further from it to a resin or other 
appropriate material, and then observed under the light or electron microscope. Many 
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techniques have been developed to analyze replicas according to different principles 
[163]. Those techniques include profilometric methods [165-166], two-dimensional image 
analysis [167] and scanning electron or confocal microscopic methods [168]. Therefore, 
methods using replicas are quite greatly useful and convenient to evaluate wrinkle levels 
in subjects or the wrinkle smoothing efficacy of products or cosmetic surgery [163]. 
However, replicas do not reflect the morphology of the skin perfectly because accurate 
morphological information of the skin might be lost during the replica process [163]. 
Attempts have been made to visualize the surface topography in 2-dimensional 
representation and to achieve 3-dimensional reconstruction [151, 169-170]. At present, 
specimens are usually observed under oblique light and the resulting shadows are read 
into an image analyzer connected to a computer, which calculates the area of detected 
shadows. Three-dimensional in-vivo optical skin imaging provided a rapid and quantitative 
assessment of surface topography and facial fine lines. With the digital fringe projection 
based on micromirror projectors from the Texas Instruments company and the PRIMOS® 
technology, respectively, a new optical 3D measurement method is presented, which 
makes it possible to measure human skin surfaces fast and very accurately, both in the 
micro and macro-ranges and to document treatment results objectively.  
The PRIMOS® optical three-dimensional in vivo skin measurement device deploys 
a parallel stripe pattern imaging technique that is projected onto the skin surface and 
depicted on the charge coupled device chip of a high resolution camera [170]. Light 
patterns are created by a digital micromirror projector. The use of micromirror-based 
digital light projectors is advantageous when applied to optical 3D in vivo skin 
measurement because the light intensity is high, exposure time is short and the light can 
be controlled point and/or pixel wise [170]. The 3D effect is achieved by means of minute 
elevation differences on the skin surface deflecting the parallel projection stripes to 
produce a qualitative and quantitative measurement of the skin’s profile [170]. Images are 
digitized and transferred for computer assisted quantitative evaluation and measurement. 
Mathematical algorithms embedded in the analytical software reconstruct the data into a 
highly precise 3D profile of the skin.  
A 3D optical scanner using fringe projection is used to acquire a 3D surface image 
of an area and its surrounding skin. For this thesis the PRIMOS® 3D portable scanner 
shown in Figure 1.12 was used.  
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Figure 1.12 – The PRIMOS® equipment (Available from http://www.in-
cosmetics.com/__novadocuments/34659?v=635120853501200000; accessed on 24.01.16). 
 
Three-dimensional in vivo optical imaging provided higher resolution of the skin 
topography than analysis by clinical photography or skin replicas changes, and was in 
agreement with clinical photography or skin replicas changes, clinical assessment and 
objective 3D in vivo imaging. Its acquisition time is <100 ms with a lateral and vertical 
resolution of 28 µm and 2 µm, respectively. 
The application of skin biophysical techniques has enabled researchers to grasp 
numerically the properties of the skin that cannot be evaluated by the human senses. This 
approach has become essential to understand not only the changes caused by skin 
diseases, but also the characteristics of normal skin reflecting age, sex, and anatomical 
location, as well as the effectiveness of cosmetic products. 
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In recent years, issues of environmental and economic sustainability are subject of 
great attention from civil and business society. Production and sustainable processing of 
cosmetics are intended to significantly reduce the waste of raw materials and minimize 
pollution, becoming mandatory components of the business model. Indeed, at 16th July 
2008, the European Commission (EU) released the EU Commission Action Plan on 
Sustainable Consumption and Production (SCP) and Sustainable Industrial Policy (SIP), 
which includes a number of proposals on eco-design standards for wide range of 
products, energy and environmental labelling, incentives rewarding eco-friendly products 
(including green public procurement work with retailers), a retailer forum, environmental 
industry support, environmental technologies, green public procurement, and promotion of 
an international sustainable industry consumption and production, to contribute to an 
improvement in performance. It also aims to encourage EU industries for innovation 
opportunities. Sustainable production and consumption are, therefore, a challenge and an 
opportunity, maximizing the business potential for turn environmental challenges into 
economic opportunities. The ability to minimize environmental impacts, coupled with the 
ability to manage the re-introduction of underutilized by-products and products in the 
production chain, can be the guarantee in the future of the balance between economics, 
politics and environmental conservation. Thus, manage value added products such as red 
clover or coffee silverskin, introducing them in the chain of active ingredients used in 
cosmetic industry, could be an added value for green chemistry and environmental 
ecology.  
The main objectives undertaken on the present thesis were: 
i) Development and characterization of extracts obtained from food by-products. 
Concerning questions of sustainability, different solvents and temperatures were tested; 
ii) Development and characterization of a cosmetic line (with and without extracts) 
containing five different products: shower bath, scrub gel, hand cream, body cream and a 
face cream. Formulations were developed taking into account appropriate characteristics 
for skin compatibility; 
iii)  Assess the in vitro biological biocompatibility of extracts and cosmetic formulations. 
Skin cell lines (keratinocytes and fibroblasts) were used to study the safety; 
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iv) Evaluate the skin and ocular compatibility of extracts considering 3-D models. The 
selected models are validated alternatives by European Union Reference Laboratory for 
alternatives to animal testing (EURL-ECVAM); 
v) Evaluate the ex vivo skin permeation of extracts in Franz cells in semi-solids 
formulations and encapsulated into lipid nanoparticles; 
vi) Evaluate the in vivo efficacy and safety of the formulations developed. Thereunto, 
formulations were used and evaluated by human volunteers.  
 52 
 
 
 
 
 
 
 
 
EXPERIMENTAL PART 
 
 53 
 
      
 
 
 
 
 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       “Um horizonte, - a saudade  
          Do que não há-de voltar;  
          Outro horizonte, - a esperança  
          Dos tempos que hão-de chegar;  
          No presente, - sempre escuro, - 
          Vive a alma ambiciosa  
          Na ilusão voluptuosa  
          Do passado e do futuro.”  
 
 Machado de Assis
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Along the laboratorial development of this PhD thesis different formulations (with 
and without extracts) were elaborated. The processing steps controlled different 
characteristics of the final formulation such as viscosity, pH and stability, and also the 
market target, leading to the presented final formulations composition. For all of them, 
stability studies and safety assessment reports, as well as sensorial analysis, were 
performed. At the moment, five of them are commercialized and the other are in the final 
stage of production for commercialization. The different formulations are: 
 
1. Hand Cream 
Ingredients 
Composition(%) / Formulations 
Function 
W X Y Z 
A 77.73 75.23 75.23 75.23 Solvent 
B 10.00 10.00 10.00 10.00 Emulsifier, emollient, 
viscosity controller 
C 5.00 5.00 5.00 5.00 Skin protector, humectant 
D 3.00 3.00 3.00 3.00 Emollient, skin 
conditioner 
F 2.00 2.00 2.00 2.00 Emollient, skin 
conditioner 
Coffee silverskin 
Extract - 2.5 1.25 
- Active Ingredient 
Medicago sativa 
Extract - - 1.25 2.5 
Active Ingredient 
G 0.90 0.90 0.90 0.90 Skin conditioner 
H 0.50 0.50 0.50 0.50 Emulsifier 
I 0.50 0.50 0.50 0.50 Preservative 
J 0.30 0.30 0.30 0.30 Buffer 
K 0.07 0.07 0.07 0.07 Parfum 
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2. Body Cream 
Ingredients 
Composition(%) / Formulations 
Function 
X Y 
A 73.10 70.60 Solvent 
B 6.80 6.80 Emollient, skin protector 
C 5.00 5.00 Emollient, skin conditioner 
D 4.00 4.00 Skin protector, humectant 
E 3.80 3.80 Emulsifier 
F 2.20 2.20 Emulsifier 
G 1.50 1.50 Emulsifier 
Coffee silverskin Extract - 1.25 Active Ingredient 
Medicago sativa Extract - 1.25 Active Ingredient 
H 0.80 0.80 Emulsifier 
I 0.70 0.70 Skin conditioner 
J 0.60 0.60 Preservative 
K 0.50 0.50 Skin conditioner 
L 0.30 0.30 Viscosity controller 
M 0.30 0.30 Buffer 
N 0.20 0.20 Parfum 
O 0.10 0.10 Opacifier 
P 0.10 0.10 Buffer 
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3. Body Scrub 
 
Ingredients 
Composition(%) / Formulations 
Function 
X Y 
A 86.7712 84.2712 Solvent 
B 6.00 6.00 Abrasive  
C 3.00 3.00 Humectant 
D 1.80 1.80 Emulsifier, foam booster 
Coffee silverskin Extract 
- 
1.25 Active Ingredient 
Medicago sativa Extract 
- 
1.25 Active Ingredient 
E 0.80 0.80 Emulsifier 
F 0.60 0.60 Preservative 
G 0.50 0.50 Foam booster 
H 0.25 0.25 Emulsifier 
I 0.16 0.16 Parfum 
J 0.068 0.068 Buffer 
K 0.05 0.05 Chelator  
L 0.0008 0.0008 Colorant 
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4. Facial Cream 
 
Ingredients 
Composition(%) / Formulations 
Function 
X Y 
A 76.20 73.70 Solvent 
B 8.00 8.00 Emulsifier 
C 6.00 6.00 Emollient 
D 3.00 3.00 Emollient 
Coffee silverskin Extract 
- 
2.50 Active Ingredient 
E 2.00 2.00 Emulsifier, emulsion stabilizer 
F 2.00 2.00 Humectant 
G 1.50 1.50 Skin conditioner, moisturiser 
H 0.70 0.70 Parfum 
I 0.60 0.60 Preservative 
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5. Cleansing Shower Cream 
 
Ingredients 
Composition(%) / Formulations 
Function 
X Y 
A 66.57 64.07 Solvent 
B 14.00 14.00 Emulsifier 
C 6.00 6.00 Humectant 
D 
4.00 4.00 
Emulsifier, emollient, foam 
booster 
E 3.00 3.00 Foam booster 
F 2.30 2.30 Emulsifier 
Coffee silverskin Extract 
- 
1.25 Active Ingredient 
Medicago sativa Extract 
- 
1.25 Active Ingredient 
G 1.00 1.00 Cleanser, foam booster 
H 0.80 0.80 Skin conditioner 
I 0.65 0.65 Viscosity controller 
J 0.63 0.63 Emulsifier 
K 0.30 0.30 Viscosity controller 
L 0.20 0.20 Parfum 
M 
0.20 0.20 
Skin conditioner, skin 
protector 
N 0.15 0.15 Preservative 
O 0.10 0.10 Preservative 
P 0.10 0.10 Buffer 
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I. Evaluation of Medicago as New Ingredient 
for Skin Care Products 
 
 
The information presented in this chapter section was published in the following 
publication: 
- Francisca Rodrigues, Ana Palmeira-de-Oliveira José das Neves, Bruno Sarmento, M. 
Helena Amaral, M. Beatriz P.P. Oliveira, Medicago spp. extracts as promising ingredients 
for skin care products, Industrial Crops and Products, 49:634-644, 2013 
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1. Introduction 
 
In recent years there is an increased demand for natural plant extracts to be 
included into cosmetics, either as fragrances or for their medicinal properties. Indeed, 
these have been increasingly used in skin care products with claims of cosmeceutical 
effects [171-172]. Given the inherent economic potential in the exploitation of natural 
resources in ecosystems, herbal extracts have been used by cosmetic science in order to 
beautify and maintain the physiological balance of the human skin. The desirable features 
of cosmetic ingredients are efficacy, safety, novelty, formulation stability, easy metabolism 
in the skin and low cost. The referred characteristics can be attributed to herbal cosmetics 
with consequent increase in public demand. Furthermore, compared to synthetic cosmetic 
products, herbal products are mild and biodegradable, and simultaneously present low 
toxicity [173]. On the other hand, by-products of plant food processing represent a major 
disposal problem for the industry concerned. But some of them could be also promising 
sources of compounds due to their favourable technological or nutritional/medicinal 
properties [174]. Nowadays, millions of tons of by-products are produced during food 
processing in agro industries without economic value but potentially recoverable as new 
ingredients for the cosmetic and pharmaceutical industries. Therefore, one can use these 
wastes to obtain new topical natural antioxidants, maximizing agro-industrial residues, 
protecting the environment and also maximizing resources. The current challenges are to 
identify new bioactive natural compounds with potential application and/or replacement of 
synthetic substances, especially for food, pharmaceutical and cosmetic industries [175]. 
It has been well established that free radicals can cause oxidation and damage to 
biological molecules while phenolic compounds, due to their antioxidant activity, are able 
to neutralize their action [176]. Several plants have been studied as sources of potentially 
safe natural antioxidants for the food industry and various compounds have been isolated, 
many of them polyphenols [174, 177]. Topical natural antioxidants may also be a useful 
strategy for the prevention of photo aging and oxidative stress mediated skin diseases 
[178]. Many herbal agents used in cosmetics have been selected by a process of ‘trial and 
error’ and, thus, are used based on experience rather than experimental investigation. 
There is now, however, growing scientific evidence that plants possess a vast and 
complex arsenal of active ingredients able not only to calm or smooth but also actively 
restore, heal and protect the human skin [179-181]. 
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In addition, plant extracts may contain compounds with antimicrobial or other 
beneficial properties, influencing the formulation of natural and non-chemical cosmetic 
products. The public trend towards natural and sustainable products is on-going. However 
the contamination of cosmetic products is an inherent risk. Natural products, due to their 
composition, are more susceptible to microbial contamination [182]. Due to this drawback, 
formulators are looking for novel approaches to keep cosmetic products microbiologically 
stable. The evaluation of antimicrobial activity of the natural extracts is now included in the 
challenge. Thus, the study of plant extracts intended for cosmetic purposes, especially as 
preservatives, or to justify their use as antimicrobial agents, is very important. Indeed, 
some bacteria, which showed resistance to certain antibiotics, can be sensitive to extracts 
[183-184]. Natural extracts are part of a group of substances considered as “tolerated” but 
not admitted as additives in a strictly legal way [182]. Vegetal extracts would be included 
in the additive group classified as “aromatic and flavoring substances”, in which are 
included all the natural products and relevant synthetic products that can be used on all 
animal species, without any restriction regarding age or product dosage. Due to the fact 
that these products are well accepted by consumers, they are a promising alternative to 
antibiotics (not being the final product considered as medicinal), and the search of new 
substances represents an important research area.  
Although the term plant extract inherently purports their beneficial and benign 
properties, these could have adverse reactions in individuals. Therefore, it is essential to 
attend the issue of ensuring quality and safety of this extracts in cosmetic products before 
embarking on the more arduous task of ensuring efficacy. In view of this underlying 
principle, the screening of natural plant extracts with scavenging activity for pro-oxidant 
reactive species is a primary requirement for the development of new topical antioxidant 
formulations [178].  Also, during the development of new topic formulations, skin irritation 
potential is investigated prior to human exposure, in order to identify chemicals which 
might induce adverse skin reactions [172]. 
In this context, the study of the antioxidant and antimicrobial properties of extracts, 
associated with the study of their cytotoxicity in different skin cell types, like keratinocytes 
or fibroblasts, should be considered basic studies.   
The genus Medicago is part of the botanical family of Leguminosae and includes 
about 56 different species mainly distributed in areas presenting Mediterranean climatic 
conditions [25]. Alfalfa (Medicago sativa), is the main Medicago species widely grown 
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throughout the world, predominantly as a source of high quality forage for livestock, 
renewable energy production, phytoremediation, and as a source of phytochemicals [26]. 
It is also used as a human food ingredient, consumed as sprouts in salads, in sandwiches 
or soups [28], as leaf protein concentrates [29], or as food supplements [30]. Alfalfa may 
help in some human health disturbances, such as anaemia, diabetes, endometriosis, 
stomach ulcers, osteoporosis, menopausal symptoms, breast and prostate cancers and 
low bone density [31-32]. To our best knowledge, there is no published data on the 
antioxidant and antimicrobial activity, or cytotoxicity potential, of any extract of Medicago 
spp. Therefore, the evaluation of these properties in different species of Medicago 
remains an important challenge in understanding the possible benefits of their application 
in cosmetic products. 
 
2. Materials and Methods 
2.1 Chemicals and reagents 
Ascorbic acid, 1,1-diphenyl-2-picrylhydrazyl (DPPH•) free radical, catechin, Folin–
Ciocalteu's reagent, gallic acid, iodine, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic 
acid, a water-soluble derivative of vitamin E (Trolox) and α-tocopherol, were all purchased 
from Sigma-Aldrich (Steinheim, Germany). Ethanol reagent grade, sodium acetate, 
sodium carbonate decahydrate, sodium nitrite, aluminium chloride and sodium hydroxide 
were purchased from Merck (Darmstadt, Germany). Dulbecco’s modified Eagle’s medium 
(DMEM) with GlutaMAX™-I, fetal bovine serum (FBS), streptomycin, penicillin and 
amphotericin B were from Invitrogen (Carlsbad, CA, USA). 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-4-sulfophenyl) -2H-tetrazolium (MTS) assay kit (CellTiter 96® 
Aqueous One Solution Cell Proliferation Assay) was purchased from Promega (Madison, 
WI, USA). Lactate dehydrogenase (LDH) colorimetric cytotoxicity assay kit (LDH 
Cytotoxicity Detection Kit) was purchased from Takara Bio Inc. (Shiga, Japan). Ultra-pure 
water was obtained in-house using a Milli-Q water purification system (TGI Pure Water 
Systems, USA).  
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2.2 Plant materials 
Leaves of six species of Medicago (M. minima, M. tornata, M. truncatula, M. 
rigidula, M. scutelata and M. segitalis) were sown at the Experimental Field of the 
University of Porto at the Agrarian Station of Vairão. Samples were collected from 
February to July 2009. M. sativa was sown and collected in Azurara, Vila do Conde, 
Portugal, in February 2012. The plant leaves were randomly selected, dried at 65 °C 
during 72 h and stored, protected from light and moisture, at room temperature (25-28 °C) 
until the preparation of extracts. 
 
2.3 Preparation of hydroalcoholic extracts  
Medicago spp. leaves were milled at particle size of approximately 0.1 mm using 
an A11 basic analysis mill (IKA Wearke, Staufen, Germany) and stored in plastic tubes at 
room temperature. 
Powdered samples (1 g) were submitted to solvent extraction by maceration with 
20 mL of 50% ethanol at 40 °C for 30 minutes. Extra cts were filtered through Whatman 
No. 1 filter paper, concentrated under vacuum at 37 °C and kept under refrigeration (4 °C) 
prior to use. 
 
2.4 Determination of total phenolic content  
Total phenolic content (TPC) was determined spectrophotometrically according to 
the Folin-Ciocalteu procedure [185] with minor modifications [186]. Briefly, 500 µL of 
extract was mixed with 2.5 mL of Folin–Ciocalteu reagent (10 x dilution) and allowed to 
react for 5 min. Then 2.5 mL of Na2CO3 7.5% solution was added and allowed to stand for 
15 min at 45 °C and 30 min at room temperature, bef ore the absorbance being 
determined at 765 nm using a Synergy HT Microplate Reader (BioTek Instruments, Inc., 
Winooski, VT, USA). A calibration curve for the standard gallic acid was used to obtain a 
correlation between sample absorbance and standard concentration (linearity range = 5-
100 µg/mL, r2>0.998). The total polyphenol content (TPC) of the extracts was expressed 
as mg of gallic acid equivalents (GAE) per gram of plant material on dry basis (db). 
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2.5 Determination of total flavonoid content  
Total flavonoid content (TFC) was determined by a colorimetric assay based on 
the formation of flavonoid-aluminum compound according to Barroso et al. [187]. Briefly, 1 
mL of a diluted extract was mixed with 4 mL of ultrapure water and 300 µL of 5% (w/v) 
NaNO2 solution. After 5 min, 300 µL of AlCl3 solution (0.1 g/mL) were spiked, and after 1 
min, 2 mL of 1 mol/L NaOH and 2.4 mL of ultrapure water were also added. The 
absorbance was read at 510 nm using the Synergy HT Microplate Reader. Catechin was 
used as reference to plot the standard curve (linearity range = 0-400 µg/mL, r2>0.999). 
Total flavonoid concentration (TFC) was expressed as milligrams of catechin equivalents 
(CAE) per gram of plant material on db.  
 
2.6 In vitro antioxidant activity 
The antioxidant activity of the samples was evaluated by DPPH• radical-
scavenging activity and ferric reducing antioxidant power (FRAP) as detailed in the 
following.   
2.6.1 DPPH free radical scavenging assay 
DPPH is known as a stable free radical which possesses a characteristic 
maximum absorption between 515 and 517 nm. In the presence of antioxidant 
compounds, the DPPH• is reduced to the corresponding hydrazine when reacts with 
hydrogen donors, such as an antioxidant, and lower absorbance values of the reactive 
mixture indicate higher free radical scavenging activity. This method is an essential tool to 
access the antioxidant potential, more specifically, the antiradical activity of extracts. The 
reaction mixture on 96 wells plate consisted of a solution by well of the different samples 
concentrations (30 µL) and methanol solution (270 µL) containing DPPH radicals (6 x 10-5 
mol/L). The mixture was left to stand for 30 min in the dark. The reduction of the DPPH 
radical was determined by measuring the absorption at 517 nm [188]. A calibration curve 
was prepared with Trolox (linearity range: 2.5-100 µg/mL, r2>0.996). The antioxidant 
capacity based on the DPPH free radical scavenging ability of the extract was expressed 
as µmol Trolox equivalents per gram of plant material on db. 
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2.6.2 Ferric reducing antioxidant power (FRAP) assay 
The relevant chemical reaction of the FRAP method involves a single electron 
reaction between Fe (TPTZ)2 (III) and a single electron donor ArOH: 
Fe(TPTZ)2 (III) + ArOH → Fe(TPTZ)2(II) + ArOH+. 
FRAP assay was carried out by the method of Benzie and Strain [189] with minor 
modification. The method is based on the reduction of a ferric 2,4,6-tripyridyl-s-triazine 
complex (Fe3+-TPTZ) to the ferrous form (Fe2+-TPTZ).  An aliquot (90 µL) of an extract 
(with appropriate dilution, if necessary) was added to 2,7 mL of FRAP reagent (10 parts of 
300 mM sodium acetate buffer at pH 3.6, 1 part of 10 mM TPTZ solution and 1 part of 
20 mM FeCl3 · 6H2O solution) and the reaction mixture was incubated at 37 °C. The 
increase in absorbance at 592 nm was measured after 30 min. Solutions of known Fe (II) 
concentrations (FeSO4-7H2O) were used for calibration. A calibration curve was prepared 
with ferrous sulphate (linearity range: 150-2000 µM, r2>0.996). 
 
2.7 Antimicrobial assay 
2.7.1 Microorganisms strains 
Eight microorganisms (seven bacteria and one yeast) were included in the study. 
Both American Type Culture Collection (ATCC) and clinical isolates were selected, 
corresponding to Staphylococcus aureus (ATCC 6538 and a clinical isolate), S. 
epidermidis (clinical isolate), Escherichia coli (ATCC 1576 and a clinical isolate), 
Klebsiella peumoniae (ATCC 4352), Pseudomona aeruginosa (ATCC 9027) and Candida 
albicans (ATCC 10231). Clinical isolates were identified to species-level with Vitek-2 
identification cards (Biomerieux, France) and all strains were kept frozen in Brain Heart 
Infusion (Difco Laboratories, USA) with 20% glycerol (Sigma) at -70° C until testing. For 
each experiment, microorganisms were subcultured twice in Nutrient agar (Difco 
Laboratories, USA) for bacteria and Sabouraud dextrose agar (SDA; Difco Laboratories, 
USA) for C. albicans, in order to access culture viability.   
2.7.2 MIC by broth dilution assay 
The antibacterial activity was tested according to the Clinical and Laboratory 
Standards Institute (CLSI) M7-A6 micromethod and the antifungal activity was tested 
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according to M27-A3 micromethod from the same protocol, after 48 h of incubation at 37 
°C [190-191]. Briefly, two-fold serial dilutions of  extracts were performed in Mueller Hinton 
broth (MH; Difco Laboratories, USA) for bacteria and in RPMI (Biochrom, Germany) for 
yeast. Concentrations ranging from 3.90 µg/mL to 500 µg/mL were tested. 
Microorganism’s growth was visually compared for each concentration with the growth 
control (without plant extract). Minimal inhibitory concentration (MIC) was defined as the 
lowest extract concentration able to completely inhibit microorganism growth, 
corresponding to 100% MIC value. All determinations were performed in duplicate for 
each assay and three independent experiments were run with concordant results. 
 
2.8 Keratinocytes and fibroblasts cytotoxicity assay 
To ensure the quality of extracts, it is very important to assess their biological 
activity and cytotoxic potential. Any study has been done regarding different extracts of 
Medicago.  
Two different assays were used to assess cell viability and cytotoxicity of the 
extracts: (1) monitoring the uptake and metabolism of the vital mitochondrial dye, 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) 
by cell mitochondria and (2) determining the leakage of the cytosolic enzyme, lactate 
dehydrogenase (LDH) into the cell medium (LDH assay). In both tests, triplicate wells 
were incubated with fresh medium in the absence or presence of extracts dissolved in cell 
culture medium containing 0.1, 1, 10, 100 and 1000 µg/mL of extracts. Extracts dissolved 
in culture medium were filtered on 0.45 µm Millex GV filters (Millipore, Nepean, ON, 
Canada) and exposed to keratinocytes (HaCaT) and fibroblasts (HFF-1) cells during 24 h. 
2.8.1 Cell Lines and Culture Conditions 
Human immortalized non-tumorigenic keratinocyte cell line HaCaT (Ethnicity, 
Caucasian; Age, 62 years; gender, Male and tissue, skin) was acquired from CLS Cell 
Lines Service, Germany. Human foreskin fibroblasts (HFF-1) were purchased from ATCC 
(ATCC Number: SCRC-1041; ATCC, Manassas, VA, USA). Passage 17-19 of HFF-1 and 
passage 77-79 of HaCaT cells were used for both MTS and LDH assay. HaCaT  and 
HFF-1 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) with 
GlutaMAX™-I (Invitrogen) supplemented with 10% FBS, 100 U/mL penicillin and 100 
µg/mL streptomycin, and 0.25 µg/mL amphotericin B, and maintained in a 5% CO2 
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environment at 37 °C. At 90-95% confluence, both ce ll lines were harvested using trypsin 
(Invitrogen), viability assessed using the trypan blue dye (Gibco) exclusion assay, and re-
plated in T75 flasks. 
2.8.2 MTS assay 
The MTS assay was performed according to the manufacturer instructions. Briefly, 
cells were cultured in 96-well microtiter plate at a density of 25 x 103 cells per mL culture 
medium for 24 h. The cells were incubated with 0.1 µg/mL - 1 mg/mL plant extract for 24 h 
at 37 °C. Following the removal of extracts from th e wells, the cells were washed with 
phosphate buffered saline (PBS pH 7.4). Then the medium was changed to fresh medium 
containing different concentrations of Medicago spp. extracts. The cells were then 
incubated at 37 °C for 24 h. Then medium was reject ed and the number of viable cells 
evaluated by adding, the MTS reagent in medium to each well and incubating for 4 h at 37 
°C. Control was determined incubating cells with cu lture medium. The absorbance was 
measured at 490 nm with background subtraction at 630 nm. Each concentration was 
tested in triplicate in three independent experiments. 
2.8.3 LDH assay 
Lactate dehydrogenase (LDH), a stable cytoplasmic enzyme found in all cells, is 
quickly released upon damage to the plasma membrane. This assay can detect as few as 
100 cells, and strongly correlates with the number of lysed cells. Briefly, cell lines were 
seeded in 96-well plates (5,000 cells for LDH) and cultured for 48 h. Serial dilutions of the 
different extracts were prepared in appropriate medium and added to the cells. Media 
without FBS were used in the case of LDH. After incubation (37 °C/ 5% CO 2), cells were 
washed twice with PBS and the kit was used according to the instructions of the 
manufacturers. The maximum LDH release (high control) from cells was determined using 
1% (w/v) Triton X-100 (Boehringer Mannheim). Spontaneous LDH release (low control) 
was determined by incubating the cells with plain medium. Absorbance was measured at 
490 nm with background subtraction at 690. Each concentration was tested in triplicate in 
three independent experiments. 
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2.9 Statistical analysis of data 
Data were reported as mean ± standard deviation of at least triplicate experiments. 
Statistical analysis of the results was performed with SPSS 19.0 (SPSS Inc., Chicago, IL, 
USA). One-way ANOVA was used to investigate the differences between different species 
for all assays. Post hoc comparisons of the means were performed according to Tukey’s 
HSD test. In all cases, p<0.05 was accepted as denoting significance. 
 
3. Results and Discussion 
3.1 Determination of total phenolic content  
The TPC of the plant extracts was determined using the Folin-Ciocalteu phenol 
reagent. It is a simple and widespread method, although it presents some limitations as 
there are some interfering substances, such as sugars, aromatic amines, sulphur dioxide 
and ascorbic acid [192]. Results are presented in Figure 4.1. The TPC of the different 
extracts varied from 21.96 mg to 36.41 mg GAE per g db sample, being the highest TPC 
obtained for M. minima and the lowest for the M. scutelata. The order of TPC of different 
extracts was: M. scutelata < M. sativa < M. segitalis < M. truncatula <M. tornata < M. 
rigidula < M.minima. 
 
 
 
Figure 4.1 - Total polyphenol content in seven hydroalcoholic Medicago spp. extracts. Values are expressed 
as means ± SD (n = 6). GAE, gallic acid equivalents. Different letters (a, b, c) indicate significant differences 
between mean values (p<0.05). 
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The Folin-Ciocalteu phenol reagent is used to obtain a crude estimate of the 
amount of phenolic compounds present in an extract. Generally, extracts that contain a 
high amount of polyphenols also exhibit high antioxidant activity [193]. Phenolic 
compounds undergo a complex redox reaction with phosphotungstic and 
phosphomolybdic acids present in the reagent. However, the assay has been shown to 
non-specific to polyphenols [194-195], and other substances could be oxidized by the 
Folin reagent. The higher phenol content of the extracts might account for the better 
results in their reducing power and radical scavenging effect on DPPH radicals. As 
expected M. minima high TPC values will correspond to a high antioxidant activity of this 
Medicago species. 
Comparing with different extracts that has been study for cosmetic application like 
Castanea sativa, Quercus sp or Trifolium sp (this from the same family of Medicago - 
Leguminosae), the importance of Medicago extract can be emphasized. In addition, these 
botanical extracts are considered by Committee on Herbal Medicinal Products of 
European Medicines Agency as safety [196-197]. Also, according to different authors, 
extracts of C. sativa can be obtained from fruits or leaves, which are most rich in TPC and 
antioxidants [198-201]. Comparing with Medicago extracts, the content in antioxidant 
compounds and the antioxidant activity of the nuts showed low TPC and discrete 
antioxidant activity [202]. The TPC ranges from 9.6 to 19.4 mg/g db of the fruit, being 
considerably lower than Medicago extracts [201-202]. Previous studies have shown that 
total phenolics of chestnut fruit range between 11.0 and 13.6 mg/g db [198, 202].  In the 
same way, Juglans regia has also demonstrated their potential as promising antioxidants 
[203-205]. The TPC of J. regia is higher than Medicago, ranging from 58.78 to 95.06 mg 
GAE/g extract [206-209].  Aesculus hippocastanum, vulgarly known as horse chestnut, is 
a native European plant which seeds and bark of young branches have been study to be 
incorporated in new cosmetic products [205]. Studies carried out with seed extract 
showed some others beneficial effects such as strong active oxygen-scavenging activity 
and cell-protective effects in vitro linked to anti-aging properties of antioxidants [210]. The 
extracts of leaves revealed a higher amount of phenolics, 75 mg GAE/g extract [204]. 
Thus, the potential source of polyphenols of Medicago is in the same range of other 
vegetable sources. 
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3.2 Determination of total flavonoid content  
Flavonoids are a group of phenolic compounds widely distributed in the medicinal 
plants, vegetables, fruit juices and a variety of beverages (tea, coffee, wines and fruit 
drinks) [211-214]. Flavonoids, and particularly quercetin derivatives, have received a lot of 
attention as dietary constituents during the last few years. Experimental studies 
demonstrated that they possess numerous beneficial effects on human health, including 
cardiovascular protection, anticancer activity, antiulcer effects, and antiallergic, antiviral, 
and anti-inflammatory properties [215-216]. As the biological activity of flavonoids is 
intimately related to their mixtures and the amount of individual flavonoids in fruits and 
plants is usually low, they have often been recorded unspecifically as ‘total phenolics’. 
TFC was measured using the aluminium chloride colorimetric method.  
 
 
 
 
 
 
 
 
 
Figure 4.2 - Total flavonoid content in seven hydroalcoholic Medicago spp. extracts. Values are expressed as 
means ± SD (n = 6). CAE, cathequin equivalents. Different letters (a, b, c) indicate significant differences 
between mean values (p<0.05). 
 
The results depicted in Figure 4.2 show that TFC varied from 5.54 to 11.67 µg in 
terms of CAE per g extract db. The order of TFC was:  M. sativa < M. truncatula < M. 
minima < M. scutelata < M. tornata < M. segitalis < M. rigidula. Figure 4.2 also show that 
extracts can be grouped according to its TFC contents (p<0.05). This is the case of M. 
rigidula, the richest one, followed by M. segitalis, M. tornata and M. scutelata. M. minima, 
M. truncatula and M. sativa presented the lowest levels. Even though it is apparent that 
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the flavonoids are an important phenolic compounds group, contributing to the antioxidant 
activity, other compounds with similar chemical behaviour can be included. 
Comparing the TFC of Medicago with other vegetable extracts, it was observed to 
be in the same concentration range. For C. sativa, the values ranging from 26.6 to 67.2 
mg CAE/g db [201] and for J. regia extracts from 61 to 124 mg CAE/100 g [206], although 
differences in the extraction procedure was observed, being difficult to clearly identify TFC 
differences.  
 
3.3 In vitro antioxidant activity 
Antioxidant activity of the extracts is related to the compounds ability to protect a 
biological system against the potential harmful effect of oxidative processes. Antioxidants 
are essential to preserve the biological system from free radicals damage to biological 
molecules [217]. In this study, the antioxidant activity of the different Medicago spp. 
extracts was evaluated by scavenging activity on DPPH and the reducing power. 
3.3.1 DPPH free radical scavenging assay 
The stable radical DPPH has been widely used for the determination of primary 
antioxidant activity, that is, the free radical scavenging activities of pure antioxidant 
compounds, plant and fruit extracts and food materials [193]. The assay is based on the 
reduction of DPPH radicals in methanol which causes an absorbance drop at 517 nm. In 
this study, the antioxidant activity was expressed as Trolox equivalents per gram of plant 
material on a db as it is a more meaningful and descriptive expression than assays that 
express antioxidant activity as the percentage decrease in absorbance. As such, the 
results provide a direct comparison of the antioxidant activity with Trolox. The DPPH free 
radical scavenging activity of 7 different hydroalcoholic plant extracts of Medicago spp. is 
shown in Figure 4.3. M. rigidula showed the lowest DPPH free radical scavenging activity 
(127.18 ± 1.96 µmol Trolox equivalent per g db) while M. segitalis had the highest activity 
(214.49 ±  6.69 µmol Trolox equivalent per g db) but with similar values to those of M. 
tornata. Other group of extracts (M. sativa, M. scutelata and M. truncatula) showed 
relatively high antioxidant activity. The order of antioxidant activity according to DPPH 
assay was M. rigidula < M. minima < M. sativa < M. truncatula < M. scutelata < M. tornata 
< M. segitalis. 
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Figure 4.3 - Antioxidant activities of seven hydroalcoholic extracts of Medicago spp. species based on their 
abilities to scavenge DPPH free radicals. Values are expressed as means ± SD (n = 6). Different letters (a, b, 
c) indicate significant differences between mean values (p<0.05). 
 
The high total phenolic content associated with a high antioxidant activity is a good 
evidence of hydroalcoholic extracts of Medicago spp. Nevertheless, it is clear that some 
species have values due to the presence of compounds not quantified in this study [218], 
not quantified as polyphenolic compounds. One possibility can be isoflavones, which will 
further increase the chances of use of this extracts in skin care products [218]. 
3.3.2 Ferric reducing antioxidant power (FRAP) assay 
The ability of the plant extracts to reduce ferric ions was determined using the 
FRAP assay [219]. The ferric reducing antioxidant power (FRAP) assay measures the 
reduction of ferric (Fe3+) to ferrous iron (Fe2+) in the presence of antioxidants, which are 
reductants with half-reaction reduction potentials above Fe3+/Fe2+.  
The antioxidant activity averages of the different extracts based on FRAP assay 
are given in Figure 4.4. M. segitalis showed the highest level of antioxidant activity based 
on FRAP assay (120.84 ± 1.86 µmol per mg db) and M. minima showed the lowest one 
(58.05 ± 6.09 µmol per mg db). The order of antioxidant activity based on FRAP assay 
was: M. minima < M. tornata < M. scutelata < M. sativa < M. rigidula < M. truncatula < M. 
segitalis. The analysis of variance (ANOVA) showed differences between the different 
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extracts (p<0.05), indicating different behaviours and consequently compositional 
differences presented by the evaluated extracts. 
Figure 4.4 -  Antioxidant activities of seven hydroalcoholic extracts of Medicago spp. species based on their 
abilities to reduce ferric iron (Fe3+) to ferrous iron (Fe2+) (n = 6, error bars represent SD). Different letters (a, b, 
c) indicate significant differences between mean values (p<0.05). 
 
The two assays of antioxidant capacity used in this study were spectrophotometry-
based methods. The differences in the antioxidant activity measurements between assays 
could be expected, as each assay has a different mechanism of action or different 
reaction conditions. DPPH is a method based on the measurement of the reducing ability 
of antioxidants toward 1,1-diphenyl-2-picrylhydrazyl (DPPH•).The ability can be evaluated 
by electron spin resonance or by measuring the decrease of its absorbance. Although 
both DPPH• and FRAP have been widely used to measure the antioxidant capacity of 
natural extracts based on their ability to reduce the radical cation, the reaction of DPPH 
with free radical scavengers present in the test sample occur rapidly and can be assessed 
by following the decrease in the absorbance at 517 nm. The reaction time of the improved 
DPPH assay is only 30 min, while the FRAP assay measures the reducing capability by 
increased sample absorbance based on the ferrous ions released, being thus more time 
consuming. On the other hand, the DPPH assay is preferred to the ABTS assay because 
it is commercially available and does not have to be generated before assay like ABTS+ 
[192]. The ABTS radical cation is generated by the oxidation of ABTS with potassium 
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persulfate, and its reduction in the presence of hydrogen-donating antioxidants is 
measured spectrophotometrically at 734 nm [220]. According to Prior et al. [192], the 
assay may not be complete even for several hours after the reaction started, such that a 
single end-point of the reaction cannot be determined. On the other hand, FRAP assay 
has some drawbacks, such as interference, reaction kinetics and quantification methods 
[221]. Various factors such as variety, growing condition, maturity, season, fertilizer, soil 
type, storage conditions and amount of sunlight received, among others, might be 
responsible for the observed differences. Thus, DPPH results are more feasible and 
probably better reflect the real antioxidant activity of the extracts. 
 
3.4 Correlation between phenolic composition and antioxidant activity 
Polyphenols have been reported as responsible for the antioxidant activity of 
herbal extracts. This activity may be related to several properties like redox properties, 
which allow them to act as reducing agents or hydrogen-atom donors. Also, the ability to 
chelate metals inhibits lipoxygenase and scavenges free radicals. Both DPPH free radical 
scavenging and FRAP assays have been used to measure antioxidant activity and the 
results of DPPH and FRAP assays should correlate with those of TPC. However, the 
correlation between the phenolic compounds and antioxidant potential is not consensual. 
Some authors showed the existence of significant correlations between the phenolic 
compounds and antioxidant potential [222-225]. Nevertheless, in other studies no 
correlation was observed [226]. 
When a regression analysis was performed between the values of µmol Trolox 
equivalents per g db sample or µmol FRAP per mg db in the antioxidant evaluation and 
the total phenolic content, an extremely negative correlation (r2= - 0,5827; p<0.01) and a 
negative correlation (r2= - 0.2218; p<0.001) were established, respectively. Thus, in this 
work, no correlations between phenolics content and antioxidant capacity were 
established. Nevertheless, the interpretation of results needs to be done with precaution, 
as the final effects of a complex extract results from the combinatory and synergic actions 
of all its constituents. Other compounds, belonging to other chemical classes, may also 
contribute to the observed effects. Further work is in progress in our laboratory to 
elucidate the identity of compounds responsible for the antioxidant activity. 
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3.5 Correlation between flavonoids and antioxidant activity 
When a regression analysis was performed between the values mg CAE 
equivalents per g db sample and the total phenolic content, a weak positive correlation 
(r2=0,1718; p<0.01) was established. As demonstrated by other authors, it is not 
mandatory a strong positive correlations between these two contents [226]. In this way, 
further work is necessary to elucidate about the flavonoid compounds. 
 
3.6 Antimicrobial assay 
The minimum inhibitory concentrations (MICs) for the active plant extracts were 
determined using modified methods of the CLSI as mentioned above. In this study, 
microorganisms were selected to cover Gram-positive bacteria (S. aureus and S. 
epidermidis), Gram-negative bacteria (E. coli, K. pneumoniae, P. aeruginosa) and yeasts 
(Candida albicans). According to different authors, the ‘normal’ resident skin flora includes 
S. epidermis, S. aureus and P. aeruginosa [227-228]. Staphylococcus is one of the most 
representative bacterial genera present in human skin and S. epidermidis is the most 
prevalent specie [227, 229-230]. S. aureus is usually thought of as a pathogen, but the 
methicillin-resistant strain is increasingly found colonizing moist skin sites of healthy 
people, being very important the evaluation of extracts effectiveness on this specie [230].  
On the skin, P. aeruginosa occasionally causes dermatitis or deeper soft-tissue infections 
[231]. E. Coli and K. pneumonia are two important species in nosocomial infections [232-
233]. Candida species are the most common fungal pathogens of humans, being the 
causative agents of candidiasis, and C. albicans is the most pathogenic Candida species 
[234]. According to that, the evaluation of extracts in these species can be considered of 
high importance. 
The antibacterial activity of the seven hydroalcoholic extracts was evaluated by the 
determination of MIC values (Table 4.1).  
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Table 4.1 - Antibacterial activity of hydroalcoholic extracts of Medicago species expressed as MIC in µg/mL. 
 
 
Bacterial Strain 
MIC (µg/mL)* 
M. minima M. tornata M. truncatula M. rigidula M. scutelata M. segitalis M. sativa 
S. aureus ATCC 6538 31.3 62.5 31.3 31.3 31.3 62.5 31.3 
S. aureus MRSA 250 500 250 500 250 500 250 
S. epidermidis B21 31.3 125 62.5 31.3 125 62.5 62.5 
E. coli ATCC 1576 125 250 125 125 125 250 250 
E. coli B26 250 250 125 125 125 250 125 
K. pneumoniae ATCC 4352 31.3 125 31.3 31.3 31.3 62.5 62.5 
P. aeruginosa ATCC 9027 > 1000 > 1000 > 1000 > 1000 > 1000 > 1000 > 1000 
C. albicans ATCC 10231 > 1000 > 1000 > 1000 > 1000 > 1000 > 1000 > 1000 
 
* Data expressed as mean of three data points (n=3) 
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Hydroalcoholic extracts of the different Medicago species presented MICs in the 
range of 31.3 µg/mL-500 µg/mL against S. aureus, S. epidermidis, E. coli and K. 
pneumoniae. All plant extracts were active against the tested microorganisms, except for 
P. aeruginosa and C. albicans. The inefficacy of these extracts against these 
microorganisms can be related with the presence of P. aeruginosa extracellular matrix 
and the complex yeast cell wall, preventing extracts to contact with cell structures. S. 
aureus and K. pneumoniae from ATCC were the most susceptible strains to all the 
extracts exhibiting MIC values between 31.3 and 125 µg/mL. Interestingly, S. aureus 
clinical isolate was notoriously more resistant to these natural products than the collection 
strains, and the same tendency was observed for E. coli clinical isolate compared to the 
ATCC strain for some extracts. 
These results are of great importance, particularly in the case of S. aureus, which 
are well-known for being resistant towards some antibiotics and for their production of 
several enterotoxins that cause many multiresistant skin infections [235-236]. According to 
Fabry et al. [237] for crude solvent extracts of plants to be considered as potentially useful 
therapeutically, they should have MIC values < 8mg/mL, whilst Gibbons [238] suggests 
that isolated phytochemicals should have MIC < 1mg/mL. The MIC values determined for 
these extracts were bellow these values, thus indicating a potential antimicrobial effect 
which may be advantageous for cosmetic products. In particular, these extracts may 
provide self-preservative properties to the formulations in which they are incorporated. 
The antibacterial activity of all extracts from Medicago spp. could be related to the 
presence of high amounts of phenolic and flavonoid compounds in their composition, as 
referred above. 
 
3.7 Keratinocytes and fibroblasts cytotoxicity assay 
The effects of the extracts on the growth of keratinocyte (HaCaT) and fibroblast 
(HFF-1) cells were investigated by MTS and LDH assays. These cell lines are regarded 
as suitable in vitro models for testing the toxicity potential of substances or products 
intended for dermatological use [239-243]. 
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3.7.1 MTS assay 
Medicago spp. extracts were added to HaCaT and HFF-1 cells to analyse their 
effects on cell viability (Figures 4.5 and 4.6). All experiments are carried out up to 1000 
µg/mL of extract.  
 
Figure 4.5 - Effect of hydroalcoholic extracts of Medicago spp. exposure on the viability of HaCaT cells at 
different concentrations, as measured by the MTS assay. Values are expressed as means ± SD (n=6). 
*p<0.05 versus positive control (cells exposed to medium). 
 
According to the obtained results, none of the extracts exhibited cytotoxicity 
against HaCaT cells (Figure 4.5) at concentrations up to 100 µg/mL. At concentration of 
1000 µg/mL there is a decrease in cell viability of keratinocytes, particularly with M. 
minima (66.2%) and M. segitalis (67.9%) extracts. Between this two species there is no 
significant statistic difference. The evidence of cytotoxicity of the extracts at doses above 
100 µg/mL implies that caution must be taken when using extracts of these plants, since 
viability of cells may be affected at higher concentrations. These data allowed selecting 
the optimal range of non-cytotoxic concentrations of each plant extract (up to 100 µg/mL), 
used in further experiments. However, no statistical differences were observed between 
the other extracts (p<0.05). 
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Figure 4.6 presents the toxicity data of the seven hydroalcoholic extracts assessed 
in HFF-1 cells. The number of viable fibroblast cells was similar at all concentration of 
Medicago spp. extract (0.1, 1.0, 10, 100, 1000 µg/mL), except for M. minima, M. tornata 
and M. scutelata extracts, with considerably inferior viability for all concentrations tested. 
The values ranged from 66.1% for M. minima (1000 µg/mL) to 79.7% for M. scutelata 
(1000 µg/mL). These results also indicate that fibroblasts are more sensitive to all extracts 
as compared to HaCaT cells.  
These results are in accordance with those obtained by different authors, who 
observed that keratinocytes were more resistant than fibroblasts when exposed to 
different substances [172, 240, 244-246]. 
Figure 4.6 - Effect of exposure to different extracts of Medicago on the metabolic activity of HFF-1 cells at 
different concentrations, as measured by the MTS assay. Values are expressed as means ± SD (n=6). 
*p<0.05 versus positive control (cells exposed to medium). 
 
Furthermore, these results suggested that hydroalcoholic extract of M. truncatula, 
M. rigidula, M. segitalis and M. sativa, at concentrations < 1000 µg/mL have no adverse 
effect on the viability of fibroblast cells in vitro. These results could indicate a probable 
protective effect of the extracts on the cell line, but further studies are needed to confirm 
that.  
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Cell viability was higher for the HaCaT cells when exposed to extracts in 
comparison to fibroblasts, at concentrations from 0.1 to 1000 µg/ml. Therefore, in light of 
these viability values, and having no cytotoxic effects at these higher concentration 
ranges, we could assume no risk of application of this extracts in skin cells. 
3.7.2 LDH assay 
An important indicator of cell damage in oxidative stress is the increase in 
membrane permeability. In this study, potential cytotoxic effects of different extracts of 
Medicago spp. were investigated by examining membrane integrity of HaCaT and HFF-1 
cells using a LDH release assay.  
In HaCaT cells (Figure 4.7), at all concentrations tested, M. rigidula, M. scutelata, 
M. segitalis and M. sativa, did not originate any effects on the LDH leakage following 24 
hours of incubation, which means that all these extracts are potentially safe to HaCaT 
cells. The evidence of possible absence of cytotoxicity of this four hydroalcoholic extracts 
at five different concentrations, namely, 0.1, 1.0, 10, 100 and 1000 µg/mL, implies that 
these extracts present low toxicity to these cells. However, M. minima, M. tornata and M. 
truncatula extracts increased cellular LDH efflux for all concentrations tested. 
Figure 4.7 - Cytotoxicity (%) of LDH in HaCaT cells after 24 h treatment with different seven hydroalcoholic 
Medicago spp. extracts. The cytotoxicity of LDH was determined using fluorescence with an excitation 
wavelength of 490 nm and an emission wavelength of 690 nm. Values are expressed as means ± SD (n=6). 
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Test on cytotoxicity of the extract on fibroblasts was conducted at 0.1, 1.0, 10, 100 
and 1000 µg/mL by quantification of LDH-release. No significant LDH-increase was 
observed, indicating the absence of cytotoxicity in this dose range on human fibroblasts 
for all extracts tested.  
Using these assays, we found that the seven hydroalcoholic extracts presented 
low toxicity potential towards HaCaT, with the exception of those prepared from M. 
minima, M. tornata and M. truncatula at the higher concentration tested, and any 
cytotoxicity for fibroblast cells. 
Quercus leaves extracts are also being study as a new source of antioxidants as 
promising active ingredients for cosmetics [247-248]. Different authors had reported the 
radical scavenging activity of lyophilised extracts of different species of Quercus leaves 
and their effect on proliferation and survival of different cells [248-250]. Glycyrrhiza 
uralensis is another specie of the same family of Medicago (Leguminosae) which 
antioxidant properties have been study [251]. The study of cytotoxicity showed that the 
extract is safe and did not show cytotoxicity in the range of 4 - 100 µg/mL, which is in 
agreement with the present results [251]. Carvalho et al. studied the antiproliferative 
effectiveness of J. regia extract using human renal cancer cell lines A-498 and 769-P and 
the colon cancer cell line Caco-2, and proved a strong antiproliferative capacity of walnut, 
showing cytotoxicity for these cells [207]. Park et al. proved that J. mandshurica leaf 
extract protects skin fibroblasts from damage by regulating the oxidative defense system, 
being safety used in cosmetic preparations [252]. Darmani et al. studied the effect of 
aqueous extracts of J. regia and concluded that they enhance the growth of fibroblasts 
and inhibit the growth of cariogenic bacteria [253]. The results of cytotoxicity of A. 
hippocastanum indicated that the extract was not able to generate lethal DNA lesions 
[204-205], being expected the same effect for Medicago extracts.    
    
4. Conclusion 
The use of by-products of fruit and vegetable processing as a source of functional 
compounds and their application in cosmetics is a promising field which requires 
interdisciplinary research of cosmetic technologists, chemists and toxicologists. The 
bioactivity, bioavailability and toxicity of phytochemicals needs to be carefully assessed by 
in vitro and in vivo studies [174]. Agro-industrial by-products are good sources of phenolic 
compounds, and have been explored as a source of natural antioxidants [254].  
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In this work, Medicago spp. residue extracts presented antioxidant and 
antimicrobial activity, and low cytotoxic potential for skin cells. Medicago spp. extracts 
may be useful for developing skin care products. 
The lack of correlation observed between the two in vitro assays carried out to 
assess antioxidant activity (DPPH and FRAP) may be due to differences in sensitivity of 
the tests and characteristics of the extracts. Evaluation of antimicrobial activity reveals 
that these extracts are effective at concentrations of 500 µg/mL against important strains 
of skin, particularly S. aureus. These results are also good indicators of their possible use 
in skin products. Last but not least important, the absence of toxicity of the extracts in 
keratinocytes is indicative of its potential safe use. With regard to fibroblasts, it was found 
that M. minima, M. scutelata and M. tornata possess some toxicity and, depending of the 
concentration used, can be unsuitable for skin use. On the other hand, M. minima, M. 
tornata and M. truncatula extracts increased cellular LDH efflux for all concentrations 
tested and so, depending on the concentrations used, can be toxic. Indeed, we can say 
that M. sativa, M. rigidula and M. segitalis extracts can be more safely used in cosmetics. 
It is, thus, suggested that Medicago spp. extracts possess non-toxic, antimicrobial 
and antioxidant activities which may render them suitable as potential active ingredients 
for use in skin cosmetics. Further investigations are now needed to establish the exact 
mechanism of action and identify the active bio-ingredient(s) of each extract in order to 
explain their therapeutic efficacy. Future assays will be performed to study the probable 
protective effect of the extracts in skin-derived cells and also to identify and quantify all 
compounds. 
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1. Introduction 
Legumes are important agricultural and commercial crops consumed in large 
amounts by both humans and animals. The Leguminosae taxonomic class includes a 
variety of plants with significant economic value, including soybean, alfalfa, clover, pea, 
peanut and various beans [25]. Nowadays, an integrated and sustainable exploitation of 
plant resources is a must as only few amounts are used for actual human consumption. 
Waste and by-products from vegetal origin are currently rising, driven by both a net 
increase in plant products consumption and the changing consumer trend towards ready-
to-use products. In this way, the importance of exploiting natural compounds from by-
products or no added value plants increased in recent years. They are considered to be 
attractive due to their low cost and easy availability, in large quantity, as raw material. 
Presently, most are taken advantage as animal feed and plant fertilizers [255]. After 
specific pre-treatments, by-products might provide valuable natural compounds of 
enormous interest to pharmaceutical, cosmetic or food industries [256].  
The concept of sustainability should also be taking into account and encompasses 
the type of chemicals and solvents used for the extraction of interesting compounds. For 
this reason, and baring in mind the question of green chemical, the extraction process 
should be designed as simple as possible and, simultaneously, considering the effective 
costs for industries.  
Phytoestrogen is a general term used to define a wide variety of compounds that 
are non-steroidal and are either of plant origin or derived from the in vivo metabolism of 
several plants used as food [37]. Phytoestrogens possess estrogen properties due to their 
structural similarities to the hormone estradiol, the most common female hormone [38]. 
Isoflavones are recognized to possess a wide range of human health benefits such as 
prevention of certain cancers [257-258], cardiovascular diseases [259-260], osteoporosis 
[261] and alleviation of menopausal symptoms [262]. Because of their structural similarity 
to ß-estradiol, health benefits of isoflavones have been evaluated in age-related and 
hormone-dependent diseases [44]. These compounds are abundant in the Leguminosae 
family (Fabaceae) and largely described in soy and red clover [45-46, 48, 263-264]. 
Soybean has attracted considerable attention worldwide for their health-promoting, 
disease-preventing effects, mainly attributed to isoflavones [265]. In fact, soybean 
isoflavones are the most studied and largely used as ingredients of food supplements. 
Glycitein (4′,7-dihydroxy-6-methoxyisoflavone), together with genistein (4’,5,7-
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trihydroxyisoflavone), daidzein (4’,7-dihydroxyisoflavone) and genistin (Genistein 7-O-ß-D-
glucoside) are the most plentiful and the best characterized compounds of this group and 
appears in large amounts in soybean [266-267]. Biochanin A (5,7-dihydroxy-4’-
methoxyisoflavone) and formononetin (7-hydroxy-4’-methoxyisoflavone) are methylated 
precursors of genistein and daidzein, respectively, and exist in high amounts in red clover 
[45, 49].  
The genus Medicago is part of the botanical family of Leguminosae and includes 
about 56 different species mainly distributed in Mediterranean climatic conditions areas 
[25]. Alfalfa (Medicago sativa) is the main Medicago species widely grown throughout the 
world, predominantly as a source of high quality forage for livestock, renewable energy 
production, phytoremediation, and as a source of phytochemicals [26-27]. It is also used 
as a human food ingredient, consumed as sprouts in salads, in sandwiches or soups [28], 
as leaf protein concentrates [29] or as food supplements [30]. Despite this use, alfalfa 
have pharmacological activities, being used in some human health disfunctions, such as 
anaemia, diabetes, endometriosis, stomach ulcers, osteoporosis, menopausal symptoms, 
breast and prostate cancers and low bone density [31-32].  
It should be also considerate that the main applications of Medicago species are 
grazing food for cattle and other livestock. Like other plants of the same family, it was 
reported that high levels of isoflavones are desirable on lamb feeding, that gain weight 
more quickly, as well as in milk production, but, in some cases, reproductive disorders 
have also been reported in sheep and cattle fed on forages with high isoflavone content 
[33-34]. Thus, depending on the final objective for cattle, Medicago could not be desired 
for farmers, originating a high amount of by-products. 
To the best of our knowledge, there is no published data on the isoflavones profile 
of any species of Medicago spp.  Therefore, the aim of this study was to ascertain the 
influence of the Medicago species and the solvent extractor on the extract content of 
daidzin, genistin, daidzein, glycitein, genistein, formononetin, prunetin and biochanina A. 
Therefore, the evaluation of these compounds in different extracts of Medicago species 
remains an important challenge to understanding the possible advantages of their 
application in pharmaceutical and cosmetic industries. 
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2. Materials and methods 
2.1 Chemicals and Solutions 
Standards of biochanin A (≥97%), prunetin (≥98%), daidzin (≥95%), daidzein 
(≥98%), genistin (≥95%), glycitein (≥97%) and genistein (≥98%) were obtained from 
Sigma-Aldrich (St. Louis, MO, USA). Stock solutions (1 g/L) were prepared in DMSO and 
stored at -20 °C in amber glass vials. A composite stock standard solution of multiple 
isoflavones (20 mg/L of biochanin A, puerarin, glycitein, daidzein, daidzin, prunetin, 
genistein, genistin, formononetin, pseudobaptigenin, pratensein and irilone) was prepared 
in H2O: methanol (25:75, v/v). The internal standard (I.S.) 2-methoxyflavone was obtained 
from Sigma. A working I.S. solution was prepared in methanol at 1 g/L and stored at -20 
°C in amber glass vials when not in use. 
Methanol and formic acid (both of HPLC grade) were from Merck (Darmstadt, 
Germany), and HPLC water was purified with a “Seradest LFM 20” system (Seral, 
Ransbach-Baumbach, Germany). The eluents were filtered through 0.45 µm filters and 
degassed under reduced pressure. Disposable filter PTFE 0.45 µm was from Macherey-
Nagel (Düren, Germany). 
 
2.2 Samples 
Leaves of six species of Medicago (M. minima, M. tornata, M. truncatula, M. 
rigidula, M. scutelata and M. segitalis) were sown at the Experimental Field of the 
University of Porto at the Agrarian Station of Vairão. M. sativa was sown and collected in 
Azurara, Vila do Conde, Portugal. The plant leaves were randomly selected, dried at 65°C 
during 72h and stored, protected from light and moisture, at room temperature (25-28 °C). 
 
2.3 Extracts preparation 
The leaves were milled at particle size of approximately 0.1 mm using an A11 
basic analysis mill (IKA Wearke, Staufen, Germany) and stored in plastic tubes at room 
temperature. Samples (1 g) were submitted to solvent extraction by maceration with 20 
mL of three different solvents: ethanol, ethanol:water (1:1) and distilled water for 30 
minutes at 40 °C.  Extracts were filtered through W hatman No. 1 paper filter and collected. 
Aqueous extracts were freeze-dried and hydroalcoholic and alcoholic ones were reduced 
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to residue using a rotary evaporator set to 37 °C. All extracts were stored at 4 °C until 
analysis. For quantification of isoflavones, the extracts were reconstituted with the original 
solvent and filtered through a PTFE membrane before HPLC analysis. The yields of each 
extract was calculated and varied between for 18.74-20.3 % for aqueous extracts, 16.9-
18.1 % for hydroalcoholic extracts and 13.8-15.2 % for alcoholic extracts. 
 
2.4 HPLC equipment 
The HPLC method used in this study to separate and quantify daidzin, genistin, 
daidzein, glycitein, genistein, formononetin, prunetin and biochanin A in Medicago extracts 
was based on the work of Visnevschi-Necrasov et al. [268]. 
The chromatographic analysis was performed in a HPLC integrated system 
(Jasco, Japan) equipped with a PU-2080 quaternary pump and a Jasco AS-950 automatic 
sampler with a 20 µL loop. Detection was performed with a Jasco model MD-2010 
multiwavelenght diode-array detector (DAD). Chromatographic   separation of compounds 
was achieved with a Luna 5U C18 (5 µm, 150 x 4.60 mm) column (Teknokroma, Spain) 
operating at 40 °C. The eluent was a gradient of 0. 1% formic acid (A) and 0.1% formic 
acid in methanol (B), at a flow rate of 1 mL/min, with a gradient as follows: 0 min 33% B, 7 
min 45% B, 15 min 50% B, 25 min 60% B, 30 min 70% B, 35 min 0% B, 37 min 33% B, 
maintaining these conditions for 10 min and returning to the initial ones within 3 min.  
Analytes were monitored at 254 nm, and quantified on the basis of the internal 
standard method. Chromatographic data were analyzed using the Borwin-PDA Controller 
Software (JMBS Developments, Le Fontanil, France). Calibration curves were prepared 
for daidzin, genistin, daidzein, glycitein, genistein, formononetin, prunetin and biochanin A, 
all at concentrations ranging from 12.5 to 200.0 mg/mL. Each extract and eight solutions 
of each standard were injected three times. Confirmation of isoflavones identities was 
performed by comparing retention times and coelution with authentic standards and by UV 
absorption spectral analysis. Correlation coefficients of calibration curves were >0.99. 
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2.5 Statistical analysis  
Data were reported as mean ± standard deviation of at least triplicate experiments. 
Statistical analysis of the results was performed with SPSS 22.0 (SPSS Inc., Chicago, IL, 
USA). One-way ANOVA was used to investigate the differences between different species 
for all assays. Post hoc comparisons of the means were performed according to Tukey’s 
HSD test. In all cases, p<0.05 was accepted as denoting significance. 
 
3. Results and Discussion 
The recycling of by-products derived from various industries is crucial, as many 
studies have reported that they contain abundant health-beneficial compounds [101, 269]. 
According to that, the present work studied the effect of Medicago species and the solvent 
used in the obtained profile and content of isoflavones. 
 
Variability within Medicago Species: M. sativa is the most popular species of the 
genus Medicago due to its peculiar characteristics: the plant is used as animal feed and 
easily available with low economic value. However, many other species complete this 
genus. Chromatograms of a hydroalcoholic extract of M. minima (A) and standards (B) are 
depicted in Figure 4.8.  
The determined amounts of daidzin, genistin, daidzein, glycitein, genistein, 
formononetin, prunetin and biochanina A, in all species studied, and with the different 
extraction solvents, are presented in Table 4.2. 
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Figure 4.8 - Chromatograms (254 nm) of a standard mixture (1 mg/mL) (A) and of hydroalcoholic extract of Medicago minima (B) and UV absorption spectra of daidzin (1), 
genistin (2), daidzein (3), glycitein (4), genistein (5), formononetin (6), prunetin (7) and biochanin A (8). 
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Table 4.2 - Isoflavone contents (mg/Kg db) in Medicago species (n = 3). Mean ± SD. n.d. - not determined. 
Values in the same line followed by different letters (in the different tables) indicate significant differences 
(p<0.05). Values in the same column followed by different numbers indicate significant differences (p<0.05). 
Different numbers in different species name indicate significant differences between them (p<0.05).  
 
 
M. minima12 
 
Aqueous2 Hydroalcoholic2 Alcoholic12 
 
Mean ± SD Mean ± SD Mean ± SD 
Daidzin 1.70 ± 0.05ed4 n.d. n.d. 
Genistin 2.42 ± 0.01fgh3 6.52 ± 0.26c1 2.82 ± 0.54efgh3 
Daidzein 3.89 ± 0.10d2 2.26 ± 0.1gh2 3.36 ± 0.00def3 
Glycitein 1.07 ± 0.00f5 1.49 ± 0.06e3 0.42 ± 0.02h5 
Genistein 3.51 ± 0.16de1 1.72 ± 0.05ghi3 9.31 ± 0.14b1 
Formononetin n.d. n.d. 4.33 ± 0.00c2 
Prunetin n.d. n.d. 3.03 ± 0.01b3 
Biochanin A n.d. n.d. 1.62 ± 0.17b4 
Total 12.59 11.99 24.89 
A 
 
M. tornata12 
 
Aqueous2 Hydroalcoholic12 Alcoholic2 
 
Mean ± SD Mean ± SD Mean ± SD 
Daidzin 1.60 ± 0.01e3 5.28 ± 0.07a2 1.82 ± 0.11d3 
Genistin 2.40 ± 0.05fgh2 8.81 ± 0.26b1 3.15 ± 0.07efgh1 
Daidzein 3.91 ± 0.35d1 3.72 ± 0.01de3 2.57 ± 0.03fg2 
Glycitein 0.41 ± 0.01h4 n.d. n.d. 
Genistein 0.72 ± 0.00i4 3.28 ± 0.04e4 1.03 ± 0.07hi4 
Formononetin n.d. n.d. n.d. 
Prunetin n.d. n.d. 3.11 ± 0.04b1 
Biochanin A n.d. n.d. n.d. 
Total 12.14 22.03 11.68 
B 
 
M. truncatula12 
 
Aqueous2 Hydroalcoholic12 Alcoholic12 
 
Mean ± SD Mean ± SD Mean ± SD 
Daidzin 1.58 ± 0.00e3 n.d. n.d. 
Genistin 2.15 ± 0.01h12 2.42 ± 0.44fgh3 2.67 ± 0.12efgh3 
Daidzein 2.74 ± 0.35efg2 4.09 ± 0.01de2 7.13 ± 0.55c1 
Glycitein 4.56 ± 0.36b1 7.39 ± 0.53a1 0.53 ± 0.01g1 
Genistein n.d. 7.08 ± 0.28c1 2.82 ± 0.38fg3 
Formononetin 2.55 ± 0.10e2 3.18 ± 0.00d23 5.46 ± 0.12b2 
Prunetin n.d. n.d. n.d. 
Biochanin A n.d. n.d. n.d. 
Total 13.58 24.16 18.61 
C 
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M. rigidula2 
 
Aqueous2 Hydroalcoholic12 Alcoholic12 
 
Mean ± SD Mean ± SD Mean ± SD 
Daidzin n.d. n.d. 1.88 ± 0.01d1 
Genistin 2.22 ± 0.05gh2 5.31 ± 0.25d2 3.62 ± 0.10be2 
Daidzein n.d. 12.21 ± 0.10b1 8.10 ± 0.11c5 
Glycitein n.d. 2.28 ± 0.02d34 n.d. 
Genistein 5.67 ± 0.24d1 1.84 ± 0.89fgh34 6.41 ± 0.17cd34 
Formononetin n.d. 2.63 ± 0.41e34 6.91 ± 0.36a4 
Prunetin n.d. 3.22 ± 0.01b3 5.92 ± 0.22a3 
Biochanin A n.d. 1.57 ± 0.03b1 1.88 ± 0.15a1 
Total 13.58 24.16 18.61 
D 
 
M. scutelata12 
 
Aqueous2 Hydroalcoholic2 Alcoholic1 
 
Mean ± SD Mean ± SD Mean ± SD 
Daidzin 2.47 ± 0.07c1 2.36 ± 0.17c2 3.52 ± 0.05b4 
Genistin n.d. 5.16 ± 0.56d1 9.60 ± 0.27a3 
Daidzein n.d. n.d. 19.20 ± 0.57a1 
Glycitein n.d. n.d. 3.92 ± 0.02b4 
Genistein n.d. n.d. 16.09 ± 0.26a2 
Formononetin n.d. n.d. n.d. 
Prunetin n.d. n.d. n.d. 
Biochanin A n.d. n.d. n.d. 
Total 2.47 7.52 52.33 
E 
 
 
M. segitalis12 
 
Aqueous2 Hydroalcoholic2 Alcoholic 2 
 
Mean ± SD Mean ± SD Mean ± SD 
Daidzin n.d. n.d. n.d. 
Genistin 2.78 ± 0.16efgh1 3.32 ± 0.07efg2 3.68 ± 0.30e1 
Daidzein 1.87 ± 0.05gh2 3.67 ± 0.18de1 2.18 ± 0.04gh2 
Glycitein n.d. n.d. n.d. 
Genistein n.d. n.d. n.d. 
Formononetin n.d. n.d. n.d. 
Prunetin n.d. n.d. n.d. 
Biochanin A n.d. n.d. n.d. 
Total 4.65 6.99 5.86 
F 
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M. sativa1 
 
Aqueous2 Hydroalcoholic2 Alcoholic 2 
 
Mean ± SD Mean ± SD Mean ± SD 
Daidzin n.d. n.d. n.d. 
Genistin 3.32 ± 0.40ef1 2.29 ± 0.14gh1 3.14 ± 0.51efgh1 
Daidzein n.d. n.d. 1.47 ± 0.05h3 
Glycitein n.d. n.d. 0.45 ± 0.01g4 
Genistein n.d. n.d. 0.93 ± 0.13i234 
Formononetin n.d. n.d. 2.40 ± 0.06e2 
Prunetin n.d. n.d. n.d. 
Biochanin A n.d. n.d. n.d. 
Total 3.32 2.29 8.39 
G 
 
A large variability in the isoflavones content was observed within all species and 
obtained extracts. The total mean content of isoflavones ranged between 2.3 and 52.3 
(mg/kg/db) for hydroalcoholic and alcoholic extracts from M. sativa and M. scutelata, 
respectively. Despite this variation, the compounds profile was relatively similar for all 
species, with genistin present in almost species (except aqueous extract of M. scutelata) 
and in higher amounts, followed by daidzein and genistein, by this order. However, the 
comparison of the individual compounds among the seven species (Table 4.2 - A, B, C, D, 
E, F and G) revealed some significant differences (p<0.05). The highest daidzin level was 
observed in extracts of M. tornata (5.3 mg/kg/db, hydroalcoholic extract). The only species 
that presented daidzin in all extracts were M. tornata and M. scutelata, being the 
hydroalcoholic extract the richest for M. tornata while for M. scutelata was the alcoholic. 
Some species do not contained this glycoside (M. segitalis and M. sativa) and in others 
only was detected in the alcoholic (M. rigidula) or in the aqueous extract (M. minima and 
M. tornata).  
The highest concentration of genistin was observed in hydroalcoholic and alcoholic 
extracts of M. scutelata, in amounts 1.8-4.47 fold higher than the other samples evaluated 
(p<0.05). Differently of the other species, the aqueous extract does not have this 
isoflavone in detectable amounts.  Daidzein, the aglycone form of daidzin, is also present 
in a high amount in M. scutelata (19.2 mg/kg db, alcoholic extract). However, it should be 
highlighted that this specie presented the highest values in alcoholic extract (compared 
with the other species), but for aqueous and hydroalcoholic was the poorest. 
Glycitein is also present in most of species but the content was lower than daidzein 
or genistein. The results showed that genistein was present in several species at 
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concentrations ranging from 0.7 (aqueous extract of M. tornata) to 9.3 mg/kg/db (alcoholic 
extract of M. minima). Formononetin, prunetin and biochanin A are absent in most species 
and their contents were considerably lower than the contents of other isoflavones. 
In terms of total isoflavones content per species, results show a significantly 
difference (p<0.05) between M. rigidula and M. sativa (Table 4.2 - D and G), being the 
total content higher in M. rigidula and lower in M. sativa. 
Comparing the isoflavones content in Medicago spp. with other plants of the 
Leguminosae family, literature reports that the highest concentrations of isoflavones occur 
in soybeans, red clover and kudzu root [31]. Concentrations of total isoflavones (sum of 
daidzein, genistein, and glycitein in aglycone equivalents) determined in different types of 
soy flour range from 60 to 265 mg/100 g [270].  At the moment, soy is reported as the 
richest source of daidzein and genistein, up to 3800 mg/kg wet weight of soybean [271-
272]. Isoflavones can also be extracted from red clover, another Leguminosae, in huge 
amounts. Different authors determined a large amount of isoflavones in this plant, which 
are mainly available as malonate conjugates, e.g. glycoside malonates of formononetin, 
irilone and biochanin A, in concentration ranging between 0.042 µg/g to 6 mg/g [45, 273-
274]. The values obtained for Medicago can also be compared with the values obtained 
by Liggins et al. in raw vegetables and vegetable products and also in fruits and nuts, 
being higher [271-272]. Daidzein and genistein were found in a variety of fruits and nuts 
with concentrations ranging from 1 to 2250 µg/kg [272]. Also according to these authors, 
legumes contained between 20 and 5750 mg/kg wet weight of food, with an average of 
620 mg/kg [271]. The daidzein and genistein contents in vegetables such as potatoes, 
cabbages or cucumber were about 8 µg/kg, considerable lower than Medicago [271]. On 
the other hand, coffee is the most important food commodity worldwide [6, 275] and has 
been intensively studied as a potential source of compounds with functional properties. As 
so, it seems interesting to compare Medicago values with those ones. Kuhnle et al. 
determined the phytoestrogen contents in coffee and tea and the values are lower (7-20 
µg/100 g) when compared with Medicago [275]. Also, it should be take in consideration 
that the main use of all these comparable plants are as food ingredients and not as active 
ingredients for different industries. As this, reutilization of food by-products could be seen 
as a new valorisation of products without economic interest, not using food that is 
necessary over the world, and so Medicago could be a good promising source of these 
compounds. Rodrigues et al. described a detailed study about this subject [101]. 
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This is, to the best of our knowledge, the first published description of these eight 
isoflavones in these extracts of Medicago species. It should be taken into consideration 
that the concentrations of isoflavones in Medicago are probably also dependent on a 
variety of factors besides genetic differences. These compounds are affected by different 
kind of factors as the growing conditions, including climate, soil, sunlight, postharvest 
conditions and age, among others [31, 276-277]. With the expectation that not only the 
species but also the solvent used for extraction (water, water: alcohol and alcohol) could 
affect the final content of isoflavones, the influence of solvent extractor was evaluated.  
Influence of solvent extractor: Three solvents (water, water: ethanol and 
ethanol) were used as extractors to embrace the most effective one, regarding the total 
isoflavones content. The main goal of this study was to found a new promising use for 
these by-products, taking into account ecological and economic sustainability of the 
process. The obtained results are discriminated in Table 4.2. 
The influence of the solvent extractor was clear demonstrated. Generally the 
alcoholic extracts were the most rich (M. minima, M. rigidula, M. scutelata and M. sativa). 
However, M. tornata, M. truncatula and M. segitalis showed best results with 
hydroalcoholic solvent while  M. sativa and M. minima had similar results for aqueous and 
hydroalcoholic extracts. For M. segitalis the different used solvents had similar extraction 
capacity, a characteristic behavior of this specie. 
When the three solvent extracts were analyzed individually by species, a general 
increase of genistin levels in alcoholic extracts was noted. For daidzein, the increase is 
not evident, being the sample of M. truncatula and M. scutelata exceptions, with higher 
contents in hydroalcoholic extracts (Table 4.2 - C and E). For genistein, the result was 
variable. These different behaviors seem to result from different factors, namely, genetics 
of species and an unexpected extractability variation. In a general way, the compounds 
extractability significantly increased (p<0.05) from aqueous to alcoholic extracts. 
Exceptions were M. segitalis and M. sativa (Table 4.2 - F and G), for which no significant 
differences (p<0.05) in total isoflavones extractability were detected with different 
solvents.  The results also show that, although the extractability of the individual 
isoflavones varied with the sample, in a general way, genistin, daidzein and genistein are 
present at higher levels than the other isoflavones, especially at M. minima (alcoholic 
extract), M. tornata (hydroalcoholic extract), M. truncatula (hydroalcoholic extract), M. 
rigidula (hydroalcoholic and alcoholic extract) and M. scutelata (alcoholic extract). 
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However, as already referred, in plants, isoflavones are usually bound to other molecules 
that modify their solubility properties [278]. Aglycones of phenolic compounds are 
hydrophobic compounds, however they have an intermediate solubility (such as 
flavonoids) [279-280]. The higher concentration of daidzein in extracts is a pattern that 
has been observed in other species of Leguminosae and, probably, is related to the 
biosynthetic pathways of these compounds. Formononetin, prunetin and biochanin A most 
of time were not determined in samples and, if so, they were not the main isoflavones and 
are more abundant in alcoholic extracts. 
An increase in the total isoflavones levels of Medicago species was observed as 
the solvent polarity decreases, for each individual sample. Independent of the species, 
aqueous extraction always contained inferior amounts of isoflavones. The use of ethanol 
as extraction solvent is very interesting if it is desired the extract application in food or 
cosmetic products, for example. The use of organic solvents in the manufacturing process 
to obtain cosmetic ingredients is regulated [109], and from the perspective of cosmetic 
safety it is preferable to use solvents such as ethanol or water: ethanol mixtures since 
they are in compliance with good manufacturing practices. Methanol is usually a good 
extraction solvent but it has a toxic character. Therefore, the extracts produced with 
methanol arise serious issues for application in food and pharmaceutical products, 
according to the present legislation [281]. 
 
4. Conclusion 
Our investigation gives for the first time a comprehensive picture on the isoflavone 
pattern of seven Medicago species (M. minima, M. tornata, M. truncatula, M. rigidula, M. 
scutelata, M. segitalis and M. sativa) extracts (aqueous, hydroalcoholic and alcoholic). 
This information may be of interest to its use in cosmetic or pharmaceutical preparations. 
As part of this work, eight isoflavone, including daidzin, genistin, daidzein, glycitein, 
genistein, formononetin, prunetin and biochanin A, were detected and quantified for the 
first time in extracts of Medicago. Genistin, daidzein and genistein were the main 
isoflavones extracted, while formononetin, prunetin and biochanin A appears in small 
amounts and in few extracts. In terms of total isoflavones content per specie, they have 
different contents being M. rigidula the richest and M. sativa the poorest. Comparing with 
other plants of the same family like Trifolium, Medicago showed a lower content of 
isoflavones. However, raw vegetables like potatoes presented a lower content than 
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Medicago. The same occurs with coffee. The influence of solvent extractor was also 
studied, and, despite the alcohol present very high values of isoflavones in some species, 
the use of a hydroalcoholic solvent must be taken into account, since it originated 
promising values and was less toxic.  
The results reported here will contribute to databases of the phytoestrogen content 
of diets applied to the dietary intake of foods of free living individuals and is the sole 
source of such information in the literature at the present time for Medicago species.
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1. Introduction 
Alongside rising interest in natural products for health and personal care 
applications, there is a trend towards the use of environmentally-friendly products 
obtained by sustainable resources. By-products valorisation is a relatively new concept in 
the field of industrial residues management, promoting the principle of sustainable 
development. Application of agro-industrial residues in bioprocesses, on one hand, 
provides alternative substrates with potential market value, while on the other hand helps 
solving pollution problems, of otherwise disposable remainders [282]. Food processing by-
products enables reduced waste and the recovery of extracts for the production of 
precious metabolites via chemical and biotechnological processes. After specific pre-
treatments with physical and biological agents followed by tailored recovery procedures, 
they might provide valuable natural antioxidants, antimicrobial agents, vitamins, etc., 
along with macromolecules, such as cellulose, starch, lipids, proteins, plant enzymes and 
pigments, of enormous interest to pharmaceutical, cosmetic and food industries [256]. In 
particular, agro-industrial by-products are good sources of phenolic compounds and have 
also been explored as source of natural antioxidants [254]. While the use of naturally 
occurring phenolic compounds as food antioxidants is particularly interesting, practical 
aspects should be considered as the extraction efficiency, availability of raw material and 
safety. 
Coffee beans contain several classes of health related chemicals such as phenolic 
compounds, diterpenes, xanthines and vitamin precursors [283-284]. Coffee phenolics 
have attracted much interest in recent years due to their strong antioxidant and metal-
chelating properties [285]. These properties are believed to provide in vivo protection 
against free radical damage and reduce the risk of degenerative diseases associated with 
oxidative stress. Advances in industrial biotechnology offer potential opportunities for 
economic utilization of agro-industrial residues of coffee such as coffee pulp, coffee husk 
or coffee silverskin [282]. Usually, two coffee beans are found in each fruit, each bean 
covered with a thin closely fitting skin called silverskin (CS), outside of which is a looser, 
yellowish skin called the parchment, the whole being encased in a pulp which forms the 
flesh of the cherry [10]. The CS is a tegument of coffee beans that constitutes a by-
product of the roasting procedure and is the most abundant solid by-product generated 
during the coffee process. CS has no commercial value and is currently discarded as a 
solid waste, being used, in some cases, as fertilizers or simply burned [10]. This has 
negative effects on the environment, and so, the disposal of CS requires proper 
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management. Alternatively, the transformation of this by-product into valuable products for 
other purposes is attractive. However, few works have been performed on the properties 
of CS, in particular the antioxidant capacity [15-16, 21].  
According to Narita & Inouye [21] consumers generally prefer natural antioxidants 
to synthetic ones because of the higher safety. Recently, it has been reported that CS is a 
rich source of antioxidants constituents [15, 21], but to the best of our knowledge, there 
are no reports on the use of CS for cosmetic applications. A recent work carried out in our 
laboratory showed that antioxidant content of CS extracts depends of temperature and 
time of extraction [20]. We consider that lower temperatures may be more attractive from 
an economical and industrial point of view. Thus, our current goal involves the extraction 
of active compounds from biological waste at relatively low temperatures. The objective of 
this work was to evaluate the antioxidant activity of aqueous, hydroalcoholic and alcoholic 
extracts of CS obtained at 40 °C. Also, the antimic robial properties and cytotoxicity of 
extracts were assessed, as relevant characteristics to the use of these ingredients in 
cosmetics. 
Thus, the present study was designed: (a) to quantify the antioxidant activity of 
different CS extracts by DPPH and FRAP assay and evaluate the total polyphenol and 
flavonoid content; (b) to evaluate the antimicrobial activity of CS extracts against bacteria 
and yeast; (c) to analyse the cytotoxicity profile of CS extracts in keratinocytes and 
fibroblasts from skin; (d) to choose the best extract to be used in cosmetic applications. 
 
2. Materials and Methods 
2.1 Materials 
Coffee silverskin samples were provided by Bicafé (BICAFÉ – Torrefacção e 
Comércio de Café Lda, Portugal), located in Porto, Portugal. Ascorbic acid, DPPH• (1,1-
diphenyl-2-picrylhydrazyl) free radical, catechin, Folin-Ciocalteu's reagent, gallic acid, 
iodine, Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, a water-soluble 
derivative of vitamin E) and α-tocopherol, were purchased from Sigma-Aldrich (Steinheim, 
Germany). Reagent grade ethanol, sodium acetate, sodium carbonate decahydrate, 
sodium nitrite, aluminum chloride and sodium hydroxide were purchased from Merck 
(Darmstadt, Germany). Dulbecco’s modified Eagle’s medium (DMEM) with GlutaMAX™-I, 
fetal bovine serum (FBS), streptomycin, penicillin and amphotericin B were from 
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Invitrogen (Carlsbad,CA, USA). MTS assay kit (CellTiter 96® Aqueous One Solution Cell 
Proliferation Assay) was purchased from Promega Co. (Madison, WI, USA). Lactate 
dehydrogenase (LDH) colorimetric cytotoxicity assay kit (LDH Cytotoxicity Detection Kit) 
was purchased from Takara Bio Inc. (Shiga, Japan). Deionized water was obtained using 
Mili-Q water purification system (TGI Pure Water Systems, USA). 
 
2.2 Preparation of coffee silverskin extracts  
CS was milled to particle size of approximately 0.1 mm using a A11 basic analysis 
mill (IKA Wearke, Staufen, Germany) and stored in silicone tubes at room temperature 
until extraction. Three samples of 1 g were submitted to maceration for 30 min at 40 °C 
with 20 mL of ethanol, ethanol: water (1:1) or distilled water.  Extracts were filtered 
through Whatman No. 1 paper filter and the filtrates collected. Aqueous filtrates were 
freeze-dried and hydroalcoholic and alcoholic filtrates were reduced to residue using a 
rotary evaporator set to 37 °C. Samples were stored  at 4 °C until analysis. For 
determination of the chemical parameters the extracts were reconstituted in the solvent 
used for extraction.  
 
2.3 Determination of total phenolic and flavonoid contents 
Total phenolic content (TPC) was spectrophotometrically determined according to 
the Folin-Ciocalteu procedure [185] with minor modifications. Briefly, 500 µl of extract (1 
mg/mL) was mixed with 2.5 mL of Folin-Ciocalteu reagent (10x dilution) and allowed to 
react for 5 min. Then, 2.5 mL of Na2CO3 7.5% (w/v) solution was added and after 15 min 
at 45°C, and 30 min at room temperature, the absorb ance was measured at 765 nm using 
a microplate reader (Synergy HT, BioTek Instruments, Inc., Winooski, VT, USA). A 
calibration curve of gallic acid with linearity range of 5-100 µg/ml and r2>0.998 was used. 
The TPC of the extract was expressed as mg of gallic acid equivalents per g of plant 
material on dry basis (mg GAE/g db). The assay was done in triplicate. 
Total flavonoid content (TFC) was determined by a colorimetric assay based on 
the formation of flavonoid-aluminum compound according to Barroso et al. [187]. Briefly, 1 
mL of extract (1mg/mL) was mixed with 4 mL of water and 300 µl of NaNO2 solution (5 % 
w/v). Then, 300 µL of AlCl3 solution (0.1 g/mL) were added, and after 1 min, 2 mL of 
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NaOH (1 M) and 2.4 mL of water. The absorbance was determined at 510 nm using the 
microplate reader. A calibration curve of catechin with linearity range of 0-400 µg/mL and 
r2>0.999 was used. The TFC of the extract was expressed as µg of catechin equivalents 
per g of plant material on dry basis (µg CAE/g db). The assay was done in triplicate. 
 
2.4 Antioxidant capacity of coffee silverskin extracts 
The antioxidant activity of the samples was evaluated by DPPH radical-scavenging 
activity and ferric reducing antioxidant power (FRAP). DPPH is known as a stable free 
radical which possesses a characteristic maximum absorption between 515 and 517 nm. 
The reaction mixture on 96 wells plate consisted of one solution per well for different 
sample concentrations (30 µL) and methanol solution (270 µL) containing DPPH radicals 
(6 x 10-5 mol/L). The mixture was left to stand for 30 min in the dark. The reduction of the 
DPPH radical was determined by measuring the absorption at 517 nm [188] using the 
microplate reader. The antioxidant capacity based on the DPPH free radical scavenging 
ability of the extract was expressed as µmol Trolox equivalents per g of plant material on 
dry basis (µmol Trolox /g db). A calibration curve of Trolox with linearity range of 2.5-100 
µg/mL and r2>0.996 was prepared. 
Ferric Reducing Antioxidant Power (FRAP) was carried out according to Benzie & 
Strain [189] with minor modifications. Briefly, 90 µL of different sample concentrations 
were added to 2.7 mL of FRAP reagent (10:1:1 of 300 mM sodium acetate buffer at pH 
3.6, 10 mM TPTZ and 20 mM FeCl3 · 6H2O) and the reaction mixture was incubated in a 
water bath at 37 °C. The increase in absorbance at 592 nm was measured after 30 min 
using a microplate reader. A calibration curve of FeSO4-7H2O with linearity range of 150-
2000 µM and r2>0.996 was used. The results were expressed as µmol Fe2+ equivalents 
per g of material on dry basis (µmol Fe2+ /g db).  
 
2.5 Antimicrobial activity of coffee silverskin extracts 
2.5.1 Microorganisms strains 
To test the antimicrobial activity, eight microorganisms (seven bacteria and one 
yeast) were enrolled in the study. Both American Type Culture Collection (ATCC) and 
clinical isolates were selected, corresponding to two Staphylococcus aureus (ATCC 6538 
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and one clinical isolate), Staphylococcus epidermidis (clinical isolate), two Escherichia coli 
(ATCC 1576 and one clinical isolate), Klebsiella peumoniae (ATCC 4352), Pseudomona 
aeruginosa (ATCC 9027) and Candida albicans (ATCC 10231). Clinical isolates were 
identified as to species-level with Vitek-2 identification cards (Biomerieux, France) and all 
strains were kept frozen in Brain Heart Infusion (Difco Laboratories, USA) with 20% 
glycerol (Sigma) at -70°C until testing. For each e xperiment, microorganisms were 
subcultured twice in Nutrient agar (Difco Laboratories, USA) for bacteria and Sabouraud 
dextrose agar (SDA; Difco Laboratories, USA) for yeasts, to assess culture viability.   
2.5.2 Determination of minimal inhibitory concentrations 
The antibacterial activity was tested according to CLSI M7-A6 microdilution [191] 
and the antifungal activity was tested according to M27-A3 microdilution from the same 
protocol, after 48 h of incubation at 37 °C and 35 °C, respectively  [190]. Briefly, two-fold 
serial dilutions of extracts were performed in Mueller Hinton broth (MH; Difco 
Laboratories, USA) for bacteria and with RPMI (Biochrom, Germany) for yeast. 
Concentrations ranging from 3.9 to 500 µg/mL were tested. Microorganisms growth was 
visually compared for each concentration with the negative control (without extracts). 
Minimal inhibitory concentration (MIC) was defined as the lowest extract concentration 
able to completely inhibit microorganisms growth, corresponding to 100% MIC value. All 
determinations were performed in triplicate for each assay and three independent 
experiments were run with concordant results. 
 
2.6 Cytotoxicity and cell viability of coffee silverskin extracts 
2.6.1 Cell lines and culture conditions 
Human immortalized non-tumorigenic keratinocyte cell line (HaCaT) and human 
foreskin fibroblasts (HFF-1) were purchased from CLS Cell Lines Service (Germany) and 
ATCC (Manassas, VA, USA), respectively. HaCaT and HFF-1 cells were individually 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) with GlutaMAX™-I 
(Invitrogen), 10% inactivated fetal calf serum (FBS; Invitrogen), 100 U/mL penicillin and 
100 µg/mL streptomycin (Invitrogen), and 0.25 µg/mL amphotericin B (Invitrogen), in a 5% 
CO2 environment at 37 °C. The number of viable cells w as periodically assessed by the 
trypan blue exclusion assay. After attachment, they were incubated in serum-free medium 
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containing 0.1 µg/mL to 1 mg/mL extracts for 24 h at 37 °C. Plant extracts were dissolved 
in cell culture medium. 
2.6.2 Cell viability and toxicity assays 
Two different assays were used to assess cell integrity and cytotoxicity of the 
extracts: (1) monitoring the uptake of the vital mitochondrial dye, 3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) by cell 
mitochondria and (2) determining the leakage of the cytosolic enzyme, lactate 
dehydrogenase (LDH) into the cell medium (LDH assay). In both cases, cells (HFF-1 or 
HaCaT) were seeded in 96-well plates (5 x 103 cells/well) and incubated with medium for 
24h (37 °C/ 5% CO 2). HFF-1 and HaCaT cells were used at passages 17-19 and 77-79, 
respectively. Then, triplicate wells were incubated with extracts dissolved in cell culture 
medium pre-filtered by 0.45 µm Millex GV filters (Millipore, Nepean, ON, Canada) at 
different concentrations (0.1-1000 µg/mL). Cells were exposed to extracts for 24 h. 
Medium without FBS was used in the case of LDH. Afterwards, MTS and LDH assays 
were performed according to manufacturers’ instructions. Briefly, cell supernatants were 
collected for the LDH assay and cells were washed twice with phosphate buffered saline 
pH 7.4 (PBS) before being incubated with 120 µL of MTS in medium for 4 h (37 °C/ 5% 
CO2). The absorbance was measured for each well at 490 nm with background 
subtraction at 630 nm using a microplate reader. In the case of LDH, absorbance after 30 
min/room temperature incubation of cell supernatants with LDH reagent was measured at 
490 nm with background subtraction at 690 nm using a microplate reader. Also, the 
maximum release of this enzyme (high control) was determined by incubating cells with 
1% (w/v) Triton X-100 (Boehringer Mannheim), while spontaneous LDH release (low 
control) was assessed by incubating the cells with DMEM alone. In MTS assay the 
positive control was the medium and the negative control was Triton X-100. In all cases, 
each concentration was tested in triplicate in three independent experiments.  
 
2.7 Statistical analysis 
Data were reported as mean ± standard deviation of at least triplicate experiments. 
Statistical analysis of the results was performed with SPSS 19.0 (SPSS Inc., Chicago, IL, 
USA). One-way ANOVA was used to investigate the differences between different 
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extracts for all assays. Post hoc comparisons were performed according to Tukey’s HSD 
test. In all cases, p<0.05 was accepted as denoting significance. 
 
3. Results  
3.1 Determination of total phenolic content (TPC) 
The broad range of effects of free radicals in biological systems has drawn the 
attention of many experimental works. It has been proved that these mechanisms may be 
important in the pathogenesis of certain diseases and aging. 
The TPC of the different CS extracts was determined using the Folin-Ciocalteu 
reagent. Results are presented in Table 5.1.  
Table 5.1 - Total Phenolic Content (TPC), Total Flavonoid Content (TFC), Ferric Reducing Antioxidant 
Potential Assay (FRAP) and 1,1-diphenyl-2-picrylhydrazyl hydrate (DPPH•) scavenging assay of coffee 
silverskin extracts (CS).  
   
  
Aqueous Extract Hydroalcoholic Extract Alcoholic Extract 
  
Mean SD Mean SD Mean SD 
TPC (mg GAE/g) 18.33b,c 0.52 30.50a,c 0.25 35.25a,b 0.25 
TFC (µg CAE/g) 1.08b,c 0.23 2.47a 0.06 2.61a 0.15 
DPPH (µmol Trolox/g) 206.00b,c 3.72 242.28a,c 5.42 386.35a,b 5.10 
FRAP (µmol Fe2+/g) 95.95c 1.50 134.0c 1.50 216.40a 2.70 
 
“a-c” Denote a significant difference between mean values, where “a” denotes a significant difference from CS Aqueous 
Extract, “b” a significant difference from CS Hydroalcoholic Extracts and “c” a significant difference from CS Alcoholic 
Extracts. Repeated measures ANOVA followed by Turkey's post-hoc test, n=3 independent experiments.  SD=standard 
deviation. 
 
The largest amount of total phenolic components (35.25 ± 0.25 mg) extracted from 
g of CS was determined with ethanol as solvent. It was almost two times higher than 
aqueous extract (18.33 ± 0.52 mg).  
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3.2 Determination of total flavonoids content (TFC) 
Flavonoids, which constitute the largest group of plant phenolics accounting for 
over half of the eight thousand naturally occurring phenolic compounds [254], were 
present in all CS extracts. Results varied between 1.08 mg (water extract) to 2.61 mg 
(ethanol extract) of CAE/g of CS (Table 5.1). The results clearly showed that the highest 
content of flavonoids was obtained with ethanol.  
 
3.3 In vitro antioxidant activity 
The antioxidant potential of the CS extracts was determined by two methods 
based on different approaches, namely the DPPH radical scavenging method and the 
FRAP assay, which have been extensively used to determine the antioxidant potential of 
various plant extracts and natural products [101]. Irrespective of the solvent used for 
extraction, all the extracts obtained from CS showed antioxidant potential (Table 5.1). 
Among them, the extracts obtained with ethanol had the highest antioxidant activity by 
both DPPH and FRAP methods.  
Similar to the DPPH results, the highest antioxidant activity in FRAP was also 
obtained in alcoholic extract (Table 5.1). A range of 95.95, 134.0 and 216.40 µmol Fe2+/g 
for aqueous, hydroalcoholic and alcoholic samples were obtained, respectively. 
 
3.4 Antimicrobial activity 
Microorganisms such as fungi and bacteria are important factors that cause 
oxidative processes during storage of cosmetic products and consequent deterioration.  
Despite several previous studies on the antimicrobial properties of coffee against many 
human’s pathogens, to the date there is not research on the antifungal and antibacterial 
activity of CS [286]. 
The antibacterial activity of CS extracts was evaluated by the determination of MIC 
values (Table 5.2). In this study, microorganisms were selected to cover Gram-positive 
bacteria (S. aureus and S. epidermidis), Gram-negative bacteria (E. coli, K. pneumoniae, 
P. aeruginosa) and yeasts (Candida albicans). The consistent and reproducible results 
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obtained showed that CS extracts exhibited an interesting antimicrobial potential (Table 
5.2). 
 
Table 5.2 - Antibacterial activity of different extracts of CS expressed as the Minimal Inhibitory Concentration 
(MIC). Data expressed as mean of the replicates (n=3). 
 
Bacterial strains 
MIC (µg/mL) 
Aqueous 
Extract 
Hydroalcoholic 
Extract 
Alcoholic 
Extract 
S. aureus ATCC 6538 31.3 125 125 
S. aureus MRSA 250 250 250 
S. epidermidis B21 62.5 62.5 62.5 
E. coli ATCC 1576 62.5 125 125 
E. coli B26 125 125 125 
K. pneumoniae ATCC 4352 31.3 31.3 31.3 
P. aeruginosa ATCC 9027 >1000 >1000 >1000 
C. albicans ATCC 10231 >1000 >1000 >1000 
 
Aqueous extracts of CS presented MICs in the range of 31.3-250 µg/mL against S. 
aureus, S. epidermidis, E. coli and K. pneumoniae. The hydroalcoholic and alcoholic 
extract showed similar activity against the microorganisms tested. Both presented MICs in 
the range of 31.3 µg/mL-250 µg/mL against those tested microorganisms. The values 
varied from 31.3 µg/mL to 1000 µg/mL of culture medium, and the lowest and highest 
mean MICs among the three groups were observed against K. pneumoniae (31.3 µg/mL) 
and C. albicans / P. aeruginosa (>1000 µg/mL), respectively. Concerning antifungal test, 
the analysed extracts failed to show any activity against C. albicans. 
 
3.5 Keratinocytes and fibroblasts cytotoxicity assay 
The effects of the extracts on the growth of keratinocyte (HaCaT) and fibroblast 
(HFF-1) cells were investigated by MTS and LDH assays. These cell lines are regarded 
as suitable in vitro models for testing the toxicity potential of substances or products 
intended for cosmetic use [242]. 
According to the obtained results for the MTS assay, none of the extracts exhibited 
cytotoxicity against HaCaT cells (Table 5.3) at all concentrations up to 1000 µg/mL.   
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Table 5.3 - Effect on the metabolic activity of HaCaT cells after the exposure to CS extracts at different 
concentrations, measured by the MTS assay. Values are expressed as the means ± SD (n=6). 
 
Concentration 
(µg/mL) 
Cell Viability (%) 
Aqueous Extract Hydroalcoholic Extract Alcoholic Extract 
Mean SD Mean SD Mean SD 
0.1 99.79 1.09 96.11 3.90 103.46(2,3) 2.21 
1.0 91.31c 3.14 93.43c 2.82 103.46(1,3,4,5)a,b 2.49 
10 96.11b,c 0.46 92.58a,c 1.11 100.78(1,2)a,b 0.4 
100 99.51b.c 4.56 97.67a 1.04 100.78(2)a 1.5 
1000 103.60 5.89 101.55 4.04 101.91(2) 0.42 
 
“a-c” Denote a significant difference between mean values, where “a” denotes a significant difference from 
aqueous extract, “b” a significant difference from hydroalcoholic extract and “c” a significant difference from 
alcoholic extracts. Repeated measures ANOVA followed by Turkey's post-doc test, n=3 independent 
experiments. “1-5” Denote a significant difference between mean values, where 1 denotes a significant 
difference from concentration 0.1 µg/mL inside an extract and 2 denotes a significant difference from 
concentration 1.0 µg/mL inside the same extract, etc. Repeated measures ANOVA followed by Turkey's post-
doc test, n=3 independent experiments. SD = standard deviation. 
 
Table 5.4 presents the cytotoxicity data of the three different extracts of CS against 
HFF-1 cells and as determined by the MTS assay. 
 
Table 5.4 - Effect on the metabolic activity of HFF-1 cells after the exposure to CS extracts at different 
concentrations, measured by the MTS assay. Values are expressed as the means ± SD (n=6). 
 
Concentration 
(µg/mL) 
 Cell Viability (%) 
Aqueous Extract Hydroalcoholic Extract Alcoholic Extract  
Mean SD Mean SD Mean SD 
0.1 91.64(4,5)b,c 7.90 130.53(2,3,5)a 5.89 132.88(3,4,5)a 3.08 
1.0 98.90(4,5)b,c 5.87 147.08(1,4,5)a,c 0.81 130.79(3,4,5)a,b 4.23 
10 96.35(4,5)b 8.60 144.00(1,5)a,c 2.95 105.31(1,2,5)b 5.06 
100 122.87(1,2,3)b,c 1.05 128.63(2,5)a,c 9.10 112.22(1,2,5)a,b 4.36 
1000 120.14(1,2,3)b,c 5.38 96.92(1,2,3,4)a 7.68 96.85(1,2,3,4)a 5.36 
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“a-c” Denote a significant difference between mean values, where “a” denotes a significant difference from 
aqueous extract, “b” a significant difference from hydroalcoholic extracts and “c” a significant difference from 
alcoholic extracts. Repeated measures ANOVA followed by Turkey's post-doc test, n=3 independent 
experiments. “1-5” Denote a significant difference between mean values, where 1 denotes a significant 
difference from concentration 0.1 µg/mL inside an extract and 2 denotes a significant difference from 
concentration 1.0 µg/mL inside an extract, etc. Repeated measures ANOVA followed by Turkey's post-doc 
test, n=3 independent experiments. SD = standard deviation. 
 
The number of viable fibroblast cells was similar for all extracts tested. The values 
ranged from 91.64% for aqueous extract (0.1 µg/mL), 96.92% for hydroalcoholic extract 
and 96.85% for alcoholic extract (1000 µg/mL).  
An important indicator of cell damage in oxidative stress is the increase in cell 
membrane permeability. In this study, potential cytotoxicity effects of different extracts of 
CS were investigated by examining membrane integrity of HaCaT and HFF-1 cells using a 
LDH release assay. In HaCaT cells, at all concentrations tested, CS extracts did not affect 
LDH leakage following 24 h incubation. The evidence of possible absence of cytotoxicity 
of this extracts at five different concentrations, namely, 0.1, 1.0, 10, 100 and 1000 µg/mL, 
implies that these extracts present low toxicity to these cells. Similarly, results for 
fibroblasts were comparable to those of HaCaT cells, with no significant increase in LDH 
being observed.  
The results between MTS and LDH are in concordance, which is in agreement with 
Issa et al. and Fotakis et al. who showed that both assays are inversely proportional [287-
288]. 
 
4. Discussion 
In this work, a new procedure was proposed in order to maximize the extraction 
results and to define the best conditions for antioxidant compounds extraction from CS to 
be used as new active ingredient for different kind of industries, especially cosmetic 
industries. In particular, aqueous, hydroalcoholic and alcoholic solvents were studied. 
Thirty minutes was fixed as the extraction time since the use of longer periods could not 
be economically advantageous. The extraction temperature was fixed at 40 °C, 
considering also economical reasons and since no significant advantage in extraction 
efficiency was observed when using higher temperatures, as previously demonstrated by 
Chapter │5  
I. Coffee Silverskin: A Possible New Cosmetic Ingredient? 
______________________________________________________________________________ 
110 
 
our group [20]. Statistical data analysis revealed a significant influence of all the studied 
solvents on the total phenolics content and antioxidant activity, which were improved 
when the ethanol was the solvent.  
The TPC of the CS extracts obtained with different solvents increased with 
decreasing polarity of solvent systems. This might be due to the fact that phenolic 
compounds are often more soluble in organic solvents, less polar than water [289]. 
Moreover, the obtained values are in agreement with the content reported in other 
important antioxidant sources by-products that are being study for antioxidant activity, 
such as spent coffee grounds (13 to 35 mg GAE/g dry matter) [281, 285], blackberry (50-
80 mg GAE/g dry matter) [290], brewer’s spent grains (9.9 mg GAE/g dry matter) [289], 
almond shells (38.0 mg GAE/g dry matter) [291] or apple pomace, which was below 15 
mg GAE/g dry matter [292]. When comparing the results obtained for CS with the ones for 
coffee, it is apparent that the coffee waste has similar phenolic content [293]. Naidu et al. 
studied the antioxidant composition of green coffee and conclude that the total polyphenol 
content from extraction with isopropanol plus water was around 32 mg GAE/g.  
On average, the flavonoid content was increased by about 2-fold, respectively, 
when water was replaced by ethanol, which can be attributed to an on-average higher 
affinity of these compounds for ethanol than for pure water.  Data examination reveals that 
the solvent had a significant effect on the extraction efficiency.  According to some 
authors, the addition of water to polar organic solvents such as acetone, methanol and 
ethanol, creates a more polar medium that facilitates the extraction of phenolic 
compounds [294].  
The content of total flavonoids was in high correlation with the content of total 
phenols (r2=0.963). According to Hečimović et al. [295], the TFC in coffee varies between 
12-20 mg CAE/g. Comparing with flavonoid content in CS, the obtained results indicate 
that roasting affects the polyphenolic compounds of CS. Comparing with other coffee by-
products like spent coffee grounds, the TFC is similar (2.11 to 8.03 mg CAE/g dry waste) 
[285].  
The DPPH radical scavenging activity of different solvents of the extract of CS was 
measured and the µmol Trolox equivalents determined. As indicated by the DPPH values 
in Table 5.1, for each waste material the use of ethanol as extraction solvent resulted in 
higher antioxidant activity. The results showed that DPPH radical scavenging activity 
efficiencies were in the order of alcoholic > hydroalcoholic > aqueous extract. The DPPH 
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values range from 206.0 to 386.35 µmol Trolox equivalents, for water and ethanol, 
respectively. This can be attributed to the higher total polyphenolic content of CS.  A good 
correlation between the total polyphenol content and DPPH scavenging radical activity 
was expected. In addition, plotting the DPPH value of the various extracts against their 
corresponding total phenolic content showed that these values were correlated. However, 
a mean r2 value of 0.69 was determined. This discrepancy could be due to a larger natural 
variation in the polyphenolic content. Also, the low correlation observed may be due to 
compounds that do not respond to the used reagent but also have antioxidant activity, 
such as caffeine or isoflavones. Furthermore, DPPH radical scavenging activity depends 
on the hydrogen donating ability of the extracted antioxidants [192].  
Comparing the total phenolic content and ferric reducing capacity of the samples a 
positive correlation (r2=0.80) was observed, as expected. Even though both the FRAP and 
DPPH assays were used to determine the antioxidant activity of the CS extracts, results 
are different due to the nature of each antioxidant assay. DPPH is a method based on the 
measurement of the reducing ability of antioxidants toward 1,1-diphenyl-2-picrylhydrazyl 
(DPPH•). This ability can be evaluated by electron spin resonance or by measuring the 
decrease of its absorbance. The reaction of DPPH with free radical scavengers present in 
the test sample occurs rapidly and can be assessed by following the absorbance 
decrease at 517 nm. The reaction time of the improved DPPH assay is only 30 min, while 
the FRAP assay measures the reducing capability by increased sample absorbance 
based on the ferrous ions released, being thus more time consuming. On the other hand, 
the DPPH assay is preferred to the ABTS assay because it is commercially available and 
does not have to be generated before assay like ABTS+ [192]. It is worth noting that the 
extracts produced with water presented low antioxidant potential and also low content of 
total phenols when compared with most of the extracts produced with organic solvents, 
like ethanol. Similar results have been reported during the extraction of antioxidant 
compounds from other raw materials such as spent coffee grounds [281, 285], grape by-
products [296] or almond [291].  
The use of ethanol as extraction solvent is very interesting if it is desired the 
extract application in cosmetic products, for example. The use of organic solvents in the 
manufacturing process to obtain cosmetic ingredients is regulated, and from the 
perspective of cosmetic safety it is preferable to use solvents such as ethanol or ethanol: 
water mixtures since they are in compliance with good manufacturing practice. Methanol 
is usually a good extraction solvent but it has a toxic character. Therefore, the extracts 
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produced with methanol arises serious issues for application in food and pharmaceutical 
products, according to the present legislation [281]. 
Analyzing the antimicrobial activity, the inefficacy of the extracts against P. 
aeruginosa may be related with the presence of the extracellular matrix. For C. albicans, 
the complex yeast wall is responsible for preventing extracts to contact with cell 
structures. Generally, Gram-negative are more resistant to bactericidal polyphenols than 
Gram-positive bacteria [297]. According to Fabry et al., for crude extracts of plants to be 
considered as potentially useful therapeutically they should have MIC values < 8 mg/mL 
[237]. Gibbons suggests that isolated phytochemicals should have MIC < 1 mg/mL [238]. 
The MIC values herein determined for CS extracts were below these values, except for C. 
albicans and P. aeruginosa, thus indicating a potential antimicrobial effect which may be 
advantageous for cosmetic products. In particular, these extracts may provide self-
preservative properties to the formulations in which they are incorporated.  
As CS is the outer layer of the roasted coffee beans, it is conceivable that some of 
the properties described for coffee brews, namely antimicrobial and antioxidant properties, 
are also maintained in CS. So, we expect that CS has similar antioxidant and antimicrobial 
activities to coffee brews. The latter is probably a consequence of the high contents of 
melanoidins generated during roasting, because CS has a lower content of free phenol 
compounds [6, 10, 15]. Also, antibacterial activity of the extracts could be related to the 
presence of high amounts of phenolic and flavonoid compounds in their composition, as 
referred above. As shown, plants are rich in a wide variety of secondary metabolites, such 
as polyphenols and flavonoids, which have been found to have antimicrobial properties in 
vitro [298]. These compounds have been suggested to interact with microorganism’s cell 
membrane causing protein membrane damages and consequently inducing its disruption. 
This effect leads to leakage of cellular content and causes interference with active 
transport and metabolic enzymes, as also as cytoplasm coagulation [298-300]. This 
cascade effects result in cell death. According to Dorman and Deans the high phenolic 
antibacterial activity could also be explained in terms of phenol nucleus alkyl substitution 
[301]. Its alkylation alters the distribution ratio between the aqueous/nonaqueous phases 
by reducing the surface tension or altering the species selectivity. This alkyl substituted 
phenolic compounds form phenoxyl radicals which interact with isomeric alkyl 
substituent’s [302]. The hydroxyl group relative position seems to exert an influence upon 
the components effectiveness against Gram-negative and Gram-positive bacteria [301]. 
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The results of previous reports about coffee, along with our findings in CS, can 
confirm the inhibitory effects of CS extracts on growth and development of fungi and 
bacteria. Further studies, to identify the responsible molecules for antibacterial activity 
observed, are being developed in our laboratory. 
The cytotoxicity results appear to indicate that fibroblasts are more sensitive to all 
extracts as compared to HaCaT cells, as previously mentioned by other authors to similar 
compounds [172, 245]. Furthermore, these results suggested that all extract of CS, at 
concentrations < 1000 µg/mL, have no adverse effect on the viability of fibroblast cells in 
vitro. These results could indicate a probable protective effect of the extracts on the cell 
line, but further studies are needed to confirm that. Ekmekcioglu et al. studied the effect of 
coffee in Caco-2 cells and no cytotoxicity was observed [303]. Other by-products, like 
brewers' spent grain, a protein-rich by-product of the brewing industry, has been tested for 
their cytotoxicity effect [304]. McCarthy et al. studied the cytotoxicity effect of Brewers' 
spent grain, against U937 and Jurkat T cells and concluded that cytotoxicity is low [304]. 
Over the three peel ethanolic extracts analyzed (Punica granatum (pomegranate), 
Nephelium lappaceum (rambutan), and Garcinia mangostana (mangosteen))  only 
rambutan may be considered potentially useful as a source of natural antioxidants for food 
or drug product because of its high antioxidant activity and non-toxic property to normal 
cells, at concentrations above 100 µg/mL [305]. In the same way, Khonkarn et al. studied 
the cytotoxicity of fruit peel extracts from rambutan, mangosteen and coconut against KB 
(human epidermal carcinoma of the mouth with HeLa contaminant) and Caco-2 cells and 
proved that coconut showed a high cytotoxic effect towards KB cells for concentration 
above 100 µg/mL [306]. This means, that most of by-products extracts have some 
cytotoxicity. However, CS showed no cytotoxicity for concentrations above 1000 µg/mL. 
For the best of our knowledge, this is the first study that reports the effects of CS in skin 
cell lines. On another hand, most of the studies of cell toxicity of by-products are not done 
in fibroblast or keratinocytes. The unique study that reports the use of these cells with by-
products was done by Rodrigues et al., who studied the effect of Medicago in fibroblast 
and keratinocytes cells, and, as well, no cytotoxicity was observed [101]. 
5. Conclusion 
The CS extracts showed high polyphenol content, mainly in the ethanolic extract 
that also presented high flavonoid content. The antioxidant activity was high and positive 
correlations with polyphenol content were observed. Also, a good antimicrobial activity 
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was observed against K. pneumoniae, S. epidermidis and S. aureus, with no cytotoxicity 
of all extracts to fibroblasts and keratinocytes at tested concentrations. 
In conclusion, CS ethanol extract can be considered the best one, as it expressed 
high antioxidant and antimicrobial potential with no toxicity. In this way, CS extracts may 
constitute a promising source of good antioxidative agents. However, investigation of the 
active constituents, associated with further purification, may provide useful comparative 
information in the future. 
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The information presented in this chapter section was published in the following 
publication: 
- Francisca Rodrigues, Carla Pereira, Filipa B. Pimentel, Rita C. Alves, Marta Ferreira, 
Bruno Sarmento, M. Helena Amaral, M. Beatriz P.P. Oliveira, Are coffee silverskin 
extracts safe for topical use? An in vitro and in vivo approach, Industrial Crops and 
Products, 63:167-174, 2015 
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1. Introduction 
In recent years, sustainable approaches have become an essential challenge for 
different industries. Answering to this issue, the present study was undertaken to 
investigate the potential use of Coffee Silverskin (CS) extracts in cosmetic products. 
Usually, per coffee fruit are found two coffee beans, each one covered by a thin closely 
skin called silverskin [10]. CS is a main by-product of the coffee roasting procedure and 
has no commercial value, being discarded as a solid waste [10]. This may have negative 
effects on the environment requiring proper management. Recent advances in industrial 
biotechnology leads to potential opportunities for economic valorisation of this by-product 
[282]. Some work has been performed on the properties of CS, in particular its antioxidant 
behaviour, which reveals a good content [15-16, 20-22, 285]. An example is chlorogenic 
acid (CGA), which is a highly valuable natural polyphenol compound used in medicine and 
industries [307]. However, some process steps in coffee production could affect CGA 
content, such as roasting, decaffeination and/or blending [308]. Also, the caffeine (CAF) 
content should be very high and similar to that of coffee beans [16, 19, 21]. These 
compounds are believed to provide in vivo protection against free radical damage. As 
coffee beans, CS contains several classes of health compounds such as phenolics, 
diterpenes, xanthines, and vitamin precursors [283-284].  Caffeine is being increasingly 
used in cosmetics due to its high biological activity and ability to penetrate the skin barrier 
[309]. A number of claims, as anti-cellulite properties, are based on the implicit 
assumption that this bioactive substance is effectively released from the formulation into 
epidermis and probably through epidermis into the dermal and subcutaneous tissues, 
preventing the excessive accumulation of fat in cells, and providing a slimming effect [309-
310]. This alkaloid stimulates the degradation of fats during lipolysis through inhibition of 
the phosphodiesterase activity and has potent antioxidant properties [309]. However, 
studies assessing the skin absorption of caffeine released from extracts are extremely 
rare in the literature. Another compound that should be taken in consideration regarding 
CS is 5-hydroxymethyl furfural (HMF), which is formed during coffee roasting [311]. HMF 
is cytotoxic, irritating to the eyes, skin and mucous membranes at high concentrations, 
being very important to quantify its presence in CS extracts [312].  
The assessment of irritation is one of the primary procedures to evaluate and 
hazards classify a substance, particularly, in cosmetics or pharmaceuticals [117]. In line 
with the 7th amendment deadlines, European Union bans the in vivo skin irritation 
assessment on ingredients for cosmetic purposes, regarding concerns about the test’s 
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reproducibility, plus animal welfare and political pressures [313]. A number of in vitro tests 
to assess potential skin or eye irritants have been developed. The reconstructed human 
epidermis EpiSkinTM test method was validated by European Union Reference Laboratory 
for alternatives to animal testing (ECVAM) as replacement test for the prediction of acute 
skin irritation. According to Cotovio et al., the assessment of ocular irritation is also one of 
the primary procedures to evaluate and hazards classify a new substance [117]. The in 
vivo Draize irritation rabbit eye test continues to be described in the current OECD test 
guidelines, but ethical questions are leading to the development of in vitro alternative 
tests, such as Human Corneal Epithelial Model (SkinEthicTM HCE), which are still under 
validation by ECVAM.  
The aim of this study is to evaluate the in vitro and in vivo irritation potential of 
three CS extracts. For both EpiSkinTM and SkinEthic HCETM assays, MTT and IL-1α were 
used as endpoints. After the extract contact with the model, the histology of the model 
was evaluated.  To ensure the possible content of CAF, CQA and HMF that pass through 
RhE, an HPLC assay was performed. In vivo skin irritation potential observed after single 
application under occlusion was assessed along with sodium lauryl sulfate (SLS) solution 
(2%, w/v) as irritant model (positive control) and water as non-irritant (negative control). 
 
2. Materials and Methods 
2.1 Chemicals 
CS samples were provided by a national coffee roaster company (BICAFÉ – 
Torrefação e Comércio de Café Lda, Portugal). EpiSkinTM and SkinEthicTM HCE model 
were purchased from SkinEthic Laboratories (Lyon, France). 3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide (MTT) and sodium lauryl sulfate (SLS; purity > 99%) 
were purchased from Sigma-Aldrich Chemical (St Quentin Fallavier, France). ELISA 
Quantikin kit for IL-1α measurements was from R&D Systems (Lille, France). Deionised 
water was obtained using Mili-Q water purification system (TGI Pure Water Systems, 
USA). Ethanol was obtained from Panreac (Barcelona, Spain). HPLC-grade acetonitrile 
was from Fluka (Madrid, Spain). 5-(Hydroxymethyl)furfural, caffeine and chlorogenic acid 
standards were from Sigma-Aldrich (Steinheim, Germany). Metaphosphoric acid, 
isopropanol, phosphate buffered saline (PBS; pH 7.4) and paraformaldehyde were from 
Sigma - Aldrich (St. Louis, Missouri, USA).  
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2.2 Preparation of extracts 
CS was milled to particle size of approximately 0.1 mm using a A11 basic analysis 
mill (IKA Wearke, Staufen, Germany) and stored in silicone tubes at room temperature 
until extract preparation, as described by different authors [22]. Samples (1 g) were 
submitted to solvent extraction by maceration with 20 mL of water, ethanol: water (1:1 v/v) 
or ethanol for 30 min at 40 °C.  The three differen t extracts obtained were filtered through 
Whatman No. 1 paper filter and the filtrates collected [20].  
 
2.3 In vitro models assays 
In order to determine the irritant potential of CS extracts on skin and eye, in vitro 
tests were performed. Three different extracts mentioned above were tested.  
The EpiSkinTM model (large model) was obtained from a standardized large-scale 
production certified by the ISO 9001 standard. EpiSkinTM units were delivered to the 
laboratory within 24 h. Upon arrival, tissues were transferred to 12 well plates containing 
37 °C pre-warmed maintenance media (2 mL/well) and incubated overnight at 37 °C/ 5% 
CO2 and 95% relative humidity. 
The SkinEthicTM HCE model is composed of immortalized human corneal epithelial 
cells cultured in a chemically defined medium and seeded on a synthetic membrane at the 
air-liquid interface. The tissue is represented by a multilayered epithelium, with 5-7 cell 
layers and a surface area of 0.5 cm2. The assay was performed according to the 
manufacturer instructions [117, 314]. Upon arrival, tissues were transferred to 24 well 
plates containing 37 °C pre-warmed maintenance medi a (1 mL/well) and incubated 24 
hours at 37 °C, 5% CO 2 and 95% relative humidity. 
2.3.1 Skin irritation test  
The in vitro reconstructed human skin tissue (EpiSkinTM) method, proposed to 
replace animal testing for skin corrosivity and skin irritation [315], is based on determining 
cell viability, and cytokine release (IL-1α) as an additional endpoint. The reconstructed 
0.38 cm2 skin inserts were used and the assay was performed according to the 
manufacturer instructions and protocol. Negative (PBS-treated) and positive controls (5% 
(w/v) of SLS) were used. After exposing to the extracts and controls for 15 min, the 
epidermis samples were washed with sterile PBS and then incubated in the maintenance 
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medium. After 42 h, the medium was collected and frozen at -20 °C for further 
determination of IL-1α. Cell viability was determined by the MTT assay. Viability was 
calculated, considering 100% for the negative control. The histology of models was also 
evaluated as described below.  
2.3.2 Ocular irritation test 
The SkinEthicTM HCE model was used and the assay performed according to the 
manufacturer instructions and protocol. Negative (PBS-treated) and positive controls 
(ethanol) were used. After exposing to the extracts and controls for 10 min, the epidermis 
samples were washed with sterile PBS and then incubated in the maintenance medium 
for 16 h. After this time, the medium was collected and frozen at -20 °C for further 
determination of IL-1α, and the cell viability was determined by the MTT assay. Viability 
was calculated, considering 100% for the negative control. The model was also analysed 
regarding the histological aspects. 
2.3.3 MTT assay 
Immediately after rinsing, the tissues were evaluated for cell viability using the 
MTT assay, where yellow MTT is reduced to purple formazan primarily by enzymes 
(reductases) located in the mitochondria of living cells. A stock solution of MTT was 
prepared in maintenance media (provided with tissues) just prior to use and warmed to 37 
°C in a water bath. Tissues were transferred to 24- well plates (Corning Inc., Corning, New 
York) containing 300 µL MTT medium per well and placed in the 37 °C, 5% C O2 
humidified incubator. After 3 h incubation, the tissues were removed from the MTT 
medium and any residual MTT media on the exterior of the tissue insert was blotted with 
absorbent pads. The formazan salt was extracted from the tissues by transferring them to 
24-well plates containing isopropanol. The submerged tissues were incubated 3 h at room 
temperature protected from light. The plates were shaken for approximately 15 min once 
the extraction was complete. The optical density of the extracted formazan was 
determined by transferring 200 µL of each extraction solution into a clean 96-well plate. 
Isopropanol was used as a blank. The plates were read using a spectrophotometer 
(Synergy HT Microplate Reader; BioTek Instruments, Inc., Winooski, VT, USA) at 570 nm. 
Relative cell viability was calculated for each tissue as percent of the mean of the negative 
control tissues. 
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For both models, if the percentage of viability was > 50%, the substance was 
predicted as Non-Irritant (EU classification: No label; GHS classification: No category); if 
the percentage of viability was ≤ 50%, the substance was predicted as Irritant (EU 
classification: R38, R41 or R36, depending on the model; GSH classification: Category 1 
or Category 2) [117]. 
2.3.4 IL-1α assay 
For assessing the release of IL-1α, the culture media underneath the tissues were 
collected at the end of the post-incubation period and kept at -20 °C until measurement. 
The quantification of IL-1α was performed using the commercial enzyme-linked 
immunosorbent assay (ELISA) kit Quantikine® DLA50 (R&D Systems, UK) according to 
the manufacturer’s instructions. Mean concentrations (pg/mL) were obtained using 
duplicate measurements per tissue. IL-1α released was expressed as absolute data. 
2.3.5 Histology 
After incubating in the presence of CS extracts, EpiSkinTM and SkinEthicTM HCE 
samples (three samples per extract) were fixed with 2% paraformaldehyde during 1 h and 
embedded in Richard-Allan ScientificTM Neg-50TM Frozen Section Medium 
(ThermoScientificTM) before cryosections (7 µm) preparation (Microm HM550 cryostat; 
ThermoScientificTM). Samples were stained with haematoxylin–eosin–safran (HE) and 
epidermal thickness was measured using image analysis with Axiovision software (Zeiss, 
Sartrouville, France). Each image was studied for changes to the epidermis and especially 
to cell morphology.  
 
2.4 Analysis of CAF, HMF and CGA content in EpiSkinTM 
The HPLC method used in this study to quantify HMF, CQA and CAF in CS 
extracts was based on the work of Lemos et al. and Rivelli et al. [316-317]. The 
chromatographic analysis was performed in a HPLC integrated system (Jasco, Japan) 
equipped with a PU-980 pump and a Jasco AS-950 automatic sampler with a 20 µL loop. 
Detection was performed with a Jasco model MD-2010 multiwavelenght diode-array 
detector (DAD). The column employed was a Luna 5U C18 (5 µm, 150 x 4.60 mm) 
chromatographic column (Teknokroma, Spain). The mobile phase adopted was aqueous 
metaphosphoric acid solution: acetonitrile (82:18 v/v) with a flow rate of 1 mL/min and a 
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column temperature of 23 °C. Analytes were monitore d at 275, 285 and 330 nm, 
respectively, for CAF, HMF and CGA, and quantification was performed on the basis of 
the internal standard method. Chromatographic data were analyzed using the ChromNAV 
Software (Jasco, Japan). Calibration curves were prepared for HMF (0.36 - 93.0 mg/mL), 
CGA (5.0 - 160.0 mg/mL) and CAF (4.25 - 136.0 mg/mL). Analyses were carried out in 
duplicate. Confirmation of compounds identities was performed by comparing retention 
times and co-elution with authentic standards and also by UV absorption spectra. 
 
2.5 In vivo skin irritation 
2.5.1 Patch Test 
A single blinded study was done in order to evaluate the in vivo skin irritation. 
Twenty healthy individuals (15 women and 5 men) with a mean age of 30 ± 5 years, 
without known dermatological diseases or allergy to substances in topical products, 
participated in the study, in accordance with Declaration of Helsinki. Informed consent 
was obtained from all volunteers. The volunteers were asked to not apply any topical 
products in the forearms 24 h before the beginning and throughout the test period. 
Additionally, solar exposure was forbidden. Along with extracts, SLS (2%, w/v, aqueous 
solution) and purified water were also assayed, respectively, as positive and negative 
control. Five sites were marked in the inner forearms of volunteers. Before application of 
patch tests, the areas on the ventral part of each forearm were marked using a skin 
marker, and basal values were obtained by non-invasive measuring method. After basal 
measures were taken, the patches were applied. Fifty microlitres of the test solutions were 
applied on a filter paper disc (12 mm, Filter Paper Discs, SmartPractice, Phoenix, USA) 
and occlusion was achieved with aluminium chambers (12 mm, Finn Chambers, 
SmartPractice, Phoenix, USA). Patches were removed after 48 h, and following a period 
of 2 h of observation patch test areas were evaluated by non-invasive measuring methods 
and visual scoring.  
2.5.2 Visual and instrumental assessments  
The visual assessment of the degree of irritation was graded according to the 
following scale, previously used by Agner et al.: 0 - no reaction; 1 - weak, spotty 
erythema; 2 - well perceptible erythema covering the total exposure area; 3 - moderate 
erythema or severe erythema that covers the total exposure area [318].  The same scale 
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was used for edema: 0 - no reaction; 1 - weak, spotty edema; 2 - well perceptible edema 
covering the total exposure area; 3 - moderate or severe edema that covers the total 
exposure area [318]. 
Non-invasive biophysical measurements were also performed. All measurements 
were made with controlled temperature (20-22 °C) an d relative humidity (45-55%). 
Transepidermal water loss (TEWL) is traditionally used to assess skin barrier function 
[319]. Barrier function was evaluated by TEWL measurements, carried out with a 
Tewameter® TM 210 (Courage & Khazaka, Köln, Germany), which measures the relative 
humidity percentage that diffuses from the dermis to the skin surface (g/cm2 h).  
 
2.6 Statistical analysis 
Data were reported as mean ± standard deviation of at least triplicate experiments. 
Statistical analysis of the results was performed with the software SPSS 22.0 (SPSS Inc., 
Chicago, IL, USA). One-way ANOVA was used to investigate the differences between 
different extracts for all assays. Post hoc comparisons were performed according to 
Tukey’s HSD test. In all cases, p<0.05 was accepted as denoting significance. 
 
3. Results and Discussion 
3.1 Skin irritability tests 
Irritation is defined as the “production of reversible damage to the skin following 
the application of a test substance for up to 4 h”, therefore, the more significant the initial 
injury (cell death), the stronger the irritant effect [320].  In order to confirm the potential of 
the extracts for topical use, irritability assays with EpiSkinTM test were performed. 
EpiSkinTM is an alternative in vitro method efficient in predicting epidermal alterations in 
vivo caused by irritants. Data for the cell viability and the IL-1α release from in vitro assays 
with reconstituted human epidermis are shown in Table 5.5. 
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Table 5.5 - EpiSkin™ tissues were exposed for 15 min to controls and extracts. Cell viability was assessed by 
MTT while the post-exposure basal media was analyzed for IL-1α release (pg/mL).  
 
Extract Viability (%) IL-1α (pg/mL) 
W 117.7 ± 11.7a 8.5 ± 0.1c 
WA 105.9 ± 15.9a 76.4 ± 2.0b 
A 117.8 ± 9.8a 17.6 ± 3.2c 
PC (SLS) 11.6 ± 2.4b 522.9 ± 32.1a 
NC (PBS) 100 ± 9.7a 28.4 ± 2.6b,c 
 
Water (W), hydroalcoholic mixture (WA), alcohol (A), a positive control (PC: SLS – sodium lauryl sulfate) and a 
negative control (NC: PBS - phosphate buffered saline) were used. Values are expressed as mean ± SD (n = 
3). Values in the same column followed by different letters indicate significant differences (p<0.05). 
 
The method distinguishes between irritants and non-irritants. Irritant chemicals are 
identified by their ability to decrease cell viability below defined threshold levels of 50%. 
The three extracts are not skin irritants for topical use in cosmetic formulations as the 
viability in all cases is higher than 50%, with values ranging between 105.9 ± 15.9 and 
117.8 ± 9.8. This potential use was also confirmed by the low release of IL-1α as endpoint 
of the irritation process (in the range of negative control), produced by keratinocytes. IL-1α 
is a highly active and pleiotropic pro-inflammatory cytokine that play a key role in 
inflammation, being the biological mirror of skin irritation [321]. Keratinocytes produces IL-
1α and IL-1β mRNA in vitro, but only IL-1α biological activity has been identified in 
keratinocytes cultures [322]. According to Zhang et al., the concentration of IL1-α released 
by keratinocytes in cultured medium increased significantly follower the exposure to 
different irritants [323].  
The IL-1α content, expressed as pg/mL, was 28.4 ± 2.6 for PBS, 522.9 ± 32.1 for 
SLS, and 8.5 ± 0.1, 76.4 ± 2.0 and 17.6 ± 3.2, respectively, for aqueous, hydroalcoholic 
and alcoholic extract of CS. The absence of skin-irritant effects in extracts tested indicated 
that CS extracts could be safe for topical use.  
The morphology alteration that occurs after the contact between the extracts and 
the model was evaluated for all samples and controls. Figure 5.1 shows the effects of 
hydroalcoholic extract and controls on the morphology of the treated tissues. No 
morphological differences were observed for the treated tissues with extracts as 
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compared to the negative control (PBS). In contrast, the adverse effects observed with 
positive control in all epidermal layers confirm the viability measurements observed. 
Results suggest that histological analysis did not assess alterations to the epidermis in 
human skin samples after exposure to CS extracts.  
 
 
Figure 5.1 - Hematoxylin-eosin (HE) staining of the EpiSkinTM tissues. (a) After topical application of 10 µl of 
hydroalcoholic extract of CS: no irritation signs. (b) Negative control (100% cell viability): no irritation signs. (c) 
Positive control (5% SDS): marked epidermolysis. 
 
There are very few reports of irritation potential in skin models using extracts as 
this model was recently validated by ECVAM.  Balboa et al. evaluated the in vitro 
antioxidants properties and the skin irritant effects of natural extracts obtained from 
underutilized and residual vegetal and macroalgal biomass [321]. Extracts did not affect 
the human reconstructed epidermis but the cell viability was lower than in this study. 
Regarding the IL-1α release, the irritation process seems to be lower. This could be 
justified by the different solvents used in both studies. Considering the extract 
composition, reported by Rodrigues et al., it is also expected no effect on skin cells, since 
the identified compounds did not interact with cells, presenting an high antioxidant activity 
and absence of cytotoxicity in keratinocytes and fibroblast [22]. Also, washing procedures 
could not remove all materials and even lead to mechanical damage to the tissues, which 
results in an impaired prediction of the true skin irritation potential of the materials [324]. 
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3.2 Analytical methods 
A further part of the study was concerned with the analysis of CAF, CGA and HMF 
in the medium after the skin in vitro model assay for the three extracts. Chromatograms of 
CS extracts and standards are depicted in Figure 5.2. Compounds were numbered 
according to their elution order. 
 
 
Figure 5.2 - Chromatograms of aqueous extract (a), hydroalcoholic extract (b) and alcoholic extract (c) of CS 
and a standard mixture (1 mg/mL) (d) of HMF (1), CQA (2) and CAF (3). 
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HPLC analysis of the CS extracts indicated the presence of CAF and HMF and the 
absence of CGA for all extracts. The quantification of CAF and HMF is reported in Table 
5.6.  
 
 
Table 5.6 - Quantification of HMF, CGA and CAF in aqueous (W), hydroalcoholic (WA) and alcoholic (A) 
extracts of CS medium after EpiSkinTM assay.  
 
Extract HMF (µg/mL extract) CGA (µg/mL extract) CAF (µg/mL extract) 
W 2.28 ± 0.18 - 1.26 ± 0.06 
WA 2.39 ± 0.27 - 1.54 ± 0.14* 
A 2.26 ± 0.09 - 1.40 ± 0.07 
Values are expressed as mean ± SD (n = 3).* means a significant difference (p<0.05). 
 
CAF content in CS extracts ranged between 1.26 ± 0.06 and 1.54 ± 0.14 µg/mL for 
aqueous and hydroalcoholic ones, respectively. There is a statistical difference between 
the CAF content of hydroalcoholic extract and the other extracts. As previous mentioned, 
determination of CAF in CS is very important, since they have a great effect on the final 
quality of the extracts used for cosmetic proposes. Previously work done in our laboratory, 
evaluated the CGA content in CS hydroalcoholic extract and results demonstrated the 
presence of this compound [325]. The absence observed in the present study is justified 
by the retention effect of the epidermal model, which prevents the compounds passage. 
For the best of our knowledge, this is the first study that reports the content of CAF after 
an EpiSkinTM assay using extracts.  
 
 
3.3 Ocular irritability tests 
The assessment of ocular irritation is part of the early testing procedure for the 
evaluation of new cosmetic ingredients [117]. The use of cosmetic products can produce 
adverse effects on the ocular surface, ranging from mild discomfort to vision-threatening 
conditions [326]. These complications can be related to allergy or toxicity [326]. In this 
field, numerous non animal test systems have been developed over the years [327-328]. 
SkinEthic™ HCE is one of the two reconstructed human tissue that are currently available 
for the purpose of eye irritation and is under validation by ECVAM [314].  
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In order to evaluate the eye irritation potential of CS extracts, a SkinEthic™ HCE 
test was done. Table 5.7 summarizes the results for cell viability and release of IL-1α 
observed with extracts and controls.  
 
Table 5.7 - SkinEthic™ HCE model was exposed for 10 min to controls and extracts. Cell viability was 
assessed by MTT while the post-exposure basal media was analyzed for IL-1α release (pg/mL).  
 
Extract Viability (%) IL-1α (pg/mL) 
W 132.6 ± 21.3a 41.4 ± 2.5c 
WA 123.6 ± 13.7a 34.2 ± 1.6c 
A 48.0 ± 7.5c 82.2 ± 22.9b 
PC (Ethanol) 2.9 ± 0.5d 114.4 ± 2.5a 
NC (PBS) 86.0 ± 6.1b 23.7 ± 1.0c 
 
Water (W), hydroalcoholic mixture (WA), alcohol (A), a positive control (PC) and a negative control (NC: PBS - 
phosphate buffered saline) were used. Values are expressed as mean ± SD (n = 3). Values in the same 
column followed by different letters indicate significant differences (p<0.05). 
 
The viability of cells with aqueous and hydroalcoholic extracts were higher than 
50%, with percentages of 132.6 ± 21.3 and 123.6 ± 13.7, respectively, which means that 
the extracts were classified as non irritants for the eyes. Ethanolic extract presented a 
percentage of viability of 48.0 ± 7.5, being in the borderline between irritant and non 
irritant, which is justify by the higher amount of alcohol used. Regarding the IL-1α release, 
no significant differences were observed between negative control and aqueous or 
hydroalcoholic extracts. However, the release of IL-1α slightly increased when using the 
positive control and ethanol extract as compared to the negative control. As mentioned by 
manufacture, ethanol was used as positive control. 
The histological images obtained after topical application of the aqueous and 
hydroalcoholic extracts of CS also confirms that both are not irritant, being good 
candidates for cosmetic ingredients.  Regarding alcoholic extract, results are very 
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different. As it is possible to confirm, this extract leads to histological alterations in 
SkinEthicTM HCE tissues, similarly to positive control (Figure 5.3).  
 
Figure 5.3 - Hematoxylin-eosin (HE) staining of the SkinEthicTM HCE tissues. After topical application of 10 µl 
of alcoholic (a) extract of CS: irritation signals. (b) Negative control (100% cell viability): no irritation signs. (c) 
Positive control (5% SLS): marked epidermolysis.  
 
As far as we know, this is also the first time that SkinEthicTM HCE is used to 
evaluate the ocular irritation for food by-products extracts in order to incorporate them in 
cosmetics as active ingredients. 
 
3.4 In vivo test 
According to Miles et al., reconstructed human epidermis like EpiSkinTM has some 
limitations [329]. This model is composed of a highly differentiated multi-layer human 
epidermis cells, but are totally lacking in any network of the pilo-sebaceous units, which 
regulate dermal homeostasis [329]. Also, the hydrolipid film cannot be totally reproduced 
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regarding its bio-physiological properties of components (urea, glycolic acid) neither to the 
occlusive effect of the film’s lipid component (ceramides) [329]. Some cells normally 
present in human skin are not present in this model such as dendritic Langerhans’ cells. 
The higher penetration rate of these tissues makes these skin models more sensitive to 
test compounds [330], which could result in over-prediction of strong irritants [331]. Thus, 
to ensure that the extract is completely safe, some other assays like patch test should be 
done. Patch testing after a single application is a widely used procedure to evaluate acute 
irritant reactions in human volunteers. 
The previous assays led us to select the hydroalcoholic extract as the best one to 
be incorporated in cosmetic products, as it did not affect the morphology of skin and 
ocular models, with high cell viability for both assays and low IL-1α release. Also the CAF 
content was higher than in the other extracts evaluated and, according to Rodrigues et al., 
the antioxidant content and antimicrobial activity is higher [22]. Considering not only these 
results but also sustainability questions and other previous works regarding the 
antioxidant activity of these extracts, hydroalcoholic extract seems to be the best one, 
being selected for the final patch test [19-21]. 
 
3.4.1 Skin compatibility by evaluation of primary skin irritation  
Initially, evaluation of irritancy testing was based on visual score. Results obtained 
by visual analyse are shown in Figure 5.4. Results of patch testing demonstrated that 
hydroalcoholic provoked a slight erythema in three volunteers 2 h after the patch test 
removal. However, when statistical analyses were applied regarding negative control, no 
differences were found. Regarding the positive control, it is possible to observe statistical 
differences when comparing with negative control and hydroalcoholic extract (p<0.05). 
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Figure 5.4 - Frequency of clinical scores attributed to positive control (PC - SLS), negative control (NC - 
purified water) and hydroalcoholic extract of CS (HA) regarding erythema and edema after patch remove.* 
means a significant difference (p<0.05). 
 
3.4.2 Transepidermal water loss variation  
The measurement of transepidermal water loss (TEWL) is a well established 
method in dermatology to assess the integrity of the skin barrier in vivo and an important 
measure of epidermal barrier function [332]. When skin is damaged, the barrier function is 
impaired which results in a higher water loss. The extract did not alter the skin barrier 
function, as TEWL values were not changed, when compared to the positive control 
(Figure 5.5). 
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Figure 5.5 - Transepidermal water loss (TEWL) variation from basal values of negative control (NC), positive 
control (PC) and hydroalcoholic extract (HA). The left boxes represent values at time 0 and the right boxes 
represent values 2 h after patch removal. Outliers are presented as circles.* means a significant difference 
(p<0.05). 
 
No significant differences were observed for TEWL measurements, in comparison 
with purified water, 2 h after patch removal (p<0.05), which indicates the absence of 
barrier disruption. Consequently, CS hydroalcoholic extract is not potentially irritating. The 
only effect on TEWL values was probably due to the eventual formation of a greasy film 
by the lipophilic components of the extract. Comparing with other extracts that are under 
investigation, CS could be consider as safe for cosmetic purposes [333-334]. Unlike 
arnica and Calendula officinalis, CS did not originate skin irritation [335]. As expected, 
SLS (PC) leads to an increase of TEWL values. 
 
4. Conclusion 
This study constitutes an objective evaluation of the safety of CS extract as 
cosmetic ingredient and contributes to the elucidation of its mechanism of action. It is an 
overview of the effect of CS extracts in a validated human skin model for irritancy and eye 
model under validation. In vitro studies on ocular and dermal irritation were carried out 
with three different extracts of CS. The in vivo study was carried out with the extract that 
revealed the best results for the in vitro assays. Results of in vitro studies revealed that 
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CS extracts are safe regarding skin and ocular irritancy as cell viability was equal to the 
negative control in both assays and the IL-1α was under 50%. The histological analysis 
demonstrated that extracts did not affect the skin neither the ocular model. Quantitative 
chromatographic investigations revealed that the three extracts contained CAF and HMF, 
but there were no traces of CGA. The in vivo patch tests proved that the hydroalcoholic 
extract did not cause skin irritation. The next steps to evaluate the safety of the extract 
would undergo sensitization and tolerance studies in normal condition of use.  
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The information presented in this chapter section was published in the following 
publication: 
- Francisca Rodrigues, Carlos Gaspar, Ana Palmeira-de-Oliveira, Bruno Sarmento, M. 
Helena Amaral, M. Beatriz P.P. Oliveira, Application of coffee silverskin in cosmetic 
formulations: Physical / antioxidant stability studies and cytotoxicity effects, Drug 
Development and Industrial Pharmacy, 2015, in press 
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1. Introduction 
Agro-industrial by-products have the potential to be used with different purposes, 
providing economical advantage to otherwise disposable residues [101]. In particular, the 
field of skin care products and cosmetics may benefit from these remaining materials 
[101]. During the last decade consumers have widely expressed their interest in natural 
products forcing the industry and the scientific community to search for alternative sources 
of raw materials. The desirable features of cosmetic ingredients are efficacy, safety, 
novelty, formulation stability, easy metabolism in the skin and low cost [101]. One of the 
most important reason for this change is the appearance of allergies and skin irritations 
due to synthetic preservatives (e.g. parabens), colourants, stabilizers, etc., that have not 
yet been fully tested in the long run for their consequences on consumers’ health [336].  
Coffee is one of the popular beverages of the world and second largest traded 
commodity after petroleum [9]. Coffee dispensation requires an elevated degree of 
processing know-how and produces large amounts of processing by-products such as 
coffee pulp, husk and silverskin, which have limited applications such as fertilizer and 
livestock feed [9-10]. Advances in industrial biotechnology offer potential opportunities for 
economic utilization of agro-industrial residues of coffee [282]. Coffee silverskin is a 
tegument of coffee beans that constitutes a by-product of the roasting procedure and is 
the most abundant solid by-product generated during the coffee process. Different authors 
evaluated the coffee silverskin properties, in particular its antioxidant properties and 
cytotoxicity against epidermal cells, but also the inhibitory activity on hyaluronidase [15-
16, 21-22]. According to different authors, coffee silverskin extracts are rich in polyphenol 
compounds, particularly chlorogenic acids and caffeine [21-22]. Thus, the use of coffee 
silverskin for topical application is a new procedure. Caffeine has been used in 
pharmaceutical and cosmetic preparations for a long time on the basis of its many 
favourable effects on the skin [337]. As proved by Bresciani et al., coffee silverskin 
contains the same amounts of caffeine as coffee beans [19]. However, cosmetic 
formulations containing coffee silverskin have to be submitted to studies of chemical 
stability in order to evaluate their quality, since the integrity of the extract must be kept 
constant during the formulation shelf-life. Stability prediction is usually performed by 
accelerated storage conditions, such as temperature variation, to induce rapid chemical 
alterations in formulations. Also, the cytotoxicity of the final formulation should be 
evaluated previously of the in vivo studies. 
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Often, the antioxidant potential of either plant extracts with active compounds or 
the pure isolated compounds is evaluated, but very few reports are available on the 
antioxidant properties of final formulations. In the present study, the hydroalcoholic extract 
of coffee silverskin, rich in antioxidant compounds and low cytotoxicity, were incorporated 
into a hand cream. This extract is easily dispersed, non-oily and can carry hydrosoluble 
active principles, for antioxidant potential assessment [22]. For the best of our knowledge, 
there are no studies analyzing the stability of this extract when vehiculated in topical 
formulations and their cytotoxicity against different skin cell lines. 
 
2. Materials and Methods 
2.1 Preparation of extracts  
Hydroalcoholic extract was prepared according to the method described by 
Rodrigues et al. [9]. Briefly, coffee silverskin was milled to particle size of approximately 
0.1 mm using a A11 basic analysis mill (IKA Wearke, Staufen, Germany) and stored in 
silicone tubes at room temperature until extraction. Samples (1 g) were submitted to 
solvent extraction by maceration with 20 mL of ethanol: water (1:1) for 30 minutes at 40 
°C.  Extracts were filtered through Whatman No. 1 p aper filter and the filtrates collected.  
 
2.2 Preparation of the formulation 
A hand cream was chosen for the experiments. The extract was added as 
antioxidant in the cosmetic preparation (CS). The hand cream was formulated with the 
following components: water, cetostearyl alcohol, dimethicone, jojoba oil, lactic acid, 
glycerin, sodium laureth sulfate, triethanolamine (if the mixture had acid pH), parfum and 
preservative. The base cream represents an oil-in-water semi-solid emulsion containing 
the same ingredients except the extract (BC). The extract was added in the final 
concentration of 2.5% and dissolved in the mixture after reaching the room temperature. 
The formulation was rested for 24 h at 20 °C before  measurements. Formulation was 
developed taking into account the final acceptance for consumers and after a scale up 
study in industry, being prepared batches both at laboratory and in industrial machines. 
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2.3 Cytotoxicity 
Two different assays were used to assess cell viability and cytotoxicity of the 
extracts: (1) monitoring the uptake and metabolism of the vital mitochondrial dye, 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) 
by cell mitochondria and (2) determining the leakage of the cytosolic enzyme, lactate 
dehydrogenase (LDH) into the cell medium (LDH assay). In both tests, triplicate wells 
were incubated with fresh medium in the absence or presence of both formulations 
dissolved in cell culture medium containing 1, 5 and 10 mg/mL of formulations. 
Formulations dissolved in culture medium were filtered on 0.45 µm Millex GV filters 
(Millipore, Nepean, ON, Canada) and exposed to keratinocytes (HaCaT) and fibroblasts 
(HFF-1) cells during 24 h. 
2.3.1 Cell lines and culture conditions 
Human immortalized non-tumorigenic keratinocyte cell line HaCaT (ethnicity, 
Caucasian; age, 62 years; gender, male and tissue, skin) was acquired from CLS Cell 
Lines Service, Germany. Human foreskin fibroblasts (HFF-1) were purchased from ATCC 
(ATCC Number: SCRC-1041; ATCC, Manassas, VA, USA). Passage 17-19 of HFF-1 and 
passage 77-79 of HaCaT cells were used for both MTS and LDH assay. HaCaT and HFF-
1 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) with GlutaMAXTM-I 
(Invitrogen) supplemented with 10% FBS, 100 µg/mL penicillin and 100 µg/mL 
streptomycin, and 0.25 µg/mL amphotericin B, and maintained in a 5% CO2 environment 
at 37 °C. At 90-95% confluence, both cell lines wer e harvested using trypsin (Invitrogen), 
viability assessed using the trypan blue dye (Gibco) exclusion assay, and re-plated in T75 
flasks.  
2.3.2 MTS assay 
The MTS assay was performed according to the manufacturer instructions. Briefly, 
cells were cultured in 96-well microtiter plate at a density of 25 × 103 cells per mL culture 
medium for 24 h at 37 °C. Following the removal of medium from the wells, the cells were 
washed with phosphate buffered saline (PBS pH 7.4). Then the medium was changed to 
fresh medium containing different concentrations of both formulations, namely 1, 5 and 10 
mg/mL. Cells were then incubated at 37 °C for 24 h.  Then medium was rejected and the 
number of viable cells evaluated by adding the MTS reagent in medium to each well and 
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incubating for 4 h at 37 °C. The positive control w as the medium and the negative control 
was Triton X-100. The absorbance was measured at 490 nm with background subtraction 
at 630 nm. Each concentration was tested in triplicate in three independent experiments. 
  
2.3.3 LDH assay 
Lactate dehydrogenase (LDH), a stable cytoplasmic enzyme found in all cells, is 
quickly released upon damage to the plasma membrane. Cell lines were seeded in 96-
well plates (5000 cells for LDH) and cultured for 48 h. Different concentration of the 
formulations, namely 1, 5 and 10 mg/mL, were prepared in appropriate medium and 
added to the cells. Media without FBS were used in the case of LDH. After incubation (37 
°C/ 5% CO 2), cells were washed twice with PBS and the kit was used according to the 
instructions of the manufacturers. The maximum LDH release (high control) from cells 
was determined using 1% (w/v) Triton X-100 (Boehringer Mannheim). Spontaneous LDH 
release (low control) was determined by incubating the cells with plain medium. 
Absorbance was measured at 490 nm with background subtraction at 690. Each 
concentration was tested in triplicate in three independent experiments. 
 
 
2.4 Long-term stability evaluation 
Batches of the formulation were prepared as earlier described and physical 
stability was evaluated by submitting the formulation to storage,  for a period of 6 months, 
at two different conditions: 25 °C/ 65% relative hu midity (RH) and at 40 °C/ 75% RH. 
Physical, chemical and microbiological properties were evaluated in samples from each 
formulation container at the initial time and after 30, 60, 90 and 180 days of storage using 
the following methods: 
2.4.1 Particles morphology  
Morphological characterization was performed using an optical microscope 
(Eclipse E400, Nikon, Tokyo, Japan) equipped with a camera at 40x resolution (Coolpix 
950, Nikon, Tokyo, Japan). 
 
 
Chapter │6  
I. In Vitro and In Vivo evaluation  
______________________________________________________________________________ 
138 
 
2.4.2 pH 
One gram of the formulation was diluted with 3 mL of neutral water and the pH of 
the aqueous mixture was analyzed with a pHmeter (691, Mettler, Greifensee, Switzerland) 
equipped with a glass electrode. The measurements were performed in triplicate for each 
sample. 
2.4.3 Accelerated stability by centrifugation 
Samples (5 g) were centrifuged at 3000 rpm for 30 min (Centrifuge 5804, 
Eppendorf, Hamburg, Germany) in order to assess their stability. 
2.4.4 Color 
Color was evaluated with a colorimeter (CR-400, Konica Minolta, Tokyo, Japan) 
and results were expressed according to the color space CIE 1976 L*a*b*, defined by the 
Comission Internationale de l’Eclairage (CIE). The three coordinates represent the 
lightness of the color (L*), its position between red and green (a*) and its position between 
yellow and blue (b*).  
2.4.5 Rheological analysis 
Apparent viscosity was measured using a Brookfield rotational viscometer 
(Brookfield DV E, Cologne, Germany). Viscosity determinations were performed using a 
spindle number 5, sequentially increasing the values of shear rate in the range 3 - 50 rpm 
to obtain the ascending curve. The procedure was repeated in reverse with progressively 
slower rates (50 - 3 rpm) to obtain the descending curve. Temperature was kept constant 
at 20 ± 0.5 °C and all samples were equilibrated at  room temperature prior to viscosity 
measurement.  
2.4.6 Texture analysis 
The textural analysis was performed in the compression mode using a 
texturometer (Stable Micro Systems TA-XT2i, Godalming, UK), by carrying out a 
penetration test (T=20 °C, penetration distance of 5 mm, test speed of 3 mm/s, probe with 
a diameter of 13 mm, load cell of 5 kg). From the graph force versus distance, the 
maximum force (N) corresponds to the firmness and the negative area (N.mm) 
corresponds to the adhesiveness.  
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2.5 Microbiological analysis 
At time 0, 30, 60, 90 and 180 days, batches were evaluated for microbiological 
quality. Dilutions were performed with buffered peptone sterile solution and 3% w/v of 
polysorbate 80 was added to culture media to neutralize the preservative. A total colony 
count was performed using Tryptic soy agar (Oxoid Ltd, Hampshire, UK). Incubation was 
carried out during 5 days at 30-35 °C. For yeast an d molds counting, sabouraud agar 
(bioMérieux, France) was used and incubation was carried out during 5 days at 25 °C. 
Additionally at time 0 and at time 180 days the preservative stability was tested according 
to the ISO 11930:2012 procedures. 
 
 
2.6 Antioxidant activity 
2.6.1 Determination of total phenolic content (TPC) 
Total phenolic content (TPC) was spectrophotometrically determined according to 
the Folin-Ciocalteu procedure [185] with minor modifications. Briefly, 500 µL of formulation 
with proper dilution were mixed with 2.5 mL of Folin-Ciocalteu reagent (10 x dilutions) and 
allowed to react for 5 min. Then, 2.5 mL of Na2CO3 7.5% (w/v) solution was added and 
allowed to stand for 15 min at  45 °C, and then 30 min at room temperature, following the 
absorbance of the reaction mixture determined at 765 nm using a microplate reader 
(Synergy HT, BioTek Instruments, Inc., Winooski, VT, USA). A calibration curve for the 
standard gallic acid was used to obtain a correlation between sample absorbance and 
standard concentration (linearity range = 5-100 µg/ml, r2>0.998). The TPC of both 
formulations were expressed as mg of gallic acid equivalents per gram of formulation. The 
assay was done in triplicate. 
2.6.2 Determination of antioxidant activity 
The antioxidant activity of the samples was evaluated by DPPH radical-scavenging 
activity. DPPH is known as a stable free radical which possesses a characteristic 
maximum absorption between 515 and 517 nm. In the presence of antioxidant 
compounds, the DPPH• is reduced to the corresponding hydrazine when reacts with 
hydrogen donors, such as an antioxidant, and lower absorbance values of the reactive 
mixture indicate higher free radical scavenging activity. This method is an essential tool to 
access the antioxidant potential, more specifically, the antiradical activity of formulations. 
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The reaction mixture on 96 wells plate consisted of one solution per well for different 
sample concentrations (30 µL) and ethanolic solution (270 µL) containing DPPH radicals 
(6 x 10-5 mol/L). The mixture was left to stand for 30 min in the dark. The reduction of the 
DPPH radical was determined by measuring the absorption at 517 nm [188] using the 
microplate reader. The antioxidant capacity based on the DPPH free radical scavenging 
ability of the formulation was expressed as µmol Trolox equivalents per gram of 
formulation. The formulations were dissolved in isopropanol: DMSO (50:50) thorough 
shaking as in some cases interferences were observed due to non-transparent solutions 
that impair this photometric assay. A calibration curve was prepared with Trolox (linearity 
range: 2.5-100 µg/mL, r2>0.996). 
 
2.7 Statistical analysis 
Data were reported as mean ± standard deviation of at least triplicate experiments. 
Statistical analysis of the results was performed with SPSS 22.0 (SPSS Inc., Chicago, IL, 
USA). One-way ANOVA was used to investigate the differences between different 
formulations for all assays. Post hoc comparisons were performed according to Tukey’s 
HSD test. In all cases, p<0.05 was accepted as denoting significance. 
 
3. Results 
3.1 Keratinocytes and fibroblasts cytotoxicity assay 
The effects of both formulations on the growth of keratinocyte (HaCaT) and 
fibroblast (HFF-1) cells were investigated by MTS and LDH assays.  
3.1.1 MTS assay 
Both formulations were added to HaCaT and HFF-1 cells to analyze their effects 
on cell viability. Experiments were carried out up in three different concentration of the 
final formulations: 1, 5 and 10 mg/mL. Figure 6.1 summarizes the results obtained in 
HaCaT and HFF-1 cells for both formulations at the same concentration. 
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Figure 6.1 - Effect of exposure to BC and CS formulations on the viability of HaCaT and HFF-1 cells at 
different concentrations, as measured by the MTS assay. Values are expressed as means ± SD (n = 6). 
*p<0.05. 
3.1.2 LDH assay 
In this study, potential cytotoxic effects of both formulations were investigated by 
examining membrane integrity of HaCaT and HFF-1 cells using a LDH release assay. In 
HaCaT cells, at all concentrations tested, BC and CS formulation did not originate any 
effects on the LDH leakage following 24 h incubation, which means that these 
formulations are potentially safe to HaCaT cells. The evidence of possible absence of 
cytotoxicity of these formulations was tested at three different concentrations, namely, 1, 5 
and 10 mg/mL. 
Test on cytotoxicity of both formulations on fibroblasts was conducted at the same 
concentrations. Also, no significant LDH-increase was observed, indicating the absence of 
cytotoxicity of these formulations on human fibroblasts. 
 
3.2 Long term stability study 
The extracts used were produced from underutilized sources and processed by 
previously optimized technologies [20, 22, 101]. Physical and chemical stability tests 
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included measurements of pH, color, and precipitation during the storage period. These 
characteristics were observed at 25 ± 2 °C/ 65 ± 5%  RH and at 40 ± 2 °C/ 70 ± 5% RH for 
180 days of storage. The chemical and physical properties of both formulations are shown 
in Table 6.1. The organoleptic characteristics were also evaluated. 
It is possible to observe that the addition of coffee silverskin extract to the 
formulations did not caused decreases in their pH values. The pH values showed minimal 
changes (< pH 1) within ranges for the storage conditions.  
The accelerated stability centrifugation test (Table 6.1) is of major interest since it 
provides fast information about comparable stability properties. No phase separation after 
centrifugation was seen in the tested formulations kept at 25 ± 2 °C/ 65 ± 5% RH neither 
at 40 ± 2 °C/ 70 ± 5% RH,  during the entire period  of study, which means that both 
formulations (with and without extract) are stable.  
Firmness and adhesiveness of both formulations along storage time are also 
summarized in Table 6.1. Along time a decrease of firmness is observed, for both 
formulations at 40 °C, with statistical differences . The same occurs for adhesiveness.  
Regarding the organoleptic characteristics of the formulations, it was observed that 
the addition of the extract confers to the formulation a characteristic appearance, color 
and smell. 
Optical microscopy pictures showed the classical appearance of emulsions, a 
dispersion of spherical droplets (Figure 6.2). As it is possible to visualize, the CS 
formulation present a higher amount of spherical droplets, which are constituted by the 
incorporated extract. In the case of BC, 180 days of storage at 40 °C led to an increase in 
droplets amount. For CS formulation the opposite occurs, as it is possible to observe a 
decrease in the amount of droplets. 
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Table 6.1 - Physical and chemical characteristics of formulations at time 0 and 180 days under different storage conditions. * means a statistical difference (p<0.05). 
 
Physical and chemical 
characteristics 
Formulations 
BC CS 
25 °C / 65% RH 40 °C / 75% RH 25 °C / 65% RH 40 °C / 75% RH 
Time (days) 0 180 0 180 0 180 0 180 
pH 5.44 ± 0.02 4.81 ± 0.05 5.44 ± 0.02 5.31 ± 0.02 5.82 ± 0.01 5.75 ± 0.00 5.82 ± 0.01 5.67 ± 0.01 
Precipitate 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Firmness (N) 0.36 ± 0.01 0.30 ± 0.00 0.36 ± 0.01 0.08 ± 0.00* 0.18 ± 0.01 0.07 ± 0.00* 0.18 ± 0.01 0.08 ± 0.00* 
Adhesiveness (N.mm) -1.66 ± 0.20* -0.86 ± 0.04 -1.66 ± 0.20* -0.30 ± 0.02 -0.83 ± 0.05* -0.35 ± 0.01 -0.83 ± 0.05* -0.32 ± 0.01 
 
Values are means ± SD (n=3). 
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Figure 6.2 - Microphotographs of the BC (A) and the CS formulations (B) at time 0 and after 180 days of 
storage at different conditions - 40 x magnification. 
 
Color changes of the formulations from the stability study are summarized in Table 
6.2.  
Table 6.2 - Color variation during the stability test conducted at 25 °C/ 65% RH and 40 °C/ 75% RH for  BC 
and CS formulation. * means a statistical difference (p<0.05). 
 
 
Formulation Time 
(days) 
Temperature 
(°C) 
L* a* b* 
BC 
0 25 77.98 ± 0.07 -6.11 ± 0.01 3.89 ± 0.01 
180 25 82.56 ± 0.01 -1.08 ± 0.01* -1.86 ± 0.01* 
40 76.93 ± 0.08 -1.68 ± 0.00* -1.86 ± 0.02* 
CS 0 25 80.75 ± 0.03 -5.85 ± 0.03 9.83 ± 0.01 
180 25 81.21 ± 0.01 -0.87 ± 0.02* 4.86 ± 0.02* 
40 80.45 ± 0.02 -1.73 ± 0.01* 4.22 ± 0.01* 
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The CS formulation hadn’t significantly lower lightness after 180 days (p>0.05). A 
reduction of the green color (a*) and the yellow color (b*) were detected with time.  
Both samples presented a rheofluidificant or shear thinning behavior, since 
apparent viscosity decreased with increasing shear rate (Figure 6.3).  
A  
B 
Figure 6.3 - Comparison of the rheograms of both formulations evaluated initially (A) and after 6 months of 
storage (B) at 25 °C/ 65% RH and 40 °C/ 75% RH. 
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The BC formulation shows an increase in the hysteresis area, which means that 
the thixotropy of this formulation increased with time (the apparent viscosity decreased 
with time after 180 days of storage). The CS cream also showed thixotropy, which is a 
beneficial characteristic of formulations for skin application.  
Microbiological quality was analyzed at time 0, 30, 60, 90 and 180 days after 
storage. The total colony count was < 10/g for all formulations and < 100/g for mould and 
yeast which did not revealed signs of microbial contamination, being an indicator of the 
use of a proper preservative system. Also, challenge test results at time 0 and after 180 
days of storage at different temperatures showed the efficacy of the preservative system 
used as no grows was observed and the product was classified as class A for all the 
tested microorganisms. 
 
3.3 Antioxidative properties 
Table 6.3 shows the TPC for all formulations. As it is possible to observe, the TPC 
of CS formulation is slightly higher than those of the normal one, although there were a 
considerable decrease of the TPC after 180 days of storage. The TPC of the CS 
formulation at time 0 (polyphenols: 2163.11 µg/mL) was significantly higher (p<0.05) 
compared to those of the BC (polyphenols: 1132.84 µg/mL). The same occurs after 180 
days. 
Table 6.3 – Total polyphenol content (TPC) and DPPH assay of BC and CS formulations at time 0 and after 
180 days of storage at 25 °C/ 65% RH and 40 °C/ 75%  RH. Different letters (a, b, c) in the same column 
indicate significant differences between mean values (p<0.05). 
 
Formulation Time (days) Temperature (°C) 
Antioxidant activity 
TPC 
(µg GAE eq./mL) 
DPPH 
(µmol Trolox eq./g) 
BC 
0 - 1132.84 ± 1.64a 1722.47 ± 178.44a 
180 25 45.90 ± 1.68b 1417.66 ± 143.11b 
180 40 114.41 ± 4.27c 1458.12 ± 189.45b 
CS 
0 - 2163.11 ± 2.15a 1896.03 ± 177.13a 
180 25 439.37 ± 18.98b 2036.23 ± 128.86b 
180 40 285.33 ± 6.55c 1296.25 ± 55.16c 
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4. Discussion 
Skin is a shield protecting us from harmful exposure to solar ultraviolet (UV) 
radiation and air pollutants, being continually exposed to the oxidative injury caused by 
free radicals [94]. The topical use of antioxidant can protect and possibly correct oxidative 
skin damage by neutralizing free radicals [338]. Indeed, is necessary to use an 
appropriate vehicle and excipients in order to obtain good formulation stability and the 
maintenance of the antioxidant activity. An oil-in-water emulsion was developed taking in 
account the consumer acceptance and the final scale-up process.  
The main concept and novelty of the present study is the sustainable use of new 
compounds as active ingredients. Skin and pulp represent almost 45% w/w of the whole 
fruit [6]. According to the International Coffee Organization (ICO), in 2014, the world 
coffee production has been around 141620 million bags of 60 kg, which means that about 
3,823,74 x 107 kg of these wastes were produced [8]. In this way, the re-use of these 
wastes has a considerable impact in the environment all over the world. Also, there are an 
increase number of reports in the literature related to the use of plant extracts 
incorporated into topical bases but none of them explore the use of wastes in cosmetics 
[339-340]. Thus, it is of extremely importance for the cosmetic industry the demonstration 
of the potentially of new active compounds obtained from food waste. 
According to the obtained results, none of the formulations, at any tested 
concentration, exhibited cytotoxicity against HaCaT cells (Figure 6.3).  Also, no statistic 
differences were observed between the tested concentrations and both formulations 
(p<0.05). The number of viable fibroblast cells was similar at all concentration for both 
formulations. These cell lines are regarded as suitable in vitro models for testing the 
toxicity potential of substances or products intended for dermatological use [239-240, 
242]. According to the results obtained for MTS and LDH assays, it is possible to conclude 
that both formulations presented low toxicity potential toward both cell lines. Considering 
the results obtained by Rodrigues et al. regarding the cytotoxicity of coffee silverskin 
against these cell lines, it was not expected any effect [22]. However the final formulation 
has new excipients that should be taken in consideration and the final effect in these cell 
lines should be evaluated. Regarding the incorporation of food by-products in topical 
formulations, very few studies were done in this field [321]. For the best of our knowledge 
this is the first study that evaluates the cytotoxicity of a final formulation against 
keratinocytes and fibroblasts.  
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It was observed that the pH of formulations was stable until the period of 180 days 
in all storage conditions evaluated. Skin pH values range from 5.0 to 6.0 and a pH of 5.5 
is considered to be the average pH of the skin. Although pH values changed slightly and 
are low, they stabilized during this period. Also, all formulations showed stable 
organoleptic characteristics during the time and conditions of storage (data not shown). 
Regarding color, comparing with the BC, CS formulation had similar lightness, however, 
as the extract color varies between green and brown, the final formulation had different 
redness. When coffee silverskin extract undergo aging, sugar and amino acid elements 
produce melanoidin, a dark-colored substance that is responsible for the color of the 
extract [341-342].  
The ability of the CS formulation to scavenge DPPH radicals was significantly 
higher than that of the base formulation (p<0.05), as shown in Table 6.3. When coffee 
silverskin extract was added to the formulation, its anti-radical efficiencies were increased. 
However, after 180 days of storage at 40 °C/ 75% RH  its anti-radical efficiencies 
considerably decrease for values below BC. This fact could be justified by the high 
temperature and humidity that leads to the destruction of antioxidant compounds [343-
345]. The TPC and DPPH assay have been widely used to determine the free radical 
scavenging activity of various plants and pure compounds, including coffee silverskin 
extract [22, 101]. The formulation of a suitable base for antioxidants is challenging due to 
their recognized instability in aqueous systems and sometimes extracts loss their 
functionality after incorporation into a base. As so, is very important to evaluate the 
antioxidant content after storage. Chlorogenic and caffeic acid are the main free phenols 
present in coffee silverskin that contribute for TPC [15]. However, according to Borrelli et 
al., the concentration of free phenolic compounds is much lower than that detectable in 
roasted beans which is justified with the higher temperature experienced by the outer 
layer of the beans during roasting, that causes fast degradation of phenol compounds 
[15]. Furthermore, melanoidins formed during roasting are rich in phenolic groups [346]. 
This high amount of antioxidant and polyphenols could be used in aging defence. 
According to Darvin et al., the utilization of a balanced mixture of antioxidants can 
substantially decrease the oxidative activity of free radicals generated in cosmetic 
formulations, providing an excellent protection against oxidation, but also the optimal 
antioxidative protection of the skin against free radicals [347].  
The stability of antioxidant formulations has been subject of various studies [336, 
338, 348-351], but few of them evaluated the use of food by-products extracts [321]. Our 
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results are in agreement with Balboa et al. who evaluated the inclusion of different by-
products extracts in different preparations and concluded that in comparison to synthetic 
antioxidants, the extracts used could be added at higher levels due to their non-toxic 
characteristics, showing strong antioxidant activity and concomitant bioactivities [321].  
 
5. Conclusion 
In this work, the physical, chemical and microbiological stability of a semisolid 
formulation containing coffee silverskin extract, a food by-product, was proven. This study 
concluded that a formulation containing 2.5% coffee silverskin extract retained physical 
stability and also had high anti-radical efficiencies. Accelerated stress conditions did not 
promoted modifications in the tested formulation, suggesting that any specific storage 
conditions should be recommended. Moreover, it is possible to suggest that this 
formulation may be safe against keratinocytes and fibroblasts. Nevertheless, the results 
must be interpreted carefully and further in vivo studies are needed in order to evaluate 
the in vivo antioxidant efficacy of formulations containing coffee silverskin extract. 
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1. Introduction 
A new tendency in cosmetic formulations is the use of ingredients with antioxidant, 
immunomodulatory or photoprotective purposes, obtained from food by-products or 
natural products without added value, taking in account questions of sustainability [22-23, 
99, 101]. Millions of tons of by-products are produced during food processing in agro 
industries without economic value but potentially recoverable as source of new ingredients 
for the cosmetic and pharmaceutical industries. An example is Coffee Silverskin (CS), a 
waste of coffee roasting industry [22]. CS is a thin closely skin that covers the coffee 
beans. Some of the properties described for coffee brews, due to the presence of several 
classes of health related chemicals (as phenolic compounds, diterpenes, xanthines, and 
vitamin precursors), namely  antimicrobial and antioxidant properties [283-285], are also 
present in CS extracts, as described by different authors [20, 22, 102]. Also, previous 
studies reported the skin compatibility and safety of CS extracts. Evaluation of CS extracts 
with in vitro skin and ocular irritation assays, using reconstructed human epidermis, 
EpiSkinTM, and human corneal epithelial model, SkinEthicTM HCE, respectively, were 
performed by Rodrigues et al. [102]. An in vivo assay was also described by the same 
research group aiming to guarantee the extract safety. The in vitro results demonstrated 
that extracts were not classified as irritants and the histological analyses proved that both 
models structure were not affected after exposures. The in vivo test carried out with the 
most promising extract (hydroalcoholic) showed that, with respect to irritant effects, it can 
be regarded as safe for topical application. 
Another product intensively studied is Medicago sativa (MS), used as spout in food 
salads or as forage for livestock. Recent reports, demonstrated that this plant is a 
potential source of natural compounds with antioxidant activity, low cytotoxicity for skin 
cells and ability to potentially prevent skin microbial infections [101]. It isoflavones content 
is also relatively high when compared to other food wastes [23].  
Nowadays, research in cosmetics aims to create innovative and well accepted 
products to perfectly come up to the sensory expectations of consumers [352]. Indeed, 
consumers generally choose a cosmetic cream for its functions, or its promise of 
efficiency, but are mostly seduced by the pleasure it brings to them, especially what 
concerns texture. The number of studies to found a correlation between instrumental and 
sensory properties of cosmetic products still remains limited and most of them only 
highlight a basic proportionality between sensory and instrumental parameters [353]. 
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Thus, it seems very important to incorporate both extracts in a topical formulation and 
evaluate not only the in vitro toxicity, but also the in vivo efficacy and safety. Some studies 
showed that antioxidants could maintain or restore a healthy skin barrier [86]. Based on 
these considerations, the dermatological effects of a body cream formulation containing 
CS and MS extracts was herein evaluated in order to improve skin conditions and to 
promote healthy skin. The efficacy perception by volunteers was also considered. The in 
vitro effect of the final formulations against keratinocytes and fibroblasts was also 
assessed. As stability is one of the main concerns regarding topical formulation, a stability 
study was carried out under different climatic conditions. Finally, considering that the 
natural ingredients under study can present antioxidant and hydrating effect, this research 
contributed to a better understanding of its effects on human skin when applied topically. 
Also, this study demonstrated the skin compatibility (by primary skin irritation) and efficacy 
of cosmetic formulations supplemented with both extracts.  
 
2. Materials and Methods 
2.1 Materials 
CS samples were provided by a national coffee roaster company (BICAFÉ – 
Torrefação e Comércio de Café Lda, Portugal). Medicago sativa was sown and collected 
in Azurara, Vila do Conde, Portugal.  
Sodium lauryl sulfate (SLS; purity > 99%), 1,1-diphenyl-2-picrylhydrazyl (DPPH·) 
free radical, Folin-Ciocalteu’s reagent and gallic acid were purchased from Sigma–Aldrich 
Chemical (St Quentin Fallavier, France). Deionised water was obtained using Mili-Q water 
purification system (TGI Pure Water Systems, USA). Ethanol was obtained from Panreac 
(Barcelona, Spain).  
Sodium carbonate decahydrate was purchased from Merck (Darmstadt, Germany). 
Dulbecco’s modified Eagle’s medium (DMEM) with GlutaMAXTM-I, fetal bovine serum 
(FBS), streptomycin, penicillin and amphotericin B were from Invitrogen (Carlsbad, CA, 
USA). 3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-4-sulfophenyl)-2H-
tetrazolium (MTS) assay kit (CellTiter 96® Aqueous One Solution Cell Proliferation Assay) 
was purchased from Promega (Madison, WI, USA). Lactate dehydrogenase (LDH) 
colorimetric cytotoxicity assay kit (LDH Cytotoxicity Detection Kit) was purchased from 
Takara Bio Inc. (Shiga, Japan).  
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2.2 Preparation of extracts 
MS leaves were randomly selected, dried at 65 °C du ring 72 h and stored, 
protected from light and moisture, at room temperature until the milling process [101]. CS 
and MS were milled to particle size of approximately 0.1 mm using a A11 basic analysis 
mill (IKA Wearke, Staufen, Germany) and stored in silicone tubes at room temperature 
until extract preparation, as described by different authors [22, 101]. Samples (1 g) were 
submitted to solvent extraction by maceration with ethanol: water (1:1, v/v) for 30 min at 
40 °C.  Extracts obtained were filtered through Wha tman No. 1 paper filter and the filtrates 
collected [22].  
 
2.3 Formulation  
A body cream formulation (F) was developed and supplemented with both extracts 
(CSMS), as described in Table 1. 
Briefly, the oil and water phase were separately heated up to 75 ± 1 °C. W/O 
emulsions were prepared by adding the aqueous phase to the oily phase under 
continuous stirring by the mechanical mixer for 15 min until the aqueous phase was added 
completely. Then, the mixer speed was reduced for a period of 10 min for complete 
homogenization until the emulsion cooled to room temperature. At this temperature the 
extract were added to the CSMS formulation. In case of base reference sample (galenic 
base) no extract was added. 
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Table 6.4 - Components of both formulations under study. 
 
Components Function 
Percentage of components in 
each formulation (w/w) 
F CSMS 
Purified water Solvent 73.1 70.6 
Paraffinum liquidum Emollient 6.8 6.8 
Decyl Oleate Emollient 5.0 5.0 
Dimethicone Skin conditioner 4.0 4.0 
Glycerin Humectant 3.8 3.8 
Polyglyceryl-3 
Methylglucose 
Distearate 
Emulsifier 
2.2 2.2 
Glyceryl Stearate Emulsifier 1.5 1.5 
Medicago sativa 
hydroalcoholic extract 
Moisturizer / Antioxidant 
- 1.25 
Coffee Silverskin 
hydroalcoholic extract 
Moisturizer / Antioxidant 
- 1.25 
Cetearyl alcohol Viscosity controller 0.8 0.8 
Lanolin Emollient 0.7 0.7 
2-Phenoxyethanol /2-
Methyl-2H-isothiazol-
3-one 
 
Preservative 
0.6 0.6 
Panthenol Skin conditioner 0.5 0.5 
Carbomer Rheology Modifier 0.3 0.3 
Lactic acid Humectant 0.3 0.3 
Parfum Fragrance 0.2 0.2 
Titanium dioxide Opacifier 0.1 0.1 
Triethanolamine Buffer 0.1 0.1 
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2.4 Long-term stability evaluation 
Batches of both formulations (F and CSMS) were prepared and physical stability 
evaluated by submitting formulations to storage, for a period of 180 days, at two different 
conditions: 25 °C/ 65% relative humidity (RH) and 4 0 °C/ 75% RH [354-355]. Physical, 
chemical and microbiological properties were evaluated in formulations packaged in a 
suitable container at the initial time and after 30, 60, 90 and 180 days of storage using the 
following methods: 
2.4.1 pH 
One gram of the formulation was diluted with 3 mL of neutral water and the pH of 
the aqueous mixture was analyzed with a pHmeter (691, Mettler, Greifensee, Switzerland) 
equipped with a glass electrode. The measurements were performed in triplicate for each 
sample. 
2.4.2 Accelerated stability by centrifugation 
Samples (5 g) were centrifuged at 3000 rpm for 30 min (centrifuge 5804, 
Eppendorf, Hamburg, Germany), and the eventual phase separation was analysed in 
order to assess their stability. 
2.4.3 Color 
Color was evaluated with a colorimeter (CR-400, Konica Minolta, Tokyo, Japan) 
and results were expressed according to the color space CIE 1976 L*a*b*, defined by the 
Comission Internationale de l’Eclairage (CIE). The three coordinates represent the 
lightness of the color (L*), its position between red and green (a*) and its position between 
yellow and blue (b*).  
2.4.4 Rheological analysis 
Apparent viscosity was measured using a Brookfield rotational viscometer 
(Brookfield DVE, Cologne, Germany). Viscosity determinations were performed using a 
spindle number 5, sequentially increasing and decreasing values of shear rate in the 
range 3-50 rpm in order to obtain the ascending and descending curves. Temperature 
was kept constant at 20.0 ± 0.5 °C and all samples were maintained at room temperature 
prior to viscosity measurements.  
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2.4.5 Microbiological analysis 
At time 0, 30, 60, 90 and 180 days, batches were evaluated for microbiological 
quality. Dilutions were performed with buffered peptone sterile solution and 3% (w/v) of 
polysorbate 80 was added to the culture media to neutralize the preservative. A total 
colony count was performed using Tryptic soy agar (Oxoid Ltd, Hampshire, UK). 
Incubation was carried out during 5 days at 30-35 °C. For yeast and molds counting, 
Sabouraud agar (bioMérieux, France) was used and incubation was carried out during 5 
days at 25 °C. Additionally at time 0 and at time 1 80 days the preservative stability was 
tested according to the ISO 11930:2012 procedures. 
 
2.4.6 Determination of total phenolic content (TPC) 
Total phenolic content (TPC) was spectrophotometrically determined according to 
the Folin-Ciocalteu procedure [86] with minor modifications. Briefly, 500 µL of formulation 
with proper dilution was mixed with 2.5 mL of Folin-Ciocalteu reagent (10 x dilutions) and 
allowed to react for 5 min. Then, 2.5 mL of Na2CO3 7.5% (w/v) solution was added and 
allowed to stand for 15 min at  45 °C, and then 30 min at room temperature. After that the 
absorbance of the reaction mixture was determined at 765 nm using a microplate reader 
(Synergy HT, BioTek Instruments, Inc., Winooski, VT, USA). A calibration curve for the 
standard gallic acid was used to obtain a correlation between sample absorbance and 
standard concentration (linearity range = 5-100 µg/ml, r2>0.998). The TPC of formulation 
was expressed as mg of gallic acid equivalents per gram of formulation. The assay was 
performed in triplicate. 
 
2.4.7 Determination of antioxidant activity 
The antioxidant activity of the samples was evaluated by DPPH radical-scavenging 
activity. The reaction mixture on 96 wells plate consisted of one solution per well for 
different sample concentrations (30 µL) and ethanolic solution (270 µL) containing DPPH 
radicals (6 x 10-5 mol/L). The mixture was left to stand for 30 min in the dark. The 
reduction of the DPPH radical was determined by measuring the absorption at 517 nm 
[101] using the microplate reader. The antioxidant capacity based on the DPPH free 
radical scavenging ability of the formulation was expressed as µmol Trolox equivalents 
per gram of formulation. The formulations were dissolved in isopropanol: DMSO (50:50) 
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through shaking as in some cases interferences were observed due to opalescent 
solutions that impair this photometric assay. A calibration curve was prepared with Trolox 
(linearity range: 2.5-100 µg/mL, r2>0.996). 
 
2.5 In vitro evaluation 
2.5.1 Keratinocytes and fibroblasts cytotoxicity assays 
Two different assays were used to assess cell integrity and cytotoxicity of the final 
cosmetic formulation: (1) monitoring the uptake of the vital mitochondrial dye, 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) 
by cell mitochondria and (2) determining the leakage of the cytosolic enzyme, lactate 
dehydrogenase (LDH) into the cell medium (LDH assay). For the cell treatment emulsions 
were diluted in water and Dulbecco’s Modified Eagle’s Medium (DMEM). Emulsions were 
prepared in a range of concentrations from 1 to 10 mg/ml. In both tests, triplicate wells 
were incubated with fresh medium in the absence or presence of formulation. Formulation 
was exposed to keratinocytes (HaCaT) and fibroblasts (HFF-1) cells during 24 h. 
2.5.2 Cell Lines and culture conditions 
Human immortalized non-tumorigenic keratinocyte cell line HaCaT (Ethnicity, 
Caucasian; Age, 62 years; gender, Male and tissue, skin) was supplied by CLS Cell Lines 
Service, Germany. Human foreskin fibroblasts (HFF-1) were purchased from ATCC 
(ATCC Number: SCRC-1041; ATCC, Manassas, VA, USA). Passage 17-19 of HFF-1 and 
passage 77-79 of HaCaT cells were used for both MTS and LDH assay. HaCaT  and 
HFF-1 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) with 
GlutaMAX™-I, 10% inactivated fetal calf serum (FBS), 100 U/mL penicillin and 100 µg/mL 
streptomycin, and 0.25 µg/mL amphotericin B, pH 7.4 and maintained in a O2 :CO2 (95:5 
v/v) environment at 37 °C. At 90-95% confluence, bo th cell types were trypsinized and 
plated in microtiter dishes. The viable cells were counted using trypan blue dye (Gibco) in 
hemocytometer. After attachment, they were incubated in serum-free medium containing 
1 mg/mL, 5 mg/mL and 10 mg/mL of emulsion for 24 h at 37 °C.  
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2.5.3 MTS assay 
Cell viability was assessed using a commercially available kit based on the 
bioreduction of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium (MTS) by metabolically active cells (CellTiter 96® Aqueous One Solution 
Cell Proliferation Assay, Promega, Madison, WI, USA), further referred to as MTS assay. 
The MTS assay was performed according to the manufacturer instructions. MTS assay 
was used to assess cell damage by formulation.  
Cells were cultured in 96-well micro titter plate at a density of 25 x 103 cells per mL 
culture medium for 24 h. The cells were incubated with 1 mg/mL - 10 mg/mL formulation 
for 24 h at 37 °C. After the removal of formulation  from the wells, cells were washed in 
phosphate buffered saline. Then the medium was changed to fresh control medium. The 
cells were then incubated in a humidified atmosphere of 5% CO2 at 37 °C for 24 h. To 
evaluate the number of viable cells, 120 µl of MTS solution was added into each well and 
incubated for 4 h at 37 °C in the dark. The absorba nce was measured at 490 nm with 
background subtraction at 630 nm by a Synergy HT Microplate Reader (BioTek 
Instruments, Inc., Winooski, VT, USA). 
 
2.5.4 LDH assay 
Briefly, cell lines were seeded in 96-well plates (5,000 cells for LDH) and cultured 
for 48 h. Formulation at different concentrations were prepared in appropriate medium and 
added to the cells. Media without FBS were used in the case of LDH. After incubation (37 
°C / 5% CO 2), cells were washed twice with PBS (pH 7.4) and the kits were used 
according to the instructions of the manufacturers. To determine maximum LDH release 
(high control), some cells were solubilised with a final concentration of 1% (w/v) Triton X-
100 (Boehringer Mannheim). Spontaneous LDH release (low control) was determined by 
incubating formulation with DMEM-gent. Absorbance was measured at 490 nm with 
background subtraction at 690 nm by a Synergy HT Microplate Reader (BioTek 
Instruments, Inc., Winooski, VT, USA). Each concentration was tested in triplicate in three 
independent experiments. 
Results were expressed as: 
% Cytotoxicity = [(Experimental value-Low control/High control-Low control) x 100] 
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2.6 In vivo skin irritation 
2.6.1 Patch test 
In order to evaluate the in vivo skin irritation a single blinded study was performed. 
Twenty healthy individuals (15 women and 5 men) with a mean age of 30 ± 5 years, 
without known dermatological diseases or allergy to substances in topical products, 
participated in the study, in accordance with Declaration of Helsinki. Written informed 
consent was obtained from all volunteers. The volunteers were asked to not apply any 
topical products in the forearms 24 h before the beginning and throughout the test period. 
Additionally, solar exposure was forbidden. Along with formulation, SLS (2%, w/v, 
aqueous solution) and purified water were also assayed, respectively, as positive and 
negative control. Sites were marked in the inner forearms of volunteers. Before application 
of patch tests, the areas on the ventral part of each forearm were marked using a skin 
marker, and basal values were obtained by non-invasive biometric method. After basal 
measurements, the patches were applied. A pre-determined amount of formulation (300 
mg), and controls were applied on skin and occlusion was achieved with aluminium 
chambers (12 mm, Finn Chambers, SmartPractice, Phoenix, USA). Patches were 
removed after 48 h of occlusion, and following a period of 2 h of observation patch test 
areas were evaluated by non-invasive measuring methods and visual scoring.  
 
2.6.2 Visual and instrumental assessments  
The visual assessment of the degree of irritation was graded according to the 
following scale, previously used by Agner et al.: 0 - no reaction; 1 - weak, spotty 
erythema; 2 - well perceptible erythema covering the total exposure area; 3 - moderate 
erythema or severe erythema that covers the total exposure area.  The same scale was 
used for edema: 0 - no reaction; 1 - weak, spotty edema; 2 - well perceptible edema 
covering the total exposure area; 3 - moderate or severe edema that covers the total 
exposure area [318]. 
Non-invasive biophysical measurements were also performed. All measurements 
were performed at controlled temperature (20-22°C) and relative humidity (45-55%). 
Transepidermal water loss (TEWL) is traditionally used to assess skin barrier function 
[319]. TEWL measurements were carried out with a Tewameter® TM 210 (Courage & 
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Khazaka, Köln, Germany), evaluating the relative humidity percentage which diffuses from 
the dermis to the skin surface (g/cm2 h).  
 
2.6.3 Long term hydratation effect  
The same volunteers were asked to apply once a day the body cream formulation. 
After 30 days of use, the skin hydratation was evaluated, for both formulations. All 
measurements were performed on forearms. Volunteers acclimatized for at least 30 
minutes under standard atmospheric conditions previously reported. Skin hydratation 
levels were measured using a Corneometer CM 825 (Courage & Khazaka, Köln, 
Germany) according to European Group for Efficacy Measurements on Cosmetics and 
Other Topical Products (EEMCO) guidelines [356]. Three measurements at least were 
taken per area.  
 
2.6.4 Sensory evaluation 
Thirty days after the beginning of the study volunteers were asked to answer a 
questionnaire about the formulation, in order to have information about their sense and 
perception concerning the cosmetic qualities (appearance, texture, smell, spreadability, 
penetration rate and overall quality). For the different categories the scale used was very 
pleasant, pleasant, unpleasant and very unpleasant. 
 
2.7 Statistical analysis 
Data were reported as mean ± standard deviation of at least triplicate experiments. 
Statistical analysis of the results was performed with the software SPSS 22.0 (SPSS Inc., 
Chicago, IL, USA). One-way ANOVA was used to investigate the differences between 
different formulations for all assays. Post hoc comparisons were performed according to 
Tukey’s HSD test. In all cases, p<0.05 was accepted as denoting significance. 
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3. Results 
3.1 Stability 
Physical and chemical stability tests included measurements of pH, color and 
phase separation during the storage period. These characteristics were observed at 25 
°C/ 65% RH and at 40 °C/ 75% RH at time 0, 30, 60, 90 and 180 days of storage. Table 
6.5 summarizes the pH values and the behaviour in what concerns phase separation of 
formulations.  
Table 6.5 – Physical characteristics of formulations at time 0 and 180 days under different storage conditions. 
* means a statistical difference (p<0.05). 
 Formulation 
 F CSMS 
Time 
(days) 
25°C  40°C  25°C  40°C  25°C  40 °C  25°C  40 °C  
pH Phase 
separation 
pH Phase 
separation 
0 4.36±0.02 - - 4.87±0.02  
30 4.52±0.02 4.55±0.01 - - 5.26±0.01 5.26±0.01 - - 
60 4.46±0.01 4.34±0.02 - - 5.32±0.01 5.25±0.01 - - 
90 4.67±0.01 4.18±0.01 - - 5.40±0.01 5.24±0.01 - - 
180 4.55±0.01 4.45±0.01 - - 5.35±0.00 5.15±0.01 - - 
 
As it is possible to observe, the pH of formulations did not decrease over time. The 
pH values showed minimal changes (< pH 1) within ranges for the storage conditions. As 
it is possible to observe, the pH of CSMS formulation is higher during all stability study, 
probably due to the presence of both extracts. 
The accelerated stability centrifugation test (Table 6.5) is of major interest since it 
provides fast information about stability properties. No phase separation, after 
centrifugation, was verified in both tested formulations kept at 25 ± 2 °C/ 65 ± 5% RH and 
at  40 ± 2 °C/ 70 ± 5% RH,  during the study, meani ng that both formulations are stable.  
The organoleptic characteristics were also evaluated, showing no significant 
variation during all study, maintaining not only the initial appearance but also color and 
smell. Color changes are summarized in Figure 6.4.  
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A 
 
B 
Figure 6.4 - Color variation during the stability test conducted at 25 °C/ 65% RH and 40 °C/ 75 % RH f or F (A) 
and CSMS (B) formulations. L – lightness, a – red to green, b – yellow to blue. * means a statistical difference 
(p<0.05). 
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As it is possible to observe, both formulations had a significantly lower lightness 
after 30 days of storage at both conditions. However, after 180 days there is no statistical 
difference when compared to 30 days of storage values. A similar reduction color 
parameter a* was detected with time. The color parameter b* did not change significantly 
during 180 days of storage. A possible explanation for this color variation could be the fact 
that extracts undergo aging. CS extract has sugar and amino acid elements that during 
aging originate melanoidin, a dark-colored substance that is responsible for the color of 
the extract [341-342]. Also, slight changes of pH and the evolution of phenolic compounds 
under aging (that suffer chemical oxidation and/or polymerization) could contribute to this 
color changes observed. 
Regarding rheological studies, all the samples presented a rheofluidificant or shear 
thinning behaviour, since apparent viscosity decreased with increasing shear rate (Figure 
6.5). 
 
Figure 6.5 - Rheograms of formulations evaluated initially and after 180 days of storage at 25 °C/ 65%  RH and 
40 °C/ 75% RH (A – Formulation F at 25 °C/ 65% RH; B – Formulation F at 40 °C/ 75% RH; C – CSMS at 25 
°C/ 65% RH; D – CSMS at 40 °C/ 75 % RH).  
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Formulations show an increase in the hysteresis area along the time of storage, at 
both temperatures, which means that the thixotropy increased with time (the apparent 
viscosity decreased with time after 180 days of storage), being a beneficial characteristic 
of formulations for skin application. The viscosity of F is slight low at time 0, but after 180 
days of storage viscosity of both formulations is similar under different conditions.  
Microbiological quality was analyzed at time 0, 30, 60, 90 and 180 days after 
storage. Results did not revealed signs of microbial contamination, being an indicator of 
the use of a proper preservative system. Also, challenge test results at time 0 and after 
180 days of storage at different temperatures showed the efficacy of the preservative 
system used. 
 
3.2 TPC content and antioxidant activity 
The TPC and DPPH values for both formulations at time 0 and after 180 days of 
storage at different temperatures are summarized in Table 6.6. 
Table 6.6 – Total polyphenol content and antioxidant activity of formulations at time 0 and after 180 days of 
storage at 25 °C/ 65% RH and 40 °C / 75 % RH. Diffe rent letters (a, b, c) in the same column indicate 
significant differences between mean values (p<0.05). 
 
Time 
(days) 
Temp. 
(°C) 
Formulations 
F CSMS 
TPC 
(µg GAE eq./mL) 
           DPPH 
(µmol Trolox eq./g) 
TPC 
(µg GAE eq./mL) 
DPPH 
(µmol Trolox eq./g) 
0 - 1979.22±28.58a 216.37±25.77c 4192.95±50.25a 312.85±17.35c 
180 25 1318.83±118.28b 482.48±54.51a 3022.03±231.31b 780.28±60.58a 
180 40 1130.31±112.19c 349.80±34.73b 2918.71±90.42b 470.52±107.25b 
 
The TPC and DPPH assays have been widely used to determine the free radical 
scavenging activity of different plants extracts and pure compounds, including CS and MS 
extracts. For these compounds the TPC determined were about 25 mg GAE/g dry basis 
and 30 mg GAE/g dry basis, respectively, for Medicago sativa and coffee silverskin [22, 
101].  The formulation of a suitable base for antioxidants is challenging due to their 
recognized instability in aqueous systems. Sometimes extracts loss their functionality after 
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incorporation into a base. As so, it is very important to evaluate the antioxidant capacity 
and content after storage. As it is possible to observe, the TPC of both formulations 
decreases significantly after 180 days of storage. For both cases, the TPC at time 0 was 
significantly higher (p<0.05) compared to the values after 180 days, at both temperatures. 
Also, after 180 days of storage there are no statistical differences between storage at 25 
°C / 65% RH or 40 °C / 75% RH. 
Considering antioxidant activity, the ability of the formulation to scavenge DPPH 
radicals was significantly higher after 180 days of storage (p<0.05), as shown in Table 6.6. 
When extracts were added to the formulation, the anti-radical efficiencies were increased. 
This could be observed for both formulations but, particularly, for CSMS formulation, after 
storage at 25 °C. 
The differences in TPC content and antioxidant activity observed between 
formulations could be explained based on the composition of extracts used in CSMS. 
Chlorogenic and caffeic acid are the main free phenols present in CS that contributes for 
TPC. This high amount of antioxidants and polyphenols could be used in aging defence. 
However, according to Borrelli et al., the concentration of free phenolic compounds is 
much lower than that detectable in roasted beans, which is justified with the higher 
temperature experienced by the outer layer of the beans during roasting that causes fast 
degradation of phenol compounds [15]. Furthermore, melanoidins formed during roasting 
are rich in phenolic groups [346]. According to Darvin et al., the utilization of a balanced 
mixture of antioxidants can substantially decrease the oxidative activity of free radicals 
generated in cosmetic formulations, providing an excellent protection against oxidation, 
but also the optimal antioxidative protection of the skin against free radicals [347]. These 
facts could easily explain the polyphenol content observed for CSMS formulation.  
Regarding M. sativa, as previously reported by us, its antioxidant activity could be 
considered high when compared to other food by-products [101]. However, few studies 
were reported regarding their exact composition. Silva et al. reported their rich 
composition in phenolic compounds, fatty acids and volatiles that could justify their high 
antioxidant activity [27]. 
As it is possible to observe, the antioxidant activity increases over 180 days of 
storage, for both temperatures of storage. However, at 25 °C the increase is higher, with 
statiscal differences to 40 °C (p<0.05). This highe r antioxidant activity could be justified by 
reactions between excipients and extracts or even between excipients that generate new 
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compounds with antioxidant activity. Also, new compounds formed could react with 
DPPH. Previously works developed by Rodrigues et al. using coffee silverskin extract 
incorporated into a hand cream showed the same antioxidant profile after 180 days of 
storage, which means that probably the extract originate compounds that react with DPPH 
reagent [100]. 
 
3.3 In vitro toxicity 
The MTS and LDH assays results in keratinocytes and fibroblasts were obtained at 
different concentrations of the final formulations. Table 6.7 summarized cellular viability 
obtained, since the IC50 could not be estimated due to the low cytotoxicity of the 
emulsion. 
Table 6.7 - Effect of body care formulations on viability of HFF and HaCaT cells at different concentrations, 
measured by MTS assay. Values are expressed as means ± SD (n=6). * p<0.05 versus positive control (cells 
exposed to medium). 
 
 
Cell Viability (%) 
Concentration 
(mg/mL) HFF-1 HaCaT 
 
F CSMS F CSMS 
1 133.45 ± 4.83 147.26 ± 5.39 122.46 ± 1.68 136.35 ± 3.63 
5 180.81 ± 8.21 146.19 ± 7.51 118.50 ± 2.79 133.75 ± 4.15 
10 173.47 ± 15.06 129.17 ± 8.21 121.72 ± 4.44 124.69 ± 7.00 
 
According to the obtained results, both formulations did not have significant effect 
on cell viability. These results are in agreement with previously results obtained for MS 
and CS extracts, which were tested against the same cell lines [22, 101].  
The data obtained from both MTS and LDH experiments together suggest that 
formulation are potentially non-toxic to fibroblasts and HaCaT at concentrations from 1 to 
10 mg/mL and can be suitable for cosmetic use. The concentrations used to determine 
their irritation potential was extremely high because lower concentrations did not provide 
expressive results. These cell lines are regarded as suitable in vitro models for testing the 
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toxicity potential of substances or products intended for dermatological use [239-240, 
242]. 
An important indicator of cell damage in oxidative stress is the increase in cell 
membrane permeability. In this study, a potential cytotoxicity effect of the final 
formulations was investigated by examining membrane integrity of HaCaT and HFF-1 
cells using a LDH release assay. In keratinocytes and fibroblasts, at all concentrations 
tested, formulations did not affect LDH leakage following 24 h of incubation, which means 
that formulations are safe on the concentration range studied.  
 
3.4 In vivo evaluation 
Taking in consideration the referred above, an in vivo evaluation of CSMS 
formulation supplemented with extracts was developed. 
 
- Skin compatibility by evaluation of primary skin irritation 
To ensure that a formulation is completely safe, some assays such as patch test 
should be performed. Patch testing after a single application is a widely used procedure to 
evaluate acute irritant reactions in human volunteers. The evaluation of irritancy after 
patch testing was initially based on visual score. Results obtained by visual analysis are 
shown in Figure 6.6. 
According to the Figure 6.6, patch test demonstrated that formulation provoked a 
slight erythema in two volunteers 2 h after the patch test removal. However, when 
statistical analyses were applied regarding negative control, no differences were found. 
Regarding the positive control, it is possible to observe statistical differences when 
comparing negative control and CSMS formulation (p<0.05). 
Regarding edema, only one volunteer showed a slight edema and no statistical 
differences were observed between the formulation developed and the negative control 
(p<0.05).  
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A 
 
B 
Figure 6.6 - Frequency of clinical scores attributed to positive control (PC - SLS), negative control (NC-– 
purified water) and formulation (CSMC) regarding erythema (A) and edema (B) after patch removal. * means a 
significant difference (p<0.05). 
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- Transepidermal water loss variation 
The measurement of transepidermal water loss (TEWL) is traditionally used to 
assess skin barrier function [319, 332]. When skin is damaged, its barrier function is 
impaired resulting in higher water loss. According to Figure 6.7 the formulation did not 
alter the skin barrier function, as TEWL values were not changed, when compared to the 
positive control (p<0.05). No significant differences were observed for TEWL 
measurements, in comparison with purified water, 2 h after patch removal (p<0.05), which 
indicates the absence of barrier disruption. Consequently, formulation could be 
considered as no potentially irritating. 
 
Figure 6.7 - Transepidermal water loss (TEWL) variation from basal values of negative control (NC), positive 
control (PC) and formulation (CSMS). The left boxes represent values at time 0 and the right boxes represent 
values 2 h after patch removal. Outliers are presented as circles. * means a significant difference (p<0.05). 
 
- Long term hydratation effect 
Still, reliable research has shown that adequate hydration of the stratum corneum 
(SC) is an effective method to prevent or treat hypertrophic scars or keloids [357]. The 
decrease of SC hydration can cause the weakening of the skin barrier function. The 
electrical capacitance examination showed that there was significant change in SC 
hydration value before and after 30 days of application of the formulation (p>0.05). After 
30 days of application of body cream, once a day, the skin hydratation was measured and 
compared with day 0. Results were statistically different. At time 0 the hydratation was 
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34.36 ± 3.95 corneometer units, while at time 30 days the value was 49.46 ± 6.16 
corneometer units, for body cream containing the extracts. Regarding formulation F, the 
hydratation was 35.97 ± 3.09 corneometer units and 42.39 ± 3.34 corneometer units, 
respectively, at 0 and 30 days of application.  
The topical hydration increased with the daily applications of the formulation, as 
shown by the slight increase in the values of capacitance in the SC. The results of the 
present study are consistent with the literature data [358-361]. In these studies different 
authors evaluated the occlusive and hydratation properties of different cosmetic 
formulations.  In particular, the results are consistent with those of Wanitphakdeedecha et 
al., who showed that a cream containing 0.1% of mucopolysaccharide polysulphate 
improves the hydration of the face skin after multiple applications during 28 days and of 
the skin of the volar side of the forearm after a single application [361]. 
 
- Sensory evaluation 
The acceptance of personal care products for the consumer often depends on the 
perceived sensory properties during use. Sensory analysis could be defined as the 
examination of a product through the evaluation of the attributes perceptible by the five 
sense organs (organoleptic attributes), such as color, odor, taste, touch, texture and 
noise, allowing the establishment of the organoleptic profile of diverse products, including 
cosmetics [362].  An important advantage of the use of sensorial analysis in the quality 
control of a cosmetic product is that it yields a complex analysis in relation to all sensorial 
attributes that a product could present. The volunteer who participates on the sensorial 
analysis should be able to give information about the fragrance, the sensation, the 
appearance, the consistence, and other features experienced when use such product. 
According to Rose et al. the association of data obtained from sensorial analysis and 
instrumental analysis (especially physicochemical analysis) provides great information 
and a more complete profile of the product [363]. Figure 6.8 shows the average results of 
the hedonic sensory evaluation on a radar plot for the body formulation tested. The 
improvement in the conditions of the application area was apparent from the objective 
epidermic hydratation measurements, on the one hand, and from the subjective judgment, 
on the other hand. The attributes of smell and texture appearance were mostly classified 
as very pleasant, penetration rate and appearance were tried as pleasant. The overall 
quality of the formulation was also considered very pleasant for most volunteers.   
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Figure 6.8 – Radar plot of hedonic sensory evaluation of the body cream formulation from different 
characteristics. 
 
Finally, the results of this work contribute to the knowledge of consumers' 
perception regarding formulations containing food by-products extracts. The use of these 
food by-products extracts in cosmetic products can be indicated in night skin care and in 
dry skin products, as well as in products for consumers living in countries with a cold 
climate as it can form an oily film that has a protective effect on skin [364-365]. 
 
4. Conclusion 
Under the experimental conditions of this work, it is possible to conclude that CS 
and MS extracts, food by-products, influenced the sensory properties of a body care 
formulation.  
The stability studies carried out suggested a shelf-life of about 12 months, 
considering international guidelines. After 180 days of storage at 25 °C / 65% RH and 40 
°C / 75% RH the physical stability remains constant . Also, the antioxidant properties of 
formulation were satisfactory.   
Results of in vitro studies revealed that the body cream formulation containing CS 
and MS extracts is safe in contact with human skin cells, namely, fibroblasts and 
keratinocytes. The in vivo patch test proved that this formulation did not cause skin 
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irritation. Also objective measurements, which are an important tool in clinical efficacy 
studies of these products, were performed. In the clinical studies on human volunteers, 
formulation containing the extracts showed significant improvement effects on skin 
hydratation. The improvement in skin conditions shown by the efficacy studies confirms 
through objective analyses how effective are cosmetic formulations containing these 
extracts when the objective is the skin hydratation and protection.  
In addition, the results contribute to the understanding of cosmetic stability and 
efficacy in formulations containing food by-products, as there are no studies evaluating 
the stability and effects of these wastes when incorporated in topical formulations. 
Finally, due to its good stability and efficacy, this formulation is a real option 
cosmetic product to improve skin conditions. 
 173 
 
 
III. In Vitro and In Vivo Evaluation 
 
The information presented in this chapter section was published in the following 
publication: 
- Francisca Rodrigues, Rita Matias, Marta Ferreira, M. Helena Amaral, M. Beatriz P.P. 
Oliveira, In vitro and in vivo comparative study of cosmetic ingredients Coffee Silverskin 
and hyaluronic acid, Experimental Dermatology, 2016, in press 
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1. Introduction 
Facial wrinkles are one of the major features of aging.  A key wrinkle-prone region 
of concern is the periorbital area, where the first signal of aging usually appear [366]. Over 
the last decades an increasing interest in reduction of aging appearance was observed 
[367]. Also, researchers aim to create innovative and well accepted cosmetics to perfectly 
come up to the sensory expectations of consumers. Traditionally, hyaluronic acid is used 
as a potent anti-wrinkle compound. HyaCare® Filler CL is a new anti-aging ingredient with 
a unique cross-linked polysaccharide made from fermentation-derived hyaluronic acid that 
contributes instantly to the reduction of facial fine lines and wrinkles, as well as increase 
skin elasticity [368]. Also, because of its high water-binding and strong short-term 
moisturization properties, HyaCare® Filler CL supports effectively the hydration of the skin 
[368]. Therefore, it is able to act as topical dermal filler, quickly reducing the appearance 
of wrinkles after application [368]. 
Recently the same purposes were made for caffeine. The topical use of caffeine is 
not a new procedure. It has been used in pharmaceutical and cosmetic preparations for a 
long time on the basis of its many favorable effects on the skin, namely, anti-cellulite and 
anti-aging effects.  According to different authors, extracts from the two most common 
species of coffee directly combat UV damage improving strength, resilience and elasticity 
of facial skin [369]. Coffea arabica seed oil significantly improves collagen and elastin 
production while Coffea robusta has a high concentration of chlorogenic acid (which 
reduces redness associated with excessive sunlight exposure) and caffeine (which limits 
photodamage, decreases skin roughness and wrinkle formation, and reduces the 
appearance of crow’s feet) [369] . However, to the best of our knowledge, any in vivo 
study in human volunteers was performed until now.  
 Nowadays, a new tendency in cosmetic formulations is the use of raw materials 
obtained from food by-products that normally are discarded as waste, with antioxidant, 
immunomodulatory or photoprotective purposes [22-23, 99, 101-102, 321, 370]. The use 
of these ingredients in cosmetic formulations answers to sustainability concerns [22-23, 
99, 101-102]. Millions of tons of by-products are discarded during food processing in agro-
industries, without economic value, but being a potential source of new ingredients for 
several industries, namely cosmetic and pharmaceutical [100]. Coffee Silverskin (CS) is a 
main by-product of the coffee roasting procedure and has no commercial value, being 
normally discarded as waste or used as fertilizer. Recent studies performed on the 
properties of CS reveals its antioxidant potential, huge content in caffeine and low 
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cytotoxicity against keratinocytes and fibroblasts [20, 22]. CS displays a diverse range of 
bioactive secondary metabolites with important antioxidant ability that could prevent free 
radicals deleterious actions. The in vitro irritancy of these extracts in skin and ocular 3-D 
models (validated and under validation by ECVAM) have been performed, according to 
the European Commission guidelines [102]. Rodrigues et al. evaluated the CS extracts 
behavior in in vitro skin and ocular irritation assays, using reconstructed human epidermis, 
EpiSkinTM, and human corneal epithelial model, SkinEthicTM HCE, respectively [102]. An in 
vivo assay was also described by the same research group aiming to guarantee the 
extract safety [102]. The in vitro results demonstrated that the extract was not classified as 
irritant and the histological analyses proved that both models structure were not affected 
after exposure. The in vivo test carried out with the most promising extract 
(hydroalcoholic) showed that, with respect to irritant effects, it can be regarded as safe for 
topical application [102]. Also, other studies showed that some antioxidants acting as 
photoprotectives could maintain or restore a healthy skin barrier [86, 102].  
In this study, a cream containing CS extract (Formulation A) as active ingredient 
was compared to an equal formulation supplemented with 1.5% of HyaCare® Filler CL 
(Formulation B). Based on these considerations, an ex-vivo assay in pig ear skin was 
performed with CS extract in order to quantify the caffeine content that cross the skin 
barrier. Also, an in vitro assay in keratinocytes and fibroblasts was performed with both 
formulations to access their safety in skin cell lines. The dermatological effects (skin 
efficacy and sensorial analysis) of both formulations in order to improve skin anti-wrinkles 
effect and to promote healthy skin were determined.  
 
2. Materials and Methods 
2.1 Materials 
CS samples were provided by Bicafé (BICAFÉ – Torrefação e Comércio de Café 
Lda, Portugal), located in Porto, Portugal. Sabowax AE (Glyceryl Stearate, Ceteareth-20, 
Ceteareth-12, Cetearyl), Sabonal C16-18 (Cetearyl alcohol), Saboderm AB (C12-15 Alkyl 
Benzoate), Cyclopentasiloxane, Glycerol and Hyacare® Filler CL were provided by DS 
Produtos Químicos (Lisbon, Portugal). Methylisothiazolinone and 
Methylchloroisothiazolinone were obtained from Thor (Barcelona, Spain). Dulbecco’s 
modified Eagle’s medium (DMEM) with GlutaMAXTM-I, fetal bovine serum (FBS), 
streptomycin, penicillin, and amphotericin B were from Invitrogen (Carlsbad, CA). MTS 
assay kit (CellTiter 96® Aqueous One Solution Cell Proliferation Assay) was purchased 
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from Promega Co. (Madison, WI). Lactate dehydrogenase (LDH) colorimetric cytotoxicity 
assay kit (LDH Cytotoxicity Detection Kit) was purchased from Takara Bio Inc. (Shiga, 
Japan). Deionized water was obtained using Mili-Q water purification system (TGI Pure 
Water Systems, St Lincoln, NE). 
 
2.2 Coffee silverskin extract preparation 
The CS extract was prepared according to the method described by Rodrigues et 
al. [102]. Briefly, the sample (1 g) was submitted to solvent extraction by maceration with 
20 mL of ethanol: water (1:1, v/v) for 30 min at 40 °C, filtered through Whatman No. 1 
paper filter and collected.   
 
 
2.3 Preparation of formulations 
Two formulations were prepared: the first one with 2.5% of CS extract (Formulation 
A) and another one with 2.5% CS and 1.5% of Hyacare® Filler CL (Formulation B). Briefly, 
Glyceryl Stearate, Ceteareth-20, Ceteareth-12, Cetearyl Alcohol, Cetyl Palmitate, Cetyl 
stearyl alcohol (50/50), Ciclopentasiloxane, Hyacare® Filler CL and C12 - C15 Alkyl 
Benzoate were heated at 70 °C, under magnetic stirr ing. Water and preservatives 
(Methylisothiazolinone and Methylchloroisothiazolinone) were mixed and heated at the 
same temperature. Water phase was slowly added to oil phase with mechanical stirring 
and allowed to reach 30 °C. At this temperature CS extract was added, the mixture 
homogenized and the formulation rested at least 24 h (20 °C). 
 
2.4 In vitro caffeine permeability 
The skin permeation of caffeine from CS was evaluated using a Franz cell 
assembly (9 mm unjacketed Franz Diffusion Cell with 5 mL receptor volume, o-ring joint, 
clear glass, clamp and stir-bar; PermeGear, Inc., USA) and pig ear skin as barrier. The 
donor medium consisted of 0.3 mL CS extract. The actual concentration of caffeine in 
donor was 151 µg/mL. The receptor medium (5 mL) was HEPES buffer in order to 
maintain skin conditions. The available diffusion area between cells was 0.785 cm2. The 
stirring rate and temperature of receptor were kept respectively at 600 rpm and 37 °C. At 
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appropriate intervals, 0.6 mL aliquots of the receptor medium were withdrawn and 
immediately replaced with equal volumes of fresh buffer. The cumulative amount of 
caffeine was determined by UV-VIS spectrophotometry (Jasco V-660 Spectrophotometer, 
USA) at 275 nm. 
 
2.5 In vivo extract hydration effect 
A single blinded study was performed in order to evaluate the in vivo skin hydration 
effect of CS. Twenty healthy individuals (15 women and 5 men) with a mean age of 30 ± 5 
years, without known dermatological diseases or allergy to substances in topical products, 
participated in the study, in accordance with the Declaration of Helsinki. Informed consent 
was obtained from all volunteers. They were asked to not apply any topical products in the 
forearms 24 h before the beginning and throughout the test period. Additionally, solar 
exposure was forbidden. Along with extracts, purified water was also assayed, 
respectively, as negative control. Before application of patch tests, the areas on the 
ventral part of each forearm were marked using a skin marker and basal values of 
hydration were obtained by non-invasive measuring method. The test solutions were 
applied, after basal measures were taken. Fifty microlitres of the test solutions (CS extract 
and the negative control (water )) were applied on a filter paper disc (12 mm, Filter Paper 
Discs, SmartPractice, Phoenix, USA) and occlusion was achieved with aluminium 
chambers patches (12 mm, Finn Chambers, SmartPractice, Phoenix, USA). Patches were 
removed after 48 h of occlusion.  2h after patches removal the levels of skin hydration 
were measured using a Corneometer® CM 825 (Courage & Khasaka, Köln, Germany) 
according to the European Group for Efficacy Measurements on Cosmetics and Other 
Topical Products (EEMCO) guidelines [371]. All measurements were performed at 
controlled temperature (20-22 °C) and relative humi dity (45-55%). Three measurements at 
least were taken per area. 
 
2.6 Formulations cytotoxicity 
To assess cell viability and cytotoxicity of the formulations, two different assays 
were used: (1) monitoring the uptake and metabolism of the vital mitochondrial dye, 3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) by cell mitochondria and (2) determining the leakage of the cytosolic enzyme, 
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lactate dehydrogenase (LDH) into the cell medium (LDH assay). In both tests, triplicate 
wells were incubated with fresh medium in the absence or presence of both formulations 
(1, 5 and 10 mg/mL) dissolved in cell culture medium. The dissolved formulations were 
filtered on 0.45 µm Millex GV filters (Millipore, Nepean, ON, Canada) and exposed to 
keratinocytes (HaCaT) and fibroblasts (HFF-1) cells during 24 h. 
 
2.6.1 Cell lines and culture conditions 
Human immortalized non-tumorigenic keratinocyte cell line HaCaT (ethnicity, 
Caucasian; age, 62 years; gender, male; tissue, skin) was acquired from CLS Cell Lines 
Service, Germany. Human foreskin fibroblasts (HFF-1) were purchased from ATCC 
(ATCC Number: SCRC-1041; ATCC, Manassas, VA, USA). Passage 17-19 of HFF-1 and 
passage 77-79 of HaCaT cells were used for both MTS and LDH assays. HaCaT and 
HFF-1 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) with 
GlutaMAXTM-I (Invitrogen) supplemented with 10% FBS, 100 µg/mL penicillin and 100 
µg/mL streptomycin, and 0.25 µg/mL amphotericin B, and maintained in a 5% CO2 
environment at 37 °C. At 90-95% confluence, both ce ll lines were harvested using trypsin 
(Invitrogen), their viability assessed using the trypan blue dye (Gibco) exclusion assay, 
and re-plated in T75 flasks.  
 
2.6.2 MTS assay 
The MTS assay was performed according to the manufacturer instructions. Briefly, 
cells were cultured in 96-well microtiter plate at a density of 25 × 103 cells per mL culture 
medium for 24 h at 37 °C. Following the removal of medium from the wells, the cells were 
washed with phosphate buffered saline (PBS pH 7.4). After the change of medium it was 
added fresh one with different concentrations of both formulations (1, 5 and 10 mg/mL) 
and cells were incubated at 37 °C for 24 h. After t hat medium was rejected and the 
number of viable cells evaluated by adding the MTS reagent in medium to each well and 
incubating for 4 h at 37 °C. The positive control w as the medium and the negative control 
was Triton X-100. The absorbance was measured at 490 nm with background subtraction 
at 630 nm. Each concentration was tested in triplicate in three independent experiments.  
 
 
Chapter │6  
III. In Vitro and In Vivo Evaluation  
______________________________________________________________________________ 
179 
 
2.6.3 LDH assay 
Lactate dehydrogenase (LDH), a stable cytoplasmic enzyme found in all cells, is 
quickly released to the plasma membrane upon damage. Cell lines were seeded in 96-
well plates (5000 cells for LDH) and cultured for 48 h. Different concentrations of the 
formulations, namely 1, 5 and 10 mg/mL, were prepared in appropriate medium and 
added to the cells. Media without FBS were used in the case of LDH. After incubation (37 
°C/ 5% CO 2), cells were washed twice with PBS and the kit was used according to the 
instructions of the manufacturers. The maximum LDH release (high control) from cells 
was determined using 1% (w/v) Triton X-100 (Boehringer Mannheim). Spontaneous LDH 
release (low control) was determined by incubating the cells with plain medium. 
Absorbance was measured at 490 nm with background subtraction at 690. Each 
concentration was tested in triplicate in three independent experiments. 
 
2.7 Clinical studies 
The present study was conducted in accordance to the principles of the 
Declaration of Helsinki and its amendments and in compliance with independent ethics 
committee requirements. 
2.7.1 Study design 
For each formulation, twenty female volunteers with clearly wrinkles signals, aged 
35 - 55 years (average 42.15 ± 6.28) and skin types II–IV, were randomly enrolled in the 
study, between November 2014 and March 2015. Informed consent was obtained from 
each volunteer. The volunteers' skin wrinkles were classified according to Fitzpatrick 
Wrinkle Scale [372]. Inclusion criteria were as follows: ocular wrinkles, voluntary 
participation and agreement not to use other creams during the study. Exclusion criteria 
were as follows: pregnancy, active skin diseases, atopy, allergic contact dermatitis, cancer 
areas, retinoid therapy, hormonal therapy, current participation in another clinical study, 
ultraviolet light exposure and lack of cooperation. 
Formulations were applied to the face of each volunteer, twice a day, during 28 
days. Before starting the measurements, the subjects stayed during 30 min in a 
temperature and humidity controlled environment (20-22 °C and 45-55%, respectively) for 
acclimatization. Measurements were performed before application (basal values) and 28 
days later (long term effect). 
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2.7.2 Biophysical techniques 
Visual Evaluation (VisioFace Quick) 
In order to guarantee standardized photo documentation a VisioFace Quick® 
machine (Courage & Khasaka, Köln, Germany) was used. The Visioface® digital 
photography imaging system consists of a cabin attached to a high resolution digital 
camera (10 megapixels) and 200 white LED and 400 UV LEDs. The visual evaluation of 
treatment results was carried out by trained professional staff at time 0 and after 28 days 
of study, in order to visualize final aspect effects. 
 
Corneometer® 
Skin hydration was investigated using a Corneometer® CM 825 (Courage & 
Khasaka, Köln, Germany) coupled to a Multi Probe Adapter® MPA 5 (Courage & Khasaka, 
Köln, Germany). Capacitance changes, depending almost solely upon the water content 
in the stratum corneum, are detected and evaluated. Different capacitance changes are 
converted into a digital measured value (arbitrary units), which is proportional to the skin 
humidity [25]. Three measurements were performed in each testing area on the periorbital 
wrinkles. 
 
Cutometer® 
The viscoelastic properties of the skin were investigated with a Cutometer® SEM 
575 (Courage & Khasaka, Köln, Germany). The measuring principle is suction/elongation. 
An optical system detects the decrease in infrared light intensity depending on the 
distance the skin is being sucked into the probe. The strain time-mode was applied in this 
study. A probe with a 2 mm opening was used, and a pressure of 450 mbar was applied in 
order to suck the skin into the probe. Each measurement consisted of five suction cycles 
(3 s of suction followed by 3 s of relaxation) on the corner eye. The parameters Uf 
(maximum deformation during the first cycle), Ur/Ue (neto-elasticity of the skin) and Ur/Uf 
(biological elasticity) were evaluated. 
 
Profilometry (PRIMOS®)  
The profilometric measurements were carried out using the PRIMOS® Premium 
(“Phase Shift Rapid Imaging of Skin”; GfMesstechnik, Germany) method in the area 
around the lateral corner of the eye (crow’s feet area). Three measurements were taken 
on days 0 and 28. Three parameters were evaluated: wrinkle depth, volume of cavities 
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and roughness. To calculate the skin profile and determine the depth of wrinkles, 
PRIMOS® software V5.7, 2010 was used. 
 
2.8 Sensory evaluation 
Twenty eight days after the beginning of the study, volunteers were asked to 
answer a questionnaire about the formulation and sensorial effects, in order to have 
information about their sense and perception concerning the cosmetic qualities and 
efficacy results.  4-option answers were used for the questionnaire evaluation of the 
attributes of penetration rate, color, smell, efficacy and overall quality after application 
(strongly agree, agree, slightly agree and disagree).  
 
2.9 Statistical analysis 
Data were reported as mean ± standard deviation of at least triplicate experiments. 
Statistical analysis of the results was performed with the software SPSS 22.0 (SPSS Inc., 
Chicago, IL, USA). In all cases, p<0.05 was accepted as denoting significance. 
 
3. Results and Discussion 
3.1 In vitro skin permeation  
When a cosmetic product is topically applied, an active agent must be released 
from the carrier (vehicle) and be able to penetrate into the stratum corneum and lower 
layers of the skin [373]. In the particular case of CS extracts, caffeine and other 
phytopharmaceuticals present in the extract are able to carry out pharmacological 
activities, and even the expected activity may be the result of synergic action of several 
compounds acting together.  For cosmetic products, it is important that the active 
compounds stay in the skin, penetrate sufficiently deep but not too deep leading to 
systemic availability [374].  
The caffeine permeation into pig ear skin treated with CS extract was analyzed. 
Franz diffusion cells were used and pig ear skin was selected as model barrier, 
considering it similarity to human skin. Results are presented in Figure 6.9.  
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Figure 6.9 - Permeation of caffeine of CS extract through pig ear skin over 8 hours. Each value represents the 
mean ± SD (n = 3). 
 
After 8 hours, only a very small amount of caffeine crossed the skin, respectively, 
about 20% of the extract content. The delivery of active substances to the skin is not easy, 
since this organ is not organized to favor the absorbance of substances from the external 
environment, but rather to provide a protective barrier [375]. Epidermis is an effective self-
renewing barrier on the surface, largely composed by hyperkeratinized cells, while dermis 
is a deeper layer of metabolically active cells and extracellular matrix. The delivery of 
active components that should address specific physio-pathological conditions, such as 
compounds endowed with anti-aging properties, should be able to efficiently pass these 
compartments. Until the present, and to the best of our knowledge, there is no published 
research works concerning the permeability of CS extracts. 
 
3.2 In vivo extract hydration effect 
The measurement of hydration is a well-established method in dermatology to 
assess the skin effect of a new ingredient. Results of CS on skin are summarized in Table 
6.8.  
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Table 6.8 - Hydration variation from basal values of negative control (NC) and CS extract (CS) at time 0 and 2 
h after patch removal following a 48h occlusion period.  
 
 
Corneometer Units 
 T0 hours T48 hours 
NC 35.98±7.06 36.48±6.58 
CS 35.98±7.07 46.56±7.08* 
 
* means a significant difference (p<0.05). 
 
According to Table 6.8, the extract clearly improves skin hydration after 48 hours 
of a patch test when compared to the negative control used (p<0.05). Probably, this effect 
is due to the well detailed extract composition [22, 102-103]. 
 
3.3 Formulation cytotoxicity 
The effects of both formulations on keratinocyte (HaCaT) and fibroblast (HFF-1) 
cell lines growth were determined by MTS and LDH assays. In the MTS assay both 
formulations were added to HaCaT and HFF-1 cells to analyze their effects on cell viability 
(Table 6.9).  
 
Table 6.9 - Effect on the metabolic activity of HaCaT and HFF-1 cells after exposure to Formulation A and B at 
different concentrations, measured by the MTS assay. Values are expressed as mean ± SD (n=6). 
 
 
Cell Viability (%) 
 
HaCaT HFF-1 
 
1 mg/mL 5 mg/mL 10 mg/mL 1 mg/mL 5 mg/mL 10 mg/mL 
Formulation A 135.05±6.89 124.37±4.09 124.37±7.56 136.40±4.24 127.33±3.77 119.09±8.12 
Formulation B 125.44±3.02 163.75±2.52 152.46±6.29 116.25±4.74 152.39±4.04 153.46±2.70 
 
In this study, potential cytotoxic effects of both formulations were also investigated 
by examining membrane integrity of HaCaT and HFF-1 cells using a LDH release assay. 
In keratinocytes, at all concentrations tested, both formulations did not originate any 
effects on the LDH leakage following 24 h incubation, which means that these 
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formulations are potentially safe. The evidence of possible absence of cytotoxicity was 
tested at three different concentrations (1, 5 and 10 mg/mL). The cytotoxicity test of both 
formulations on fibroblasts was conducted at the same concentrations and also no 
significant LDH-increase was observed, indicating the absence of cytotoxicity of these 
formulations on human fibroblasts. These results are in line with the cytotoxicity of CS 
extract previously evaluated by our research group, that also demonstrated a low toxicity 
against keratinocytes and fibroblasts cells lines [22]. 
 
3.4 In vivo evaluation  
3.4.1 Safety and efficacy studies 
The purpose of this study was to evaluate the safety and cosmetic efficacy of a 
new cosmetic ingredient, namely CS extract, incorporated in a facial cream and compares 
its efficacy with the same formulation containing a well known ingredient with anti-wrinkles 
effect, Hyacare® Filler CL. With the aim to standardize templates, all subjects were asked 
to wash off any make-up before photographic sessions and rest sitting for 15 minutes at 
constant thermal comfort room parameters: temperature (20-22 °C) and relative humidity 
(45-55%). At the end of each photographic session an in vivo 3D photographic 
quantitative evaluation of skin wrinkles was performed. 
Standardized clinical photographs were taken at baseline and after 28 days using 
a Visioface®, in order to obtain standardized images in terms of brightness, image size 
and field of vision. Figure 6.10 and 6.11 are examples of clinical photographs obtained at 
time 0 and after 28 days of application of Formulation A and B, respectively.  
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Figure 6.10 - Illustrative images obtained with the digital photography imaging system Visioface® at time 0 and 
after 28 days of Formulation A application. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.11 - Illustrative images obtained with the digital photography imaging system Visioface® at time 0 and 
after 28 days of Formulation B application. 
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Hydration 
As it is well known, skin hydration is very important for normal cutaneous 
metabolism and to prevent skin alterations and early aging. The skin moisture content was 
measured at time 0 and after 28 days of the study period. Results for both formulations 
are summarized in Table 6.10. 
 
Table 6.10 - Hydration variation from basal values of Formulation A and Formulation B at time 0 and after 28 
days of study.  
 
 
Corneometer Units 
T0 Days T28 Days 
Formulation A 54.74 ± 6.57 65.54 ± 5.67* 
Formulation B 55.76 ± 5.98 62.08 ± 9.20* 
* means a significant difference (p<0.05). 
 
As it is possible to observe the hydration improvement was similar for both creams, 
with statistical differences regarding time 0. No statistical differences were observed 
between Formulations A and B.   
 
Mechanical properties of skin 
The elasticity is one of the basic measurements for all cosmetic products that are 
intended to be claimed as anti-aging. Different parameters from the different portions of 
the measurement curve could be obtained. Table 6.11 summarized the obtained results. 
 
Table 6.11 - Effects of topical application of Formulation A and B on mechanical properties of skin.   
 
 
 Cutometer parameters 
 
Day Uf Ur/Ue Ur/Uf 
Formulation A 
0 0.37±0.09 0.50±0.13 0.23±0.04 
28 0.35±0.06 0.57±0.04* 0.26±0.04* 
Formulation B 0 0.36±0.09 0.48±0.15 0.22±0.04 
28 0.35±0.08 0.58±0.13* 0.26±0.04* 
* means a significant difference (p<0.05). 
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The Cutometer® parameter UF (maximum deformation during the first cycle) gives 
information about the firmness of the skin. Lower amplitude correlates with firmer skin. 
During the application period, UF decreased for Formulation A, from 0.37 mm (SD 0.09) to 
0.35 mm (SD 0.06), and Formulation B, from 0.36 mm (SD 0.09) to 0.35 mm (SD 0.13). 
However, no significant differences (p<0.05) were detected at time 28 days. Therefore, 
the tightening effects on the skin are negligible. Also, it has to be critically remarked that 
the inter-individual differences of this absolute parameter were well-pronounced. In order 
to make valuable statements on effects which influence the viscoelasticity of the skin, 
relative parameter seem to be useful instead of absolute parameters. The relative 
Cutometer® parameter Ur/Ue stands for the neto-elasticity of the skin. The initial values 
were similar for both formulations (Table 6.11). The application period of 28 days lead to 
an increase of Ur/Ue from 0.50 mm (SD 0.13) to 0.57 mm (SD 0.04) for Formulation A and 
from 0.48 mm (SD 0.15) to 0.58 mm (SD 0.13) for Formulation B (Table 6.11). Both 
formulations increased the neto elasticity of the skin to a certain extent with statistically 
differences. Also, there was no difference in effectiveness between the formulations. 
Regarding the Ur/Uf parameter, that allows for biological elasticity, it is also possible to 
observe an increase for both formulations. Formulation A presented an increase from 0.23 
mm (SD 0.04) to 0.26 mm (SD 0.04), while Formulation B had an increase from 0.22 mm 
(SD 0.05) to 0.26 (SD 0.05). Once again, inside both formulations it is possible to observe 
statistical differences at time 28 days. However, no statistical differences were observed 
between Formulations A and B. Using the chosen conditions, it was possible to monitor an 
increase in elasticity on the skin for both formulations. The comparison of Formulation A 
with other formulations containing extracts or even nanoparticles, led us to conclude that 
CS extract present clear effects on skin firmness [351, 376]. 
 
Effect on skin relief 
PRIMOS® is an optical system that produces three-dimensional measurements of 
the skin surface. A pattern consisting of parallel stripes is projected onto the skin surface 
by micro-mirrors contained within a digital projector. The PRIMOS® test was conducted at 
the corner of the eye, for technical reasons, and allows a precise evaluation of depth, 
roughness and volume of a wrinkle. The resulting wrinkle profile enables quick and 
efficient visualization of changes in the analyzed wrinkle [63]. The detailed skin surface 
analyses were carried out and one example is shown in Figure 6.12. The photographs 
obtained with PRIMOS® (Figure 6.12 and Figure 6.13) were also utilized to evaluate 
different parameters: wrinkle depth, volume of cavities and roughness. 
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Figure 6.12 - Photos of periocular area acquired with PRIMOS® equipment of one of the volunteers who 
exhibited reduced depth of wrinkles at time 0 and after 28 days of Formulation A application. (A) Photography. 
(B) Representation of relief in a colored image, where each color corresponds to a height (positive values) or 
depth (negative values) with respect to the reference plane, showing a decrease of wrinkle depth throughout 
the study. 
 
Figure 6.13 - Three-dimensional representation of the periocular area acquired with PRIMOS® equipment of 
one of the volunteers who exhibited reduced depth of wrinkles. 
Chapter │6  
III. In Vitro and In Vivo Evaluation  
______________________________________________________________________________ 
189 
 
Figure 6.12 reveals a gradual refilling of an eye wrinkle during the treatments. As 
shown, the analyzed wrinkle depth decreased from 206 µm to 179 µm after an application 
period of 28 days of Formulation A. However, no statistical differences were observed 
considering all volunteers. Also, between Formulation A and Formulation B no differences 
were observed. The volume of the wrinkle did not change after 28 days of treatment, but a 
slight decrease could be observed, with no statistical differences (Figure 6.14). Also, 
results revealed that older volunteers presented a clear improvement of wrinkles depth, 
unlike the younger volunteers, where it was possible to observe a decrease not 
significant. The percent of changes in the values for volunteers were calculated and 
summarized in Figures 6.14, 6.15 and 6.16. 
 
 
 
Figure 6.14 - Illustrative box plot graphs of the depth values of wrinkles at baseline and 28 days after using the 
test products. (A) Formulation A; (B) Formulation B. 
 
Regarding volume of cavities, it is also possible to observe a slight decrease for 
both formulations, but no statistical differences were observed at time 0 and 28 (Figure 
6.15). 
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Figure 6.15 - Illustrative box plot graphs of volume of cavities at baseline and 28 days after using the test 
products. (A) Formulation A; (B) Formulation B. 
 
Also, for roughness the scenario is the same, with no statistical differences for any 
formulation (Figure 6.16). 
 
 
 
Figure 6.16 - Illustrative box plot graphs of the roughness parameters at baseline and 28 days after using the 
test products. (A) Formulation A; (B) Formulation B. 
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It has to be remarked that the volunteers had middle initial values of roughness, 
wrinkle depth and volume of cavities. Due to the fact that they were 42.15 ± 6.28 years 
old, volunteers probably did not have the so-called ‘aged’ skin. This is supported by the 
fact that older volunteers presented statistical differences between time 0 and 28. Also, a 
longer study period, 56 days for example, could determine statistical differences between 
time 0 and time 56. At this point, it is possible to conclude that there are no statistical 
differences between time 0 and time 28 intra and inter-formulation. 
The results in this report are relevant and confirm observations from other authors, 
showing the efficacy of anti-aging formulations containing antioxidants, such as vitamins 
and flavonoids, and an improvement in skin microrelief, objectively or determined in a 
subjective manner as a perception of efficacy [334, 351, 377-378]. A complete efficacy 
study of cosmetic formulations containing CS and/or other active substances such as 
hyaluronic acid is of fundamental importance in order to obtain conclusive results and as 
an indicator of adequate components to be included in stable and efficient products. 
According to the results obtained in efficacy studies, CS was shown to be an effective 
ingredient, with similar results to hyaluronic acid, in the improvement of skin conditions, 
particularly, skin hydration and firmness. In addition, according to Rodrigues et al. [22, 
102] the extract had a good antioxidant activity and low cytotoxicity in skin cell lines. Also, 
the compound is described as a stable substance in topical formulations, which is very 
important in terms of efficacy [100, 103]. However, these formulations did not improved 
skin microrelief, especially in relation to wrinkle depth, volume of cavities and roughness. 
A possible justification for the lack of results could be the young age of the volunteers. In 
fact, old volunteers presented statistical differences at time 28 in all microrelief 
parameters. Also, a longer study period could probably lead to considerable differences. 
No statement can be made regarding the influence of both test formulations on 
biomechanic skin properties. 
 
Sensorial evaluation 
 
Nowadays, the actual development of cosmetics include sensory analysis to find 
the best formulation for a certain product from a number of candidates. Table 6.12 
summarizes the obtained results in sensorial evaluation. 
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Table 6.12 - Sensory evaluation of both formulations considering different characteristics such as color, smell, 
penetration rate, efficacy and overall quality.  
 
 
Formulation A 
 
Strongly agree Agree Slightly agree Disagree 
I liked this cosmetic product. 94.74 5.26 0.00 0.00 
I liked the cosmetic product color. 94.74 5.26 0.00 0.00 
I liked the cosmetic product smell. 73.68 21.05 5.26 0.00 
The cosmetic product had a good 
penetration rate. 
88.89 5.56 5.56 0.00 
I believe that the cosmetic product was 
effective. 
57.89 26.32 15.79 0.00 
I would like to continue using this cosmetic 
product. 
68.42 21.05 10.53 0.00 
I would buy this cosmetic product. 63.16 26.32 10.53 0.00 
 
Formulation B 
I liked this cosmetic product. 68.75 25.00 6.25 0.00 
I liked the cosmetic product color. 87.50 12.50 0.00 0.00 
I liked the cosmetic product smell. 68.75 31.25 0.00 0.00 
The cosmetic product had a good 
penetration rate. 
68.75 25.00 0.00 6.25 
I believe that the cosmetic product was 
effective. 
75.00 18.75 6.25 0.00 
I would like to continue using this cosmetic 
product. 
50.00 37.50 6.25 6.25 
I would buy this cosmetic product. 50.00 31.25 6.25 12.50 
 
 
Based on responses to the administered questionnaire it was determined that: 
• 58% of trial participants felt that Formulation A was effective at reducing their wrinkles, 
comparing with 75% for Formulation B; 
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• 89% of women felt that the penetration rate of Formulation A was good, comparing with 
69% for Formulation B;  
• 100% of women were likely to recommend Formulation A to a friend, while for 
Formulation B was 94%.  
In a general way it is possible to observe that almost all volunteers appreciated both 
formulations and classified them in a positive way regarding effectiveness and 
characteristics, with no differences. 
 
4. Conclusion 
In vitro permeation studies using Franz diffusion cells demonstrates that CS 
extract permeate into pig ear skin and, therefore, presumably should permeate human 
skin in vivo if incorporated in a cosmetic product. The amount of caffeine that penetrated 
was about 20% after 8 hours.  
Two formulations (supplemented or not with hyaluronic acid) were developed and 
in vitro and in vivo evaluations were performed. The in vitro cytotoxicity assay in 
fibroblasts and keratinocytes demonstrated that both formulations are safe. Also, the in 
vivo efficacy studies on human skin, in twenty volunteers per each formulation, 
demonstrated that both formulations enhanced stratum corneum moisture content when 
compared with the baseline values.  
The viscoelastic-to-elastic ratio after 28 days of application improved for 
Formulation A and B. For both parameters, no differences where found between 
formulations.  
Regarding microrelief, a slightly decrease in wrinkle depth, roughness and volume 
of cavities could be observed after 28 days of study. However, no statistical differences 
were detected. Probably a longer clinical trial with evaluation after 56 days could originate 
a clear decrease in these parameters. These results are similar for both formulations.  
In the sensorial evaluation, all volunteers expressed satisfaction with the product. 
Both formulations were classified as safe and effective, in a consumer perspective. 
In conclusion, it can be stated that there are no differences between coffee 
silverskin extract and the well documented hydration ingredient hyaluronic acid. Also, 
according to CS composition, this could be considered as a new effective ingredient for 
cosmetic purposes. 
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Chapter │7 
Nanoencapsulation of Coffee Silverskin: A 
Future Approach? 
 
The information presented in this chapter was partially published in the following 
publications: 
- Francisca Rodrigues, Ana Catarina Alves, Cláudia Nunes, Bruno Sarmento, M. Helena 
Amaral, Salette Reis, M. Beatriz P.P. Oliveira, Permeation of topically applied caffeine 
from a food by-product in cosmetic formulations: a nanoscale in vitro approach, 
International Journal of Nanomedicine, submitted 
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1. Introduction 
Over the last years increasing research interest has been focused on natural 
compounds and their therapeutic potential. For most topically applied pharmaceuticals 
and cosmetics, permation through the skin barrier is essential for exert their effects [379].  
The use of caffeine in topical application is not a new procedure. It has been used 
in pharmaceutical and cosmetic preparations for a long time on the basis of its many 
favorable effects on the skin, namely, anti-cellulitis and anti-aging effects.  According to 
different authors, extracts from the two most common species of coffee plant directly 
combat UV damage, by improving the strength, resilience and elasticity of facial skin 
[369]. Coffea arabica seed oil significantly improves collagen and elastin production while 
Coffea robusta has a high concentration of chlorogenic acid (which reduces redness 
associated with excessive sunlight exposure) and caffeine (which limits photodamage, 
decreases skin roughness and wrinkle formation, and reduces the appearance of crow’s 
feet) [369]. Also, its high biological activity and ability to penetrate the skin barrier had lead 
to a wide use [309]. Recently, there is also some evidence that dermally applied caffeine 
can protect the skin from cancer caused by sun exposure [380]. Caffeine and its 
derivatives are used in a number of commercial anti-cellulite creams as an additive 
ingredient. However, there are limited direct evidences to support their role in cellulite 
reduction. A number of claims, as anti-cellulite properties, are based on the implicit 
assumption that this bioactive substance is effectively released from the formulation into 
the epidermis and then passes to the dermal and subcutaneous tissues, preventing the 
excessive accumulation of fat in cells, and providing a slimming effect [309-310, 381]. 
According to Herman et al. this alkaloid stimulates the degradation of fats during lipolysis 
through inhibition of the phosphodiesterase activity and has potent antioxidant properties 
[309]. However, studies assessing the skin absorption of caffeine released from extracts 
are extremely rare in the literature. 
In recent years, sustainable approaches have become an essential challenge for 
different industries, particularly cosmetic industry, looking for new active ingredients, 
always taking in account questions of sustainability and green chemistry. Coffee Silverskin 
(CS) is a main by-product of the coffee roasting procedure and has no commercial value, 
being discarded as a solid waste [10]. Some work has been performed on CS properties, 
particularly regarding its antioxidant and caffeine content, cytotoxic effects and isoflavones 
profile [15, 19-20, 22, 102]. According to Bresciani et al. caffeine content in CS is about to 
10 mg/g of product [19]. Recent changes in regulatory requirements and social views on 
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animal testing have incremented the development of reliable alternative tests for 
predicting skin and ocular irritation potential of products based on new raw materials 
[102]. Thus, we evaluated the in vitro and in vivo safety of this new possible cosmetic 
ingredient. An in vitro skin and ocular irritation assay (using reconstructed human 
epidermis, EpiSkinTM, and human corneal epithelial model, SkinEthicTM HCE) and an in 
vivo assay (patch test) were performed with very good results. 
Lipid nanoparticles, namely solid lipid nanoparticles (SLNs) and nanostructured 
lipid carriers (NLCs) are among the popular research topics for the delivery of drugs [382]. 
Overall, lipid nanoparticles present many advantages such as low production costs, easily 
to scale up and additionally low toxicity, since organic solvents are not required for the 
synthesis of these nanoparticles [383]. NLCs represent the second generation of lipid 
nanoparticles and are composed of a blend between solid and liquid lipids which allows 
the formation of an overall amorphous nanostructure with many imperfections within its 
matrix, providing NLCs with higher drug loading capacity and lesser degree of drug 
expulsion during storage comparing with SLNs.  
In order to improve the permeation of caffeine into skin, the incorporation of CS in 
NLCs could be a new approach. The aim of this work intends to evaluate NLCs 
formulations potential for the dermal treatment of different skin conditions, such as aging 
or cellulite, with caffeine obtained from a coffee by-product, comparing with the extract 
directly applied into skin.  
 
2. Materials and Methods 
2.1. Materials 
CS samples were provided by Bicafé (BICAFÉ - Torrefação e Comércio de Café 
Lda, Portugal), located in Porto, Portugal. Precifac® ATO (cetyl palmitate) was a kindly gift 
from Gattefossé (Cedex, France). Miglyol® 812 was obtained from Acofarma (Madrid, 
Spain). Tween® 60 (Polysorbate 60) was purchased from Merck KGaA (Darmstadt, 
Germany). All chemicals and solvents were of analytical grade. Aqueous solutions were 
prepared with double-deionized water (Arium Pro Sartorius AG, Göttingen, Germany, 
conductivity less than 0.1 µS cm-1). 
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2.2. Preparation of coffee silverskin extract 
CS was milled to particle size of approximately 0.1mm using a A11 basic analysis 
mill (IKA Wearke, Staufen, Germany) and stored in silicone tubes at room temperature 
until extraction. Samples of 1 g were subjected to maceration for 30 min at 40 °C with 20 
mL of ethanol: water (1:1). Extracts were filtered through Whatman No. 1 paper filter and 
the filtrate collected. Samples were stored at 4 °C  until analysis [22, 102].  
 
2.3. Preparation of NLCs 
The method for the preparation of nanoparticles was based on hot homogenization 
followed by sonication. Briefly, the excipients (lipids and surfactant) were mixed together 
and kept at a temperature above the lipids melting point (70 °C) to promote their mixture. 
Extract was added to the lipid phase. The primary emulsion was poured in a hot aqueous 
phase to obtain a nanoemulsion with sonication (Vibra-Cell™; Sonics and Materials, Inc, 
Newtown, CT, USA). The sonicator adjustable frequency used was 70% during 20 
minutes, after which was cooled to room temperature, allowing the inner oil phase to 
solidify and forming NLCs dispersed in an aqueous phase.  
To optimize the caffeine association in the NLCs and to determine the best 
concentration of the different excipients in order to obtain a mean size and polydispersity 
index (PDI) of almost 200 nm and below 0.250, respectively, different concentrations of 
excipients were tested. The choice of the best rate was based on the analyses of the size 
and zeta potential. The final composition of the formulations is shown in Table 7.1. 
 
Table 7.1 - Composition of the developed NLCs formulations (NLC - empty formulation; NLC-CS- coffee 
silverskin formulation). 
 
Formulation Code Polysorbate 60 Miglyol 812 Precifac ATO CS Water 
NLC 10 3 7 - 80.0 
NLC-CS  10 3 7 2.5 77.5 
Amounts expressed in g/100 g of formulation. 
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2.4. Determination of association efficiency 
The association efficiency (AE) was determined by quantifying the difference 
between the total amount of caffeine used to prepare the systems and the amount of 
caffeine that remained in the aqueous phase after NLC isolation, determined by HPLC. A 
1:5 dilution of NLC formulations in double-deionized water was subsequently centrifuged 
(HeraeusTM MultifugeTM x 1R Centrifuge, USA) through centrifugal filter units (Amicon® 
Ultra Centrifugal Filters, Ultracel - 50 KDa, Darmstadt, Germany) at 4500 rpm and 20 °C, 
during 45 min or until complete separation between the NLCs retained in the filter unit and 
the aqueous phase corresponding to the filtrate. The filtrate was used to quantify the 
amount of non-incorporated caffeine.  
The HPLC method used in this study to quantify caffeine was based on the work of 
Lemos et al. and Rivelli et al. [316-317]. The chromatographic analysis was performed in 
a HPLC integrated system (Jasco, Japan) equipped with a PU-980 pump and a Jasco AS-
950 automatic sampler with a 20 µL loop. Detection was performed with a Jasco model 
MD-2010 multiwave length diode-array detector (DAD). The column employed was a Luna 
5U C18 (5 µm, 150 mm × 4.60 mm) chromatographic column (Teknokroma, Spain). The 
mobile phase adopted was aqueous metaphosphoric acid solution: acetonitrile (82:18, v/v) 
with a flow rate of 1 mL/min and a column temperature of 23 °C. Caffeine was monitored 
at 275 nm and quantification was performed on the basis of the internal standard method. 
Chromatographic data were analysed using the ChromNAV Software (Jasco, Japan). 
Calibration curves were prepared (0.244 - 750 µg/mL) and analyses carried out in 
duplicate. Confirmation of compounds identities was performed by comparing retention 
times and co-elution with authentic standards and by UV absorption spectra. 
Taking into account the drug initially added to the NLCs formulation and 
subtracting the free caffeine remaining in the filtrate, it was possible to determine the 
amount of drug incorporated in the NLCs and thus the association efficiency by the 
following equation: 
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2.5. Determination of particle size, surface charge and physical stability 
The particle size and PDI were determined by dynamic light scattering (DLS), while 
the zeta potential (surface charge) was evaluated by electrophoretic light scattering (ELS), 
using a ZetaPALS zeta potential analyzer (Brookhaven Instruments Corporation, 
Holtsville, NY, USA). Samples were diluted with Milli-Q-water to suitable concentration to 
determine particle size and PDI at 25 °C. All measu rements were performed in triplicate. 
For each sample, the corresponding mean diameter standard deviation values were 
obtained from six determinations and calculated by the multimodal analysis. 
The zeta potential Smoluchowski mathematical model was used to obtain the 
corresponding measurements of surface charge analysis. For each sample, the 
corresponding mean ± standard deviation values were obtained from six runs of ten 
cycles. For each final formulation, at least three batches were analysed for mean particle 
size, polydispersity and zeta potential as described. 
 
2.6. Morphology 
Cryogenic scanning electron microscopy (cryo-SEM) was performed in all 
dispersions in order to obtain information about particle size, shape and surface 
morphology, at the Materials Centre of the University of Porto, Portugal (CEMUP). A 
1:500 dilution of NLCs in double-deionized water was dropped on a support and rapidly 
frozen in liquid nitrogen. Cryofactures were then performed using an ALTO 2500 (Gatan 
Alto 2500 (Pleasanton, CA, USA), with subsequent sublimation and coating with Au/Pd by 
sputtering for 35 s. The samples were then observed at -150 °C using a JSM 6301F 
microscope (JEOL, Tokyo, Japan). The cryo-SEM was performed at time 0 and after 
stability studies. 
 
2.7. Stability studies 
Stability studies are important for providing evidence on formulation quality during 
time, under influence of different conditions. Parameters such as size, zeta potential and 
AE were measured over 180 days under different conditions (25 °C/ 65% relative humidity 
(RH) and 40 °C/ 75% RH). Particle size determinatio n during time at different conditions 
allows the possibility to observe the aggregation and sedimentation tendency. The particle 
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charge determination is also important to predict stability, since highly charged 
nanoparticles will be more stable, given that the electric repulsion prevents nanoparticle 
aggregation [384]. The NLC characterization (particle size and zeta potential) was done 
on the production day and 30, 60, 90 and 180 days later. The particle size and zeta 
potential were assessed by DLS and electrophoretic light scattering, respectively, as 
previously described. 
In order to evaluate NLC stability, AE was also evaluated after 180 days of 
storage, in all three batches, to analyze possible compounds expulsion from the NLCs, 
according to the methodology previously described.  
 
2.8. Cell viability and toxicity 
2.8.1 Cell lines and culture conditions 
Human immortalized non-tumorigenic keratinocyte cell line (HaCaT) was 
purchased from CLS Cell Lines Service (Eppelheim, Germany). HaCaT cells were 
individually maintained in Dulbecco’s modified Eagle’s medium (DMEM) with GlutaMAXTM-
I (Invitrogen, Grand Island, NY), 10% inactivated fetal calf serum (FBS; Invitrogen), 100 
U/mL penicillin and 100 µG/mL streptomycin (Invitrogen, Grand Island, NY) and 0.25 
µG/mL amphotericin B (Invitrogen, Grand Island, NY), in a 5% CO2 environment at 37 °C. 
The number of viable cells was periodically assessed by the trypan blue exclusion assay. 
2.8.2 Cell viability assay 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) assay was 
used to assess cell integrity and cytotoxicity of NLC and NLC-CS formulations. Cells 
(HaCaT) were seeded in 96-well plates (10x103 cells/well) and incubated with medium for 
24 h (37 °C/ 5% CO 2). HaCaT cells were used at passages 86-88, respectively. Then, 
triplicate wells were incubated with formulations dissolved in cell culture medium pre-
filtered by 0.45 µm Millex GV filters (Millipore, Nepean, ON, Canada) at different 
concentrations. Cells were exposed to formulations for 24 h. Afterwards, MTT assay was 
performed according to manufacturers’ instructions. Briefly, cells were washed twice with 
phosphate buffered saline pH 7.4 (PBS) before being incubated with 120 µL of MTT in 
medium for 3 h (37 °C/ 5% CO 2). The absorbance was measured for each well at 490 nm 
with background subtraction.  
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2.9. In vitro skin permeation study 
The skin permeation of caffeine in CS and NLC-CS was evaluated using Franz 
cells assembly (9 mm unjacketed Franz Diffusion Cell with 5 mL receptor volume, o-ring 
joint, clear glass, clamp and stir-bar; PermeGear, Inc., USA) and pig ear skin as barrier. 
The donor medium consisted of 300 µL of vehicle systems. The actual concentration of 
caffeine in donor was 151 µg/mL and 63 µg/mL, for extract and NLCs, respectively. The 
receptor medium (5 mL) was HEPES buffer in order to maintain sink conditions. The 
available diffusion area between cells was 0.785 cm2. The stirring rate and temperature of 
receptor were respectively kept at 600 rpm and 37 °C. At appropriate intervals, 600 µL 
aliquots of the receptor medium were withdrawn and immediately replaced with equal 
volumes of fresh buffer. The cumulative amount of caffeine was determined by UV-Vis 
spectrophotometry (Jasco V-660 Spectrophotometer, USA) at λ max 275 nm. 
  
2.10. Statistical analysis 
Data were reported as mean ± standard deviation of at least triplicate experiments. 
Statistical analysis of the results was performed with the software SPSS 22.0 (SPSS Inc., 
Chicago, IL, USA). The Student’s t-test (two-tailed) was used to evaluate the statistical 
significance of differences in mean values in the experimental groups. The one-way 
analysis of variance-test was used to assess the differences in means between 
formulations in the in vitro skin permeation. Post hoc comparisons were performed 
according to Tukey’s HSD test. In all cases, p<0.05 was accepted as denoting 
significance. 
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3. Results 
 
3.1 CS-loaded NLCs characterization: particle size, PDI, surface charge and 
morphology 
For the characterization of NLCs, particle size and surface charge (zeta potential) 
were analyzed and the results showed that nanoparticles loaded with extract present a 
mean size and PDI of almost 200 nm and below 0.250, respectively, as desired to achieve 
delivery into the skin. The physicochemical characteristics of NLCs are depicted in Table 
7.2. 
 
Table 7.2 – Characterization of NLC and NLC-CS. 
 
Formulation Particle Size (nm) PDI Zeta Potential (mV) AE (%) 
NLC 178 ± 8 0.182 ± 0.008 -30 ± 3 - 
NLC-CS 183 ± 15 0.19 ± 0.01  -23.9 ± 0.5 33 ± 3 
*p<0.05, Student’s t-test showed mean particle size to be statistically equal between NLC and 
NLC-CS. 
It is possible to observe that after associate CS extract, the mean particle was 
maintained. This indicates that the incorporation of this ingredient does not have a great 
influence on nanoparticles size. The particles present an overall size beneath of 200 nm, 
which should be suitable for a topical administration. In fact, according to Kohli et al., a 
desirable value of particle size for NLCs is established as < 500 nm, in order to permeate 
the skin epithelium [385]. 
The results obtained from zeta potential measurements reveal that the NLCs were 
negatively charged. The zeta potential is an important parameter that allows predictions 
on the physical stability of colloidal dispersions. In theory, higher values of zeta potential, 
either positive or negative, tend to stabilize the suspension and aggregation phenomena 
are less likely to occur for charged particles with pronounced zeta potential (>|30|mV), due 
to the electrostatic repulsion between particles with the same electrical charge [386]. Also, 
the measured slight negative zeta potential is in agreement with literature and result from 
the surface coverage by polysorbate 60, giving them a steric stabilization at the 
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particle/water interface [387-388]. As skin is negatively charged slight interactions can be 
expected [389], as positively charged and neutral particles of all sizes do not penetrate 
[385]. The NLC without extract presented charges around -30 mV at time 0, which 
indicates that the nanoformulations had good physical stability. However, NLC-CS had a 
charge of about -24 mV, indicating some possible instability of the formulation along time. 
AE is another important parameter to characterize nanoparticles. This should be 
high enough to avoid losing compounds during the production and also to avoid the need 
of using a higher concentration of compounds. Percentages obtained on the day of 
production show that about 30% of caffeine was incorporated. Caffeine is a hydrophilic 
compound - a behavior that does not favor the interaction with lipids - which explains 
these results. 
At the time of production, both formulations presented a PDI below 0.20. Mitri et al. 
suggested that polydispersity values below 0.25 reveals homogeneous nanoparticles, with 
minimum predisposition to aggregation [390]. The values obtained also indicate a fairly 
narrow and monomodal particle size distribution. Statistical analysis indicated no 
differences between the polydispersity index of NLC and NLC-CS (p>0.05).  
Morphology of the produced nanoparticles was analyzed by cryo-SEM after 
production and along time (Figure 7.1) in order to obtain more information about the 
particle size and morphology of NLCs.  All formulations exhibited a spherical shape and a 
smooth surface. The sizes of the NLCs observed by cryo-SEM were in the range of 150-
200 nm, with no observable difference being noted between NLC and NLC-CS.  
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Figure 7.1 - NLC and NLC-CS images. Cryo-scanning electron microscopy (cryo-SEM) images at time 0 and 
after 180 days of storage at 25 °C/ 65% RH and 40 ° C/ 75% RH. The scale indicated below the pictures is 2 
µm. Amplification: 30,000 x. 
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3.2 Stability studies 
To evaluate the stability of the formulations in study, particle size and surface 
charge, were measured over 15, 30, 60, 90 and 180 days of storage at different 
conditions, according to the ICH Guidelines [355]. Also, the AE over 180 days of stability 
was measured. 
 
Particle size 
Table 7.3 shows the mean particle size of NLC and NLC-CS evaluated at different 
times over 180 days of storage. 
 
Table 7.3 - Storage stability. Effect of time of storage at 25 °C/ 65% RH and 40 °C/ 75% RH on particle  size of 
NLC and NLC-CS. All data represent the mean ± standard deviation (n = 4). Different letters (a,b,c,d) indicate 
significant differences between mean values during storage (p<0.05). 
 
 Particle Size 
 NCL NCL-CS 
 
25 °C/  65% RH 40 °C/  75% RH 25 °C/  65% RH 40 °C/  75% RH 
0 Days 178 ± 8b,c 178 ± 8a,b 183 ± 15a 183 ± 15a 
15 Days 189 ± 8c 181 ± 8a 182 ± 14a 182 ± 11a 
30 Days 186.6 ± 13c 185 ± 9a 183 ± 7a 182 ± 7a 
60 Days 185.4 ± 12 c 179 ± 11a,b 171 ± 12a,b 172 ± 7a 
90 Days 160.6 ± 0.9a,b 154.8 ± 0.9c 148 ± 6b 148 ± 6b 
180 Days 155 ± 7a 157.9 ± 0.9b,c 150 ± 17a,b 148 ± 8b 
 
 
The results show that mean particle size decrease slowly over the observation 
period for both formulations (both loaded and unloaded), with sizes in the range of 155 to 
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178 nm for NLC, and 148 to 183 nm for NLC-CS. However, no statistical differences were 
observed between both stability conditions inside the same formulation, meaning that 
temperature did not affect particle size. The mean sizes of all formulations were, over 180 
days, almost 200 nm as desired for dermal application.  
 
Zeta potential 
Regarding the determination of the zeta potential, results are summarized in Table 
7.4. 
 
Table 7.4 - Storage stability. Effect of time of storage at 25 °C/ 65% RH and 40 °C/ 75% RH on zeta pote ntial 
of NLC and NLC-CS. All data represent the mean ± standard deviation (n = 4). Different letters (a,b,c,d) 
indicate significant differences between mean values during storage (p<0.05).  
 
 Zeta Potential 
 NCL NCL-CS 
 25 °C/  65% RH 40 °C/  75%RH 25 °C/  65% RH 40 °C/  75%RH 
0 Days 
-30 ± 3a -30 ± 3a -23.9 ± 0.5a -23.9 ± 0.5a 
15 Days -21 ± 2b -21.5 ± 0.3b,c -22 ± 3a,b -22 ± 5a,b 
30 Days -24 ± 2a,b -16 ± 3d -20 ± 4a,b,c -21.25 ± 3.73a,b 
60 Days -23 ± 2a,b -19 ± 1b,c,d -18.2 ± 0.3b,c -19.5 ± 0.4b 
90 Days -22.1 ± 0.3a,b -24 ± 4b -17 ± 4bc -12 ± 2c 
180 Days  -17.6 ± 0.2b -16.9 ± 0.6c,d -15 ± 3c -17.6 ± 0.6b 
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It is possible to observe that these values were always negative, but a clear 
decrease is observed for both formulations. Once again, the storage temperature did not 
influence these results. Both formulations presented zeta-potential values between -12 
and -30 mV during storage period at both conditions, which predicts some long-term 
instability.  
 
Association efficiency 
The AE of a delivery system such as NLCs is one of the most important features to 
be controlled since will give us information about the percentage of caffeine from CS that 
was associated to the lipid and produced the NLC-CS. AE is defined as the percentage of 
compound incorporated into the lipid nanoparticles relative to the total compound added. 
In the present study, the AE was evaluated immediately after production and after 180 
days of storage at different temperatures and relative humidity. 
Table 7.5 shows the results of the NLC-CS association efficiency at time 0 and 
over 180 days of investigation.  
Table 7.5 - Association efficiency (%) into NLC-CS with time under different storage conditions. Values are 
mean of three assays. Within each formulation along the time, data were not statistically different, for p<0.05. 
 
Association Efficiency (%) 
0 Days 33.20 ± 3.11 
180 Days / 25 °C 65% RH 34.24 ± 0.48 
180 Days / 40 °C 75% RH 33.90 ± 2.58 
 
 
The amount of caffeine present in the NLCs after the storage period was identical 
to the values determined with fresh produced formulation. The percentages of AE were 
relatively low, at time 0 and after 180 days of storage, with no statistical differences, 
meaning that the caffeine association did not change throughout storage time. Regarding 
association efficiency, values are low, but relatively high, considering that this extract is 
hydrophilic. 
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With regard to CS entrapped in NLCs, a good chemical stability of all formulations 
was observed, i.e. the percentage of active ingredient remaining within the systems was 
equal when stored at 25 °C/ 65% RH and 40 °C/ 75% R H during 180 days. The results 
suggest that caffeine from CS is a stable molecule and did not degrade easily at studied 
temperatures.  
3.3 Cell viability studies 
Different concerns have been raised regarding the potential toxicity of NLCs. In 
vitro models have been shown useful in providing important guidance towards the 
understanding of the toxicity potential of different compounds and drug vehicles intended 
for cosmetic preparations. To understand the role of different concentration of NLC and 
NLC-CS formulations in terms of cytotoxicity, the cell viability in human keratinocytes was 
investigated. As it is well documented, the cytotoxicity of NLC might be influenced by both 
the nature of the lipid-core material used as well as by the surfactant. However, the 
specific contribution of these components is difficult to extrapolate from the literature due 
to the lack of reports dealing with the comparison of NLC formulations. Figure 7.2 
summarizes the cytotoxicity results.  
 
Figure 7.2 – Effect of exposure of NLC and NLC-CS with different concentrations of caffeine (CAF) on the 
metabolic activity of HaCaT cells. Cell viability was determined by the MTT assay. Each value represents the 
mean ± SD (n = 3). 
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Cell viability for NLC-CS was 85.9 %, 10.8 % and 3.9 %, respectively, to 0.1, 1.0 
and 10.0 µg CAF/mL. For NLC results were similar. Cell viability decreases with 
increasing nanoparticles concentration of caffeine, which indicates a concentration 
depending effect. For the lower studied concentration cell viability was not affected. 
However, the high concentration tested indicates a significant cell viability decrease for 
NLC-CS and NLC. No difference was observed between formulations with or without 
caffeine. The results indicate that both formulations have cell viability decrease in high 
concentrations, probably due to nanoparticles composition and not CS. These results are 
consistent with cytotoxicity tests previously reported for these CS extract [22, 102]. 
 
3.4 In vitro permeation study 
When synthetic or natural compounds are applied topically on the skin, an active 
agent must be released from the carrier (vehicle) and be able to penetrate into the stratum 
corneum and lower layers of the skin [373]. In the particular case of CS extracts, caffeine 
and other phytochemicals present are able to carry out pharmacological activities, and 
even the expected activity may be the result of synergic action of several compounds 
acting together.  For cosmetic products, it is important that the active compounds stay in 
the skin, penetrate sufficiently deep but not too deep leading to systemic availability [374]. 
Indeed, penetration should be sufficient to lead to a cosmetic but not a pharmaceutic 
effect.  
According to Muller et al., considering their submicron-size and pearl-like nature, 
NLCs could be a promising help for penetration of some compounds in certain layers of 
the skin [374, 391]. Caffeine, as it is well known, is a hydrophilic compound. However, as 
we are using a natural extract with a caffeine content of about one-third of coffee beans, 
the incorporation into NLCs could guarantee that huge amounts are delivered into fat 
cells. The caffeine permeation into pig ear skin treated with CS extract and NLC-CS was 
analyzed. The extract not encapsulated was also evaluated in order to compare the skin 
permeation. Franz diffusion cells were used and pig ear skin was selected as model 
barrier, considering it similarity to human skin. Results are presented in Figure 7.3.  
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Figure 7.3 - Permeation of caffeine of NLC-CS and CS extract through pig ear skin over 8 hours. Each value 
represents the mean ± SD (n = 3).  
 
Under the experimental conditions, the release profile of caffeine from NLC was 
almost found in the first eight hours of study. Probably this is due to the high hydrophilicity 
of caffeine. The data show an improved permeation of caffeine from NLC-CS when 
compared to CS extract.  After 8 hours, a small quantity of caffeine crossed the skin, 
respectively, about 20% for extract and 25% for NLC-CS. A possible way to promote 
permeation is the application of permeation enhancers. It has been demonstrated that 
ethanol can enhance skin permeation of drugs when simultaneously applied with 
compounds [392-393]. Ethanol seems to be an effective carrier of caffeine topically-
applied, penetrating the tissue model. However, the permeation enhancing effect of 
ethanol on the permeation of caffeine appears to be rapidly attenuated, by evaporation or 
dissipation into the skin, or perhaps as ethanol changes the hydration state. Nevertheless, 
it should always be considered that caffeine is a hydrophilic compound.   
The caffeine permeation was assessed by UV/VIS. A possible justification for 
some variability in the results could be due to the fact that the skin used for experiments 
was from different ears and pigs, which introduces variance. However, to decrease the 
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analytical error, in vivo studies should be performed in future experiments to circumvent 
practical problems of in vitro permeation experiments such as complete dehydration of the 
porcine ear skin samples with longer residence times. 
Also, it should be considered that the delivery of active substances to the skin is 
not easy, since this organ is not optimized to favor the absorbance of substances from the 
external environment, but rather, to provide a protective barrier [375]. Epidermis is an 
effective self-renewing barrier on the surface, largely composed of hyperkeratinized cells, 
while dermis is a deeper layer of metabolically active cells and extracellular matrix. The 
delivery of active components that should address specific physio-pathological conditions, 
such as compounds endowed with anti-cellulite properties, should be able to efficiently 
pass these compartments. Nanolipid carriers could represent an effective strategy to 
maximize this delivery. Until the present date, and to the best of our knowledge, there are 
no published research works concerning the use of CS extracts encapsulated in NLCs. 
 
4. Conclusion 
Through this work, it was possible to successfully produce NLCs loaded with CS 
extracts, rich in caffeine, which possess characteristics that would render them as a 
promising alternative for the topical treatment of cellulite. Nanostructured lipid carriers 
were prepared by a double emulsion. Furthermore, previous in vivo studies indicate safety 
of the extracts for topical application as well as for final cosmetic formulations.  The 
produced NLCs had acceptable dimensions (<200 nm), accompanied by high absolute 
zeta potential levels, low values of PDI and relatively high values of association efficiency 
for hydrophilic compounds, with a spherical shape and smooth surface in terms of 
morphology at time of production. The formulations stability was also confirmed after 
storage during 180 days at different temperatures and relative humidities. 
The in vitro evaluation of compound release from the produced NLCs in a 
simulated physiological environment revealed a biphasic compound release profile, 
characterized by a quick initial phase release followed by a phase with prolonged release 
until 8 h. Evaluation of the in vitro skin permeation of caffeine in CS extracts showed its 
capability to go through the skin barrier when loaded within nanoparticles.  
Overall, the results of the present work confirm some potential of NLCs as carriers 
for caffeine from CS extracts and their feasibility for topical delivery.  
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"Apesar das ruínas e da morte,  
Onde sempre acabou cada ilusão,  
A força dos meus sonhos é tão forte,  
Que de tudo renasce a exaltação  
E nunca as minhas mãos ficam vazias. " 
 
Sophia de Mello Breyner Andresen 
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The importance of new active ingredients for cosmetics obtained from sustainable 
sources, such as food by-products, gained a new breath in the last years. This is a result 
of the important advances in the field of food by-products and the common sense of 
sustainability from industries and consumers, which, in turn, allowed the development of 
new and improved cosmetic ingredients. Also, new insights on the understanding of 
extracts composition and mechanics boosted the development of innovative ingredients 
obtained with eco-friendly solvents and adapted for the challenges imposed by the new 
formulations. Still, the development of efficient and safe formulations to topical delivery of 
ingredients obtained from food by-products imposes numerous challenges. 
In this thesis it was pursued to achieve formulations for topical administration of 
new cosmetic ingredients, based on food by-products. Two food by-products, CS and M. 
sativa, were initially selected to be characterized, owing to huge amounts disposable in 
the region behind the enterprise Fourmag.  
In a first step both wastes were evaluated with different sustainable solvents and 
temperatures in order to obtain extracts with a cosmetic profile. From the different 
conditions tested, the combination of water and ethanol mixed in equal proportions, and 
temperature of 40 °C, were selected to produce extr acts with an interesting composition. 
Both were characterized regarding antioxidant, flavonoid and polyphenol content, 
antimicrobial activity and cytotoxicity against different skin cell lines (keratinocytes and 
fibroblasts). Medicago extracts from different species were also evaluated and compared 
regarding isoflavones composition. Results showed that these food wastes are rich in 
antioxidant and polyphenols, presenting antimicrobial activity and low cytotoxicity against 
skin cell lines. Also, M. sativa extracts were founded as good source of isoflavones. 
Interestingly, the content of caffeine in CS extracts was in the same concentration range 
of the caffeine of coffee beans.  
According to the European Community guidelines, that had banned the animal 
tests, skin and ocular irritation potential of CS extracts were evaluated in 3D models, 
using reconstructed human epidermis, EpiSkinTM, and human corneal epithelial model, 
SkinEthicTM HCE. EpiSkinTM was validated by ECVAM and SkinEthicTM HCE is under 
validation. The histology of the models after extracts applications was analysed. The in 
vitro results demonstrated that extracts were not classified as irritants and the histological 
analysis proved that they did not affect both models structure. The content of caffeine, 
HMF and CGA was quantified after the epidermal assay. The in vivo patch test carried out 
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with the most promising extract (hydroalcoholic) showed that, with respect to irritant 
effects, these extracts can be regarded as safe for topical application. The hydratation 
effect of CS extract on skin was also improved after 48 hours of a patch test.  
Different cosmetic formulations (with and without extracts) were developed and 
characterized considering different parameters such as viscosity, pH and color. The 
formulations were a facial cream, a body cream, a body scrub, a hand cream and a 
shower gel. In vitro toxicity was screened in two skin cell lines (fibroblasts and 
keratinocytes) for all formulations and any toxicity was reported. 
Regarding stability, all formulstions were stored at 25 ºC and 40 ºC for 6 months 
and the pH, color, viscosity and antioxidant activity were analyzed over time. No 
significant differences on the formulation characteristics were observed up to six months. 
Additionally, the antioxidant activity was maintained. 
Besides characterization and toxicological relevance of extracts and formulations 
were guaranteed by in vitro model systems, the study of the effective biologic potential 
required a minimum amount of in vivo experiments. Thus, in vivo effects of formulations 
were assessed in volunteers. A facial formulation with CS (Formulation A) and the same 
cream enriched with hyaluronic acid (Formulation B) were compared. Formulations were 
applied twice a day by volunteers (n=20 for each formulation) during 28 days. The 
influence on skin hydration and viscoelastic properties were investigated with validated 
devices (Corneometer® and Cutometer®). Wrinkles depth, roughness, volume of cavities 
and Visioface® images were analysed at time 0 and after 28 days. Volunteers were asked 
about efficacy perception. Both formulations significantly improved the skin hydration and 
viscoelastic parameters. However, no differences were observed regarding wrinkles 
depth, roughness and volume of cavities for both formulations. CS represents an effective 
ingredient for cosmetic creams which are intended to increase skin hydration and 
firmness. 
Regarding body cream, it can be classified as safe for topical application and the 
skin hydratation improved after 30 days of application. Also, considering the consumer 
acceptance, more than 90% of volunteers classified it as very pleasant.  
The development of these new formulations with active ingredients obtained from 
food by-products provided a further insight on cosmetic industry, benefiting from the huge 
amounts of these products without added value and providing new potential applications 
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for these wastes. However, in research, there is always another experiment to be done. At 
this point, the performed work may be a good contribution to the food by-products and 
cosmetic fields.  
Finally, as a new perspective, NLCs were developed and characterized with CS in 
order to observe if the amount of caffeine that crosses the skin was higher or not. 
Additionally, in vitro release studies using Franz cells with pig ear skin were performed. 
The produced NLCs were within the nanosized range (≈200 nm) with relatively low 
polydispersity index (<0.25) and zeta potential values around - 30 mV. Also, NLCs 
demonstrated storage stability at 25 °C/ 65% RH and  40 °C/ 75% RH up to 180 days. The 
AE was about 30% at time of production and after storage period. Cryo-SEM images 
showed the spherical shape of the empty and caffeine-loaded NLCs. The in vitro skin 
permeation study demonstrated that caffeine loaded into NLCs was similarly permeable 
through skin compared to non encapsulated caffeine. 
Future works may be extended to encapsulation of extracts and in vivo efficacy 
studies, in order to compare them with the present one. Also, the evaluation of other food 
by-products with interesting composition for the cosmetic industry, such as olive by-
products, should be consider and investigated.  Nevertheless, an interesting field could be 
the isolation of specific ingredients from food by-products using green techniques, such 
as, supercritical fluids, to be re-used. 
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